
<html lang="en"     class="pb-page"  data-request-id="a2cf7bb8-c597-416c-980c-9f7bb435a016"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2012.55.issue-17;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm301022v"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts" /></meta><meta name="dc.Creator" content="Yimin  Qian" /></meta><meta name="dc.Creator" content="Matthew  Hamilton" /></meta><meta name="dc.Creator" content="Achyutharao  Sidduri" /></meta><meta name="dc.Creator" content="Stephen  Gabriel" /></meta><meta name="dc.Creator" content="Yonglin  Ren" /></meta><meta name="dc.Creator" content="Ruoqi  Peng" /></meta><meta name="dc.Creator" content="Rama  Kondru" /></meta><meta name="dc.Creator" content="Arjun  Narayanan" /></meta><meta name="dc.Creator" content="Terry  Truitt" /></meta><meta name="dc.Creator" content="Rachid  Hamid" /></meta><meta name="dc.Creator" content="Yun  Chen" /></meta><meta name="dc.Creator" content="Lin  Zhang" /></meta><meta name="dc.Creator" content="Adrian J.  Fretland" /></meta><meta name="dc.Creator" content="Ruben Alvarez  Sanchez" /></meta><meta name="dc.Creator" content="Kung-Ching  Chang" /></meta><meta name="dc.Creator" content="Matthew  Lucas" /></meta><meta name="dc.Creator" content="Ryan C.  Schoenfeld" /></meta><meta name="dc.Creator" content="Dramane  Laine" /></meta><meta name="dc.Creator" content="Maria E.  Fuentes" /></meta><meta name="dc.Creator" content="Christopher S.  Stevenson" /></meta><meta name="dc.Creator" content="David C.  Budd" /></meta><meta name="dc.Description" content="Lysophosphatidic acid is a class of bioactive phospholipid that mediates most of its biological effects through LPA receptors, of which six isoforms have been identified. The recent results from LP..." /></meta><meta name="Description" content="Lysophosphatidic acid is a class of bioactive phospholipid that mediates most of its biological effects through LPA receptors, of which six isoforms have been identified. The recent results from LP..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 29, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm301022v" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm301022v" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm301022v" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm301022v" /></link>
        
    
    

<title>Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm301022v" /></meta><meta property="og:title" content="Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0017.jpeg" /></meta><meta property="og:description" content="Lysophosphatidic acid is a class of bioactive phospholipid that mediates most of its biological effects through LPA receptors, of which six isoforms have been identified. The recent results from LPA1 knockout mice suggested that blocking LPA1 signaling could provide a potential novel approach for the treatment of idiopathic pulmonary fibrosis. Here, we report the design and synthesis of pyrazole- and triazole-derived carbamates as LPA1-selective and LPA1/3 dual antagonists. In particular, compound 2, the most selective LPA1 antagonist reported, inhibited proliferation and contraction of normal human lung fibroblasts (NHLF) following LPA stimulation. Oral dosing of compound 2 to mice resulted in a dose-dependent reduction of plasma histamine levels in a murine LPA challenge model. Furthermore, we applied our novel antagonists as chemistry probes and investigated the contribution of LPA1/2/3 in mediating the pro-fibrotic responses. Our results suggest LPA1 as the major receptor subtype mediating LPA-induced proliferation and contraction of NHLF." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm301022v"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm301022v">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm301022v&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm301022v&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm301022v&amp;href=/doi/10.1021/jm301022v" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 7920-7939</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm301016m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm3008882" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yimin++Qian">Yimin Qian</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Hamilton">Matthew Hamilton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Achyutharao++Sidduri">Achyutharao Sidduri</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Gabriel">Stephen Gabriel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yonglin++Ren">Yonglin Ren</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruoqi++Peng">Ruoqi Peng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rama++Kondru">Rama Kondru</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Arjun++Narayanan">Arjun Narayanan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry++Truitt">Terry Truitt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rachid++Hamid">Rachid Hamid</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yun++Chen">Yun Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Zhang">Lin Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adrian+J.++Fretland">Adrian J. Fretland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruben+Alvarez++Sanchez">Ruben Alvarez Sanchez</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kung-Ching++Chang">Kung-Ching Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew++Lucas">Matthew Lucas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ryan+C.++Schoenfeld">Ryan C. Schoenfeld</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dramane++Laine">Dramane Laine</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+E.++Fuentes">Maria E. Fuentes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+S.++Stevenson">Christopher S. Stevenson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+C.++Budd">David C. Budd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Discovery Chemistry, <sup>‡</sup>Discovery Inflammation and Respiratory Diseases, <sup>§</sup>Discovery Technology, <sup>∥</sup>Pharmaceutical and Analytical Research, and <sup>⊥</sup>Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug Development, Hoffmann-La Roche, 340 Kingsland Street, Nutley, New Jersey 07110, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (973)235-3240. E-mail: <a href="/cdn-cgi/l/email-protection#6c1505010502421d050d022c1e030f0409420f0301"><span class="__cf_email__" data-cfemail="b2cbdbdfdbdc9cc3dbd3dcf2c0ddd1dad79cd1dddf">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm301022v&amp;href=/doi/10.1021%2Fjm301022v" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 7920–7939</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 15, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>13 July 2012</li><li><span class="item_label"><b>Published</b> online</span>29 August 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 September 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm301022v" title="DOI URL">https://doi.org/10.1021/jm301022v</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7920%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYimin%2BQian%252C%2BMatthew%2BHamilton%252C%2BAchyutharao%2BSidduri%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D17%26contentID%3Djm301022v%26title%3DDiscovery%2Bof%2BHighly%2BSelective%2Band%2BOrally%2BActive%2BLysophosphatidic%2BAcid%2BReceptor-1%2BAntagonists%2Bwith%2BPotent%2BActivity%2Bon%2BHuman%2BLung%2BFibroblasts%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7939%26publicationDate%3DSeptember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm301022v"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3870</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">33</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm301022v" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yimin&quot;,&quot;last_name&quot;:&quot;Qian&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Hamilton&quot;},{&quot;first_name&quot;:&quot;Achyutharao&quot;,&quot;last_name&quot;:&quot;Sidduri&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Gabriel&quot;},{&quot;first_name&quot;:&quot;Yonglin&quot;,&quot;last_name&quot;:&quot;Ren&quot;},{&quot;first_name&quot;:&quot;Ruoqi&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Rama&quot;,&quot;last_name&quot;:&quot;Kondru&quot;},{&quot;first_name&quot;:&quot;Arjun&quot;,&quot;last_name&quot;:&quot;Narayanan&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;Truitt&quot;},{&quot;first_name&quot;:&quot;Rachid&quot;,&quot;last_name&quot;:&quot;Hamid&quot;},{&quot;first_name&quot;:&quot;Yun&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Adrian&quot;,&quot;last_name&quot;:&quot;J. Fretland&quot;},{&quot;first_name&quot;:&quot;Ruben&quot;,&quot;last_name&quot;:&quot;Alvarez Sanchez&quot;},{&quot;first_name&quot;:&quot;Kung-Ching&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;Lucas&quot;},{&quot;first_name&quot;:&quot;Ryan&quot;,&quot;last_name&quot;:&quot;C. Schoenfeld&quot;},{&quot;first_name&quot;:&quot;Dramane&quot;,&quot;last_name&quot;:&quot;Laine&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;E. Fuentes&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;S. Stevenson&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;C. Budd&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;29&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;7920-7939&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm301022v&quot;},&quot;abstract&quot;:&quot;Lysophosphatidic acid is a class of bioactive phospholipid that mediates most of its biological effects through LPA receptors, of which six isoforms have been identified. The recent results from LPA1 knockout mice suggested that blocking LPA1 signaling could provide a potential novel approach for the treatment of idiopathic pulmonary fibrosis. Here, we report the design and synthesis of pyrazole- and triazole-derived carbamates as LPA1-selective and LPA1/3 dual antagonists. In particular, compound 2, the most selective LPA1 antagonist reported, inhibited proliferation and contraction of normal human lung fibroblasts (NHLF) following LPA stimulation. Oral dosing of compound 2 to mice resulted in a dose-dependent reduction of plasma histamine levels in a murine LPA challenge model. Furthermore, we applied our novel antagonists as chemistry probes and investigated the contribution of LPA1/2/3 in mediating the pro-fibrotic responses. Our results suggest LPA1 as the major receptor subtype mediating LPA-induced pro&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301022v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301022v" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301022v&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301022v" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm301022v&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301022v" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm301022v&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm301022v&amp;href=/doi/10.1021/jm301022v" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm301022v" /></input><a href="/doi/pdf/10.1021/jm301022v" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm301022v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm301022v%26sid%3Dliteratum%253Aachs%26pmid%3D22894757%26genre%3Darticle%26aulast%3DQian%26date%3D2012%26atitle%3DDiscovery%2Bof%2BHighly%2BSelective%2Band%2BOrally%2BActive%2BLysophosphatidic%2BAcid%2BReceptor-1%2BAntagonists%2Bwith%2BPotent%2BActivity%2Bon%2BHuman%2BLung%2BFibroblasts%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D17%26spage%3D7920%26epage%3D7939%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291012" title="Organic acids">Organic acids</a>,</li><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291241" title="Phenyls">Phenyls</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jmcmar.2012.55.issue-17/production/jmcmar.2012.55.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Lysophosphatidic acid is a class of bioactive phospholipid that mediates most of its biological effects through LPA receptors, of which six isoforms have been identified. The recent results from LPA1 knockout mice suggested that blocking LPA1 signaling could provide a potential novel approach for the treatment of idiopathic pulmonary fibrosis. Here, we report the design and synthesis of pyrazole- and triazole-derived carbamates as LPA1-selective and LPA1/3 dual antagonists. In particular, compound <b>2</b>, the most selective LPA1 antagonist reported, inhibited proliferation and contraction of normal human lung fibroblasts (NHLF) following LPA stimulation. Oral dosing of compound <b>2</b> to mice resulted in a dose-dependent reduction of plasma histamine levels in a murine LPA challenge model. Furthermore, we applied our novel antagonists as chemistry probes and investigated the contribution of LPA1/2/3 in mediating the pro-fibrotic responses. Our results suggest LPA1 as the major receptor subtype mediating LPA-induced proliferation and contraction of NHLF.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Idiopathic pulmonary fibrosis (IPF) represents the most severe form of interstitial pneumonias with a typical survival time of between three to five years after diagnosis. In addition, the lack of pharmaceutical treatments capable of altering the natural course of the disease underlies the exceptionally high unmet medical need and underscores the urgent necessity of identifying and developing novel efficacious treatment options. Although the exact molecular mechanisms of IPF are incompletely understood, it is recognized that the pathogenesis of pulmonary fibrosis is characterized by excessive extracellular matrix (ECM) protein deposition into lung alveolar interstitium leading to irreversible scarring, loss of function of the capillary alveolar unit, impaired gas exchange, and ultimately respiratory failure and death. Numerous pathways have been implicated in driving these diverse processes, highlighting the complexity of the pathophysiological mechanisms driving interstitial lung fibrosis.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> The paucity of approved therapies that demonstrate robust efficacy for IPF is most likely due to the involvement of multiple pathways and mechanisms that ultimately contribute to irreversible lung scarring. The lung myofibroblast represents the central effector cell in pulmonary fibrosis by virtue of the ability of this cell type to synthesize and secrete extracellular matrix proteins.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Thus, pathways that act to induce the accumulation of interstitial lung myofibroblasts or promote their synthetic, profibrotic properties represent attractive pharmaceutical targets for the treatment of IPF.</div><div class="NLM_p">Lysophosphatidic acid (LPA) is a class of biologically active phospholipids produced from lysophosphatidyl choline (LPC) catalyzed by the enzyme autotaxin.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> LPA exerts a wide range of cellular responses, such as calcium mobilization, cell proliferation, cell transformation, and chemotaxis through a family of membrane bound GPCRs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> There are at least six LPA receptors (LPAR1–6) identified and characterized, with LPA1/2/3 from the EDG family sharing a relatively high homology.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> LPA has been demonstrated to induce the proliferation of lung fibroblasts,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> to promote the differentiation of lung fibroblasts to myofibroblasts,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and to augment fibroblast-mediated contraction of released three-dimensional collagen gels<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> underscoring the importance of this pathway in mediating profibrotic responses of lung fibroblasts <i>in vitro</i>. Using an <i>in vivo</i> murine unilateral ureteral obstruction (UUO) model to study renal fibrosis, expression of LPA1 was significantly up-regulated, while LPA3 was down-regulated, with no change in expression of LPA2 or LPA4 reported.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In the <i>in vivo</i> model of murine bleomycin-induced pulmonary fibrosis, LPA levels were increased in bronchoalveolar lavage fluid (BALF) following lung injury.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> In support of a role of the LPA pathway in mediating lung fibrosis in response to bleomycin challenge, LPA1 knockout mice displayed a significant reduction in fibroblast recruitment, reduced vascular leakage, and increased survival following bleomycin challenge compared to wild-type animals.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Additional murine models of pulmonary fibrosis such as the radiation-induced model of lung fibrosis report the possible involvement of LPA1 and LPA3 in driving the fibrotic responses.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In IPF patients, LPA levels were elevated in BALF, and LPA1 was identified as the predominant LPA receptor expressed in lung fibroblasts and was responsible for mediating enhanced migration of these cells.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Similarly, in our own studies we have also detected the expression of LPA1, LPA2, LPA3, LPA4, and LPA6 using quantitative PCR with the predominant isoform being LPA1 in normal human lung fibroblasts (NHLFs) and lung fibroblasts isolated from IPF patients (unpublished data). Taken together, this preclinical and clinical data suggests that targeting the LPA1 receptor could provide a novel therapeutic approach to treat IPF.</div><div class="NLM_p">Several LPAR antagonists have been reported in the literature.<a onclick="showRef(event, 'ref13 ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15 ref16">(13-16)</a> These antagonists have been classified as lipid-like molecules, such as nonhydrolyzable LPA analogues, and non lipid-like small molecules. The first non lipid-like LPAR antagonist, Ki16425, was reported as a dual LPA1/3 antagonist.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> On the basis of the structure of Ki16425, biphenyl substituted isoxazole analogues AM095 and AM966 were reported as orally active, selective LPA1 antagonists.<a onclick="showRef(event, 'ref18 ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20">(18-20)</a> Recently, LPA2 signaling has also been implicated in LPA-induced αvβ6 integrin-mediated TGF-β activation.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> LPA2-selective antagonists have also been reported (compound <b>1</b> in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LPAR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In order to identify novel LPA1-selective antagonists, we undertook a bioisostere approach and discovered pyrazole and triazole-derived carboxylic acids as LPA1-selective and LPA1/3 dual antagonists. In particular, compound <b>2</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) to our knowledge represents the most selective LPA1 antagonist so far reported. Compound <b>2</b> demonstrated dose-dependent oral efficacy in blocking LPA-induced histamine release in mice. Furthermore, we applied our novel LPAR antagonists as chemical probes to study the contribution of LPAR isoforms in mediating the pro-fibrotic responses of normal human lung fibroblasts (NHLFs) in response to LPA stimulation. Our results clearly suggest LPA1, but not LPA2 or LPA3, is the major receptor mediating LPA-stimulated proliferation and contraction in NHLFs. Herein we report the design, synthesis, and biological studies of a novel series of LPA1 antagonists (compounds <b>2</b>–<b>43</b>) from the substituted pyrazole and triazole chemical class.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08326" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08326" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>3</b>–<b>10</b> were prepared as described in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. The commercially available 4-bromo-1-methyl-1<i>H</i>-pyrazole-5-carboxylic acid methyl ester was reacted with an arylboronic acid under Suzuki coupling conditions. Following saponification and Curtius rearrangement, compounds <b>3</b>–<b>7</b> were obtained. Alternatively, aminopyrazole <b>44</b> was reacted with an arylboronic acid under Suzuki coupling conditions. The resulting 5-amino-4-aryl-1-methylpyrazole was converted to the corresponding carbamate <b>8</b>–<b>9</b> through the intermediate isocyanate. For the preparation of compound <b>10</b>, 4-bromo-1-methypyrazole-5-carboxylic acid was first converted to carbamate <b>45</b>, which was further coupled with arylboronate <b>46</b> followed by saponification.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>3</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) Pd(PPh<sub>3</sub>)<sub>4</sub> (cat), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) LiOH (aq), THF, 60 °C; (b) diphenylphosphoryl azide, triethylamine, toluene, 85 °C; (c) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 95 °C; (d) triphosgene, triethylamine, dichloromethane, 85 °C; (e) THF/LiOH (aq), rt.</p></p></figure><div class="NLM_p">The preparation of compounds <b>11</b>–<b>20</b> is described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. The required biphenylboronic acid esters <b>47</b> and <b>48</b> were synthesized in three steps from the corresponding arylbromide. Compound <b>11</b> was obtained from the coupling of <b>47</b> with <b>45</b> followed by saponification. Using the same synthetic sequence, the cyclopropanecarboxylic acid analogues <b>12</b>–<b>20</b> were prepared as shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>11</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 4-hydroxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (cat), K<sub>2</sub>CO<sub>3</sub>, DMF; (b) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, triethylamine, dichloromethane, −78 °C to rt; (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf) (cat), dioxane, 90 °C; (d) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C; (e) LiOH (aq), THF, rt; (f) triphosgene, triethylamine, dichloromethane, 85 °C; (g) NaOH (aq), ethanol, THF, rt.</p></p></figure><div class="NLM_p">The synthesis of <i>N</i>-aryltriazole analogues is described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. The reaction of arylazide with substituted alkyne gave triazole derivatives. The desired triazole was confirmed by NOE analysis. Following the sequence of saponification, Curtius rearrangement, biaryl coupling, and the final saponification, the acetic acid derivative (compound <b>21</b>), cyclopropanecarboxylic acid derivatives (<b>2</b>, <b>22</b>–<b>28</b>, <b>31</b>–<b>32</b>), and <i>N</i>-acylsulfonamide <b>29</b> were synthesized. The preparation of compound <b>30</b> was through the conversion of the intermediate cyanide to the corresponding tetrazole using methods previously described in the literature.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Aryltriazole Compounds <b>2</b> and <b>21</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) sodium azide, Cu(OAc)<sub>2</sub> (cat), methanol, rt; (b) toluene, sealed vessel, 150 °C, 4.5 h; (c) (i) LiOH (aq), THF, rt; (ii) diphenylphosphoryl azide, triethylamine, toluene, 65 °C; (d) S-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C, 4 h; (e) NaOH (aq), THF, ethanol, rt; (f) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf) (cat), dioxane, 90 °C; (g) TMSN<sub>3</sub>, n-Bu<sub>2</sub>SnO (2 equiv), 100 °C, 15 h.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> describes the synthesis of 4-<i>N</i>-aryl-3-amino-4<i>H</i>-[1,2,4]triazole analogue <b>33</b>. 4-Bromoaniline was converted to 2-methyl-1-arylisothiourea through a sequence of thioisocyanate formation, thiourea formation, and then methylation of the thiourea. After displacement of the methylthio group by hydrazine and subsequent ring formation with formic acid, 4-<i>N</i>-aryl-3-amino-4<i>H</i>-[1,2,4]triazole <b>52</b> was formed. Conversion of the arylbromide to the corresponding biphenyl derivative followed by carbamate formation and final saponification gave compound <b>33</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-<i>N</i>-Aryl-[1,2,4]triazole Derivative <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) thiophosgene, CaCO<sub>3</sub>, dichloromethane; (b) NH<sub>3</sub>/THF; (c) MeI, methanol, rt; (d) hydrazine monohydrate; (e) formic acid, 120 °C, 3.5 h; (f) PdCl<sub>2</sub>(dppf) (cat), Na<sub>2</sub>CO<sub>3</sub> (aq), dioxane, 100 °C, 24 h; (g) LiHMDS, THF; (h) LiOH (aq), THF.</p></p></figure><div class="NLM_p">Finally, the synthesis of <i>N</i>-methyltriazole analogues <b>34</b>–<b>43</b> is described in Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>. The required <i>N</i>-methyltriazole was formed through the reaction of an arylacetylene derivative with trimethylsilymethylazide. The structures of the two regio-isomers were assigned by NOE analysis. Following the deprotection of the trimethylsilyl group and ester saponification, 1<i>N</i>-methyl-4-aryl-[1,2,3]-triazole-5-carboxylic acid and 1<i>N</i>-methyl-5-aryl-[1,2,3]-triazole-4-carboxylic acid were obtained. Conversion of the carboxylic acid to compounds <b>34</b>–<b>42</b> was carried out using the same method described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. For the preparation of the cyclohexane acetic acid analogue <b>43</b>, 4-iodocyclohexane acetic acid ethyl ester was coupled with an arylbromide through the formation of an alkyl zinc intermediate. The 1,4-substitutions of cyclohexane in <b>43</b> compose a mixture of cis/trans isomers.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>34</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) benzene, reflux, 4 h; (b) TBAF, THF, 0 °C; (c) LiOH (aq), THF, rt; (d) diphenylphosphoryl azide, triethylamine, toluene, 80 °C; (e) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C; (f) NaOH (aq), THF, ethanol, rt; (g) activated zinc, THF; (h) Pd(OAc)<sub>2</sub> (cat), S-Phos (cat), THF; (i) Pd/C, H<sub>2</sub>; (j) diphenylphosphoryl azide, (<i>R</i>)-phenylethanol, triethylamine, 80 °C; (k) NaOH (aq), THF, ethanol; (l) PdCl<sub>2</sub>(dppf) (cat), DPPF (cat), DMF, Na<sub>2</sub>CO<sub>3</sub> (aq), 80 °C.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_22233" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_22233" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The design of novel bioisosteres has been practiced in drug discovery to optimize drug–target interactions.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> We envisioned that aminopyrazole and aminotriazole could function as bioisosteres of the aminoisoxazole in Ki16425 and AM095. In particular, these novel heterocyclic bioisosteres could provide unique selectivity toward LPAR isoforms. To this end, we investigated the potential of <i>N</i>-methyl-5-aminopyrazole as a bioisostere of 4-amino-3-methylisoxazole. Compounds prepared in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a> were tested in a fluorometric imaging plate reader (FLIPR) assay using an engineered Chem-1 cell line overexpressing the human LPA1 or LPA3 receptors. The natural ligand LPA (18:1) was used to stimulate calcium mobilization at a final concentration of 1 μM. To prevent false positives in the FLIPR assay, compounds were also tested in wild-type Chem-1 cell lines without LPAR overexpression and stimulated with ionomycin. LPA1 and LPA3 antagonist activity is expressed as IC<sub>50</sub>, the compound concentration to inhibit 50% activity of the intracellular calcium responses following stimulation of the cells with the natural ligand agonist, LPA (18:1). As indicated in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, the carboxylic acid is not required for LPA1 inhibition (<b>3</b>, <b>6</b>, <b>7</b>, and <b>8</b>). The 2-chloro substitution at the R2 position of the carbamate significantly improved the potency from a partial antagonist (compound <b>3</b>) to a full antagonist (compound <b>6</b>). Interestingly, the same carbamate moiety was present in both Ki16425 and AM966. Substitution at the 4-position of the phenyl ring (R1 in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) with a methoxy or phenyl group completely abolished LPA1 inhibition potency (<b>4</b> and <b>5</b>). While the 4-fluorine substitution did not change the potency, the 2-fluorine substitution improved activity by 2- to 3-fold (compare <b>6</b> with <b>7</b> and <b>8</b>). We also observed a stereochemical preference in favor of the (<i>R</i>)-enantiomer (compare <b>8</b> with <b>9</b>), which was consistent with the structure of AM095. When an acetic acid moiety was attached at the 4-position (compound <b>10</b>), inhibition of LPA receptor activity was completely lost.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of the <i>N</i>-Methylpyrazole Derived Non-Carboxylic Acid LPA1 Antagonists <b>3</b>–<b>10</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">R2</th><th class="colsep0 rowsep0" align="center">(<i>R</i>) or (<i>S</i>)</th><th class="colsep0 rowsep0" align="center">LPA1 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LPA3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">17.5 (65%@30)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">4-OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">4-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)/(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">3.59 (>97%@30)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)/(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">3.97 (>97%@30)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.644 (>97%@30)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">2-F</td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>COOH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">>30</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Mean value from at least three FLIPR assay IC<sub>50</sub> determinations; the average CV of the assay was 15%.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">% inhibition at the indicated concentration.</p></div></div></div><div class="NLM_p">LPA has been reported to act as a potent mitogenic factor on NHLFs.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In order to assess the effects of LPA on the proliferation of NHLFs, we measured the incorporation of nucleoside bromodeoxyuridine (BrdU) into the newly synthesized DNA of NHLFs following stimulation with LPA (18:1). Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A demonstrates that LPA enhanced the proliferation of NHLFs in a concentration-dependent manner (EC<sub>50</sub> = 12 μM). Since LPA1/2/3 belong to the same EDG family and they share significant structural homology,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> we applied our selective LPAR antagonists as chemical tools to determine which receptor isoforms were responsible for the NHLF proliferation mediated by LPA (18:1). For NHLF proliferation assays, NHLFs were stimulated with 15 μM LPA (18:1). Compound <b>1</b>, a potent LPA2 antagonist (IC<sub>50</sub> = 17 nM),<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> showed no LPA1 or LPA3 antagonist activity in our FLIPR assay. As displayed in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B, compound <b>1</b> did not reach 50% inhibition even at high compound concentrations (10 μM). Compound <b>8</b>, the (<i>R</i>)-enantiomer with LPA1 activity in our FLIPR assay (LPA1 IC<sub>50</sub> = 0.64 μM), inhibited LPA-induced NHLF proliferation more than 50% at 1 μM (IC<sub>50</sub> = 0.81 μM) and reached complete inhibition at higher concentrations, while the inactive (<i>S</i>)-enantiomer, compound <b>9</b> (IC<sub>50</sub> > 30 μM in the LPA1 FLIPR assay), showed significantly less potency (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). Taking the combined data from Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A and B, our data strongly suggest that LPA1, and not LPA2, plays a critical role in mediating NHLF proliferation in response to LPA (18:1) addition.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of LPA-induced NHLF proliferation by LPA1 and LPA2 antagonists. (A) LPA concentration-dependently increases NHLF proliferation. (B) Effects of compounds <b>1</b>, <b>8</b>, and <b>9</b> on LPA (18:1) (15 μM)-induced NHLF proliferation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Despite noncarboxylic acid <b>8</b> demonstrating reasonable potency in both FLIPR and NHLF proliferation assays, the microsomal instability of this compound (mouse liver microsomal clearance of 89 mL/min/kg and human liver microsomal clearance of 22 mL/min/kg) prevented us using this for <i>in vivo</i> studies. After unsuccessful attempts to identify more potent noncarboxylic acid LPA1 antagonists in this chemical class (data not shown), we investigated carboxylic acid analogues of biphenyl substituted aminopyrazoles. Compounds <b>11</b>–<b>20</b> were studied in the LPA1/3 FLIPR assay (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of the <i>N</i>-Methylpyrazole Derived Carboxylic Acid LPA1 Antagonists <b>11</b>–<b>20</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0014.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">(<i>R</i>) or (<i>S</i>)</th><th class="colsep0 rowsep0" align="center">LPA1 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">LPA3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">BrdU IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.035</td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">0.047</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">65%@30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">>30</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.021</td><td class="colsep0 rowsep0" align="left">8.34</td><td class="colsep0 rowsep0" align="left">0.0026</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">2-F-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">5.80</td><td class="colsep0 rowsep0" align="left">0.0045</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4-F-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)/(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">0.057</td><td class="colsep0 rowsep0" align="left">8.26</td><td class="colsep0 rowsep0" align="left">0.005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.041</td><td class="colsep0 rowsep0" align="left">0.478</td><td class="colsep0 rowsep0" align="left">0.037</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.038</td><td class="colsep0 rowsep0" align="left">0% @ 30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.048</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.106</td><td class="colsep0 rowsep0" align="left">9% @ 30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.03</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.176</td><td class="colsep0 rowsep0" align="left">13.7% @ 30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0.192</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0% @ 30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">0% @ 30<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Mean value from at least three FLIPR assay IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">NHLF proliferation induced by LPA (18:1) (15 μM) and determined by BrdU incorporation.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">% inhibition at the indicated concentration.</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">Although direct attachment of an acetic acid moiety at the 4-position of the phenyl group (compound <b>10</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) abolished LPA1 activity, and substituting phenyl with a biphenyl resulted in an inactive compound (compound <b>5</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), adding an acetic acid to the 4-position of the biphenyl (compound <b>11</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) led to a very potent LPA1 antagonist with high selectivity against LPA3 (>850-fold). Replacing the acetic acid with cyclopropanecarboxylic acid gave similar LPA1 potency but significantly improved antiproliferation activity (compare <b>11</b> with <b>13</b>). The carboxylic acid was also found to be crucial for LPA1 inhibition (compare <b>12</b> with <b>13</b>). The improved inhibitory potency in the NHLF proliferation assay observed with the cyclopropanecarboxylic acid prompted us to further study this chemical class. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, an aryl carbamate is not necessary to maintain LPA1 antagonist potency (R group in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, substituting aryl with alkyl groups decreased the inhibitory activity of the series in the NHLF proliferation assay (compare <b>13</b> with <b>17</b> and <b>18</b>). Introduction of polar groups, such as oxetane, caused complete loss of antagonist activity (compare <b>19</b> with <b>20</b>). Trifluoromethyl substitution at the meta-position significantly increased inhibitory potency in the LPA3 FLIPR assay (17-fold) with little impact on the LPA1 FLIPR assay (compare <b>13</b> with <b>16</b>). Interestingly, the LPA1/3 dual antagonist <b>16</b> was 10-fold less potent than the LPA1-selective antagonist <b>13</b> in the NHLF proliferation assay.</div><div class="NLM_p">To our surprise, the acetic acid derivative of <i>N</i>-aryltriazole (compound <b>21</b>) showed significantly reduced LPA1 antagonist activity in the FLIPR assays (compare <b>21</b> with <b>11</b>). However, the corresponding cyclopropanecarboxylic acid analogue (compound <b>2</b>) displayed very potent and highly selective inhibitory activity toward LPA1, with little inhibition on LPA3 even at very high concentrations (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). To our knowledge, compound <b>2</b> is the most selective nonlipid LPA1 antagonist so far reported in the literature. It appears that compounds from the <i>N</i>-aryltriazole chemical class were much more selective for LPA1 than compounds from the corresponding pyrazole series (compare Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> with Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Substitution on the phenyl ring of the carbamate or replacing the phenyl group with alkyl groups led to reduced antiproliferative potency (compounds <b>22</b>–<b>28</b>). In comparison with Ki16425 and AM095, compound <b>2</b> showed much improved antiproliferative activity (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A). The carboxylic acid isosteres <b>29</b> and <b>30</b> maintained LPA1 potency but were less active in blocking proliferation (compare <b>29</b> and <b>30</b> with <b>2</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). For the heterocyclic triazole core, deletion of the methyl group or substitution with an ethyl group was well tolerated (<b>31</b> and <b>32</b>). Interestingly, unlike the <i>N</i>-aryl-[1,2,3]triazole <b>32</b>, the <i>N</i>-aryl-[1,2,4]triazole <b>33</b> was significantly less active. The observed differences between the two heterocycles can be explained by the stable conformation analysis as illustrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>. It is likely that the NH group in compound <b>33</b> exists as the less active conformation due to the unfavorable electronic repulsion. The similar effects of conformational preference due to dipole–dipole interaction on biological activity were reported in GSK3 inhibitors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. SAR of <i>N</i>-Aryltriazole Derived LPA1 Antagonists <b>2</b> and <b>21</b>–<b>33</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0015.gif" alt="" id="fx3" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">(<i>R</i>) or (<i>S</i>)</th><th class="colsep0 rowsep0" align="center">LPA1 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">LPA3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">BrdU IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">41% @ 30</td><td class="colsep0 rowsep0" align="left">3% @ 30</td><td class="colsep0 rowsep0" align="left">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.0252</td><td class="colsep0 rowsep0" align="left">20% @ 30</td><td class="colsep0 rowsep0" align="left">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2-F-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.0345</td><td class="colsep0 rowsep0" align="left">42% @ 30</td><td class="colsep0 rowsep0" align="left">0.021</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">2-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.112</td><td class="colsep0 rowsep0" align="left">55% @ 30</td><td class="colsep0 rowsep0" align="left">0.077</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.174</td><td class="colsep0 rowsep0" align="left">6.86</td><td class="colsep0 rowsep0" align="left">1.20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.217</td><td class="colsep0 rowsep0" align="left">17% @ 30</td><td class="colsep0 rowsep0" align="left">0.060</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">ethyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.398</td><td class="colsep0 rowsep0" align="left">0% @ 30</td><td class="colsep0 rowsep0" align="left">0.178</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">cyclobutyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)/(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">0.161</td><td class="colsep0 rowsep0" align="left">26% @ 30</td><td class="colsep0 rowsep0" align="left">0.189</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">gem-dimethyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">0.985</td><td class="colsep0 rowsep0" align="left">0% @ 30</td><td class="colsep0 rowsep0" align="left">1.62</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.032</td><td class="colsep0 rowsep0" align="left">7% @ 30</td><td class="colsep0 rowsep0" align="left">0.060</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.023</td><td class="colsep0 rowsep0" align="left">28% @ 30</td><td class="colsep0 rowsep0" align="left">0.105</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.042</td><td class="colsep0 rowsep0" align="left">63% @ 30</td><td class="colsep0 rowsep0" align="left">0.016</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.036</td><td class="colsep0 rowsep0" align="left">23% @ 30</td><td class="colsep0 rowsep0" align="left">0.040</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">11% @ 30</td><td class="colsep0 rowsep0" align="left">17% @ 30</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Mean value from at least three FLIPR assay IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">NHLF proliferation induced by LPA (18:1) (15 μM).</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">% inhibition at the indicated concentration.</p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div><figure id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Stable Conformation Analysis of <b>32</b> and <b>33</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To support our conformational analysis, we investigated the differences in the energetic landscapes of the triazole-carbamate torsion angles of <b>2</b>, <b>32</b>, and <b>33</b> through gas-phase density functional theory (DFT) calculations at the B3LYP/6-31G** level. The energy and torsion angle plots revealed that both <b>32</b> and <b>2</b> have energetic minima at 0° and 40°, respectively, near the orientation shown on the left of Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). In contrast, the less active analogue <b>33</b> shows a minimum near 100°, where the plane of the carbamate is approximately perpendicular to the plane of the triazole. The difference in energies for <b>33</b> between the minimum energy conformation and the conformations with 0° and 40° torsion angles are 4.36 and 3.57 kcal/mol, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). These calculations support the hypothesis that differences in conformational preference underlie the differences in activity of <b>32</b> and <b>33</b>.</div><figure id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Energy as a function of the triazole-carbamate torsion angle for the [1,2,3]-triazole compound <b>32</b> (magenta circles), its active 4-methyl analogue <b>2</b> (cyan squares), and the less active [1,2,4]-triazole compound <b>33</b> (green diamonds). A torsion angle of 0° or 360° corresponds to the conformations drawn on the left side of Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, while a torsion angle of 180° corresponds to the conformations drawn on the right side of Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Finally, we investigated 1<i>N</i>-methyl-4-aryl-[1,2,3]triazole derivatives. As listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, unlike <i>N</i>-aryl-[1,2,3]triazole <b>21</b>, the acetic acid analogue <b>34</b> exhibited potent inhibition of LPA1 in the FLIPR assays with good selectivity over LPA3. However, the cyclopropane carboxylic acid analogues displayed much higher potency in inhibiting NHLF proliferation induced by LPA (18:1) (compare <b>34</b> with <b>35</b> and <b>36</b>). Fluorine substitution improved the LPA1 selectivity by 10-fold over LPA3 without affecting the LPA1 potency (compare <b>35</b> with <b>36</b>). The nonbiaryl acetic acid analogue <b>43</b> not only maintained LPA1 inhibitory potency but also displayed high inhibitory activity in blocking LPA-induced NHLF proliferation. The regio-isomeric 1<i>N</i>-methyl-5-aryl-[1,2,3]triazole derivative <b>40</b> showed significantly less inhibitory activity toward LPA1 or LPA3 in the FLIPR assays. This can also be explained by the unfavorable dipole–dipole interaction that causes the less active conformation as illustrated in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of <i>N</i>-Methyltriazole Derived LPA1 Antagonists <b>34</b>–<b>43</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0016.gif" alt="" id="fx4" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center">R1</th><th class="colsep0 rowsep0" align="center">(<i>R</i>) or (<i>S</i>)</th><th class="colsep0 rowsep0" align="center">LPA1 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">LPA3 IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">BrdU IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">21.94</td><td class="colsep0 rowsep0" align="left">0.06</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">2.29</td><td class="colsep0 rowsep0" align="left">0.003</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.018</td><td class="colsep0 rowsep0" align="left">27.35</td><td class="colsep0 rowsep0" align="left">0.002</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">isopropyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="left">24% @ 30</td><td class="colsep0 rowsep0" align="left">0.020</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.017</td><td class="colsep0 rowsep0" align="left">0.132</td><td class="colsep0 rowsep0" align="left">0.074</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>S</i>)</td><td class="colsep0 rowsep0" align="left">2.65</td><td class="colsep0 rowsep0" align="left">6.30</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">12% @ 30</td><td class="colsep0 rowsep0" align="left">10% @ 30</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.019</td><td class="colsep0 rowsep0" align="left">2.31</td><td class="colsep0 rowsep0" align="left">0.004</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>-phenyl</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub>NH</td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.024</td><td class="colsep0 rowsep0" align="left">0.065</td><td class="colsep0 rowsep0" align="left">0.331</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">phenyl</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">(<i>R</i>)</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">18.6</td><td class="colsep0 rowsep0" align="left">0.007</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Mean value from at least three FLIPR assay IC<sub>50</sub> determinations.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">NHLF proliferation induced by LPA (18:1) (15 μM).</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">% inhibition at the indicated concentration.</p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">Not determined.</p></div></div></div><div class="NLM_p">The most interesting observations were obtained using the LPA1/3 dual antagonists. The trifluoromethyl substitution increased LPA3 inhibition potency by 17-fold without affecting LPA1 inhibitory activity (compare <b>38</b> with <b>35</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>), which is consistent with the data obtained with the corresponding pyrazole analogues (compare <b>13</b> and <b>16</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The same trend was observed with <i>N</i>-acylsulfonamide analogues (compare <b>41</b> with <b>42</b> in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). More interestingly, the LPA1/3 dual antagonist was significantly less active than the LPA1-selective antagonist in inhibiting NHLF proliferation mediated by LPA (18:1) despite demonstrating comparable LPA1 inhibitory potency (compare <b>42</b> with <b>41</b>). This observation may be due to the differential roles of individual LPAR isoforms that effect cellular responses to LPA such as migration and colony formation in soft agar as has been observed in transfected B103 cells.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Interestingly, in these studies, LPA1 and LPA3 exhibited opposing effects in B103 cell migration and colony formation in soft agar in response to LPA challenge.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> It should be noted that in NHLFs we can detect the expression of both LPA1 and LPA3 by quantitative PCR (data not shown). Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows the concentration-dependent inhibition of LPA (18:1)-induced NHLF proliferation by LPA1 and LPA1/3 dual antagonists. Taking the results from Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, we conclude that in NHLFs, LPA (18:1)-induced proliferation is mediated mainly through LPA1 and not LPA2 or LPA3 signaling.</div><figure id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of LPA (18:1)-induced NHLF proliferation by LPA1 and LPA1/3 dual antagonists. (A) Concentration-dependent inhibition of LPA (18:1) (15 μM)-stimulated NHLF proliferation by <b>2</b>, AM095, and Ki16425. (B) Effects of LPA1 and LPA1/3 dual antagonists (<b>41</b> and <b>42</b>) on LPA (18:1) (15 μM)-stimulated NHLF proliferation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">LPA has been reported to act as a contractile agent on NHLFs using the three-dimensional collagen gel contraction assay.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Additional studies using lung fibroblasts obtained from the lung of IPF patients suggests that these cells may exhibit elevated expression of contractile proteins and to demonstrate enhanced contraction in three-dimensional collagen gels.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We used NHLFs cultured in three-dimensional collagen gels to assess the effect of LPA (18:1) on NHLF contraction. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A, LPA concentration-dependently induced contraction of collagen gel matrices containing cultured NHLFs. At concentrations as low as 1 μM, LPA was able to decrease the gel size, with the maximum effect at 30 μM. We next studied the most selective LPA1 antagonist (compound <b>2</b>) and the literature LPA2-selective antagonist (compound <b>1</b>). Following LPA stimulation (15 μM), the LPA2 antagonist showed no detectable inhibition of the collagen gel contraction, while the LPA1-selective antagonist concentration-dependently inhibited the contraction as shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B. To further determine the relationship between NHLF contraction and proliferation induced by LPA, we evaluated LPA1 and LPA1/3 dual antagonists (compound <b>41</b> and <b>42</b>). As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C, the LPA1/3 dual antagonist <b>42</b> demonstrated significantly less activity in preventing NHLF contraction than LPA1-selective antagonist <b>41</b>. Interestingly, this trend correlated well with LPA-induced NHLF proliferation (Figures <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>C). Therefore, using our novel LPAR antagonists as probes, we have pharmacologically dissected the role of LPA1/2/3 function in mediating LPA-stimulated NHLF proliferation and contraction, processes critical in the progression of lung fibrosis. Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> lists the IC<sub>50</sub> determinations of selected potent LPA1 antagonists in inhibiting NHLF contraction in response to LPA (18:1).</div><figure id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LPA-mediated contraction of NHLFs assessed in three-dimensional collagen gels. (A) LPA (18:1) concentration-dependently increased NHLF contraction. (B) Photo image of the effects of LPAR inhibitors on 15 μM LPA (18:1)-mediated contraction. (C) Effects of LPA1 and LPA1/3 dual antagonists (<b>41</b> and <b>42</b>) on 15 μM LPA (18:1)-mediated NHLF contraction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. IC<sub>50</sub> Determinations of Selected Potent LPA1 Antagonists in Inhibiting NHLF Contraction in Response to 15 μM LPA (18:1)</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">inhibition of contraction IC<sub>50</sub> (μM)<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>AM095</b></td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>Ki16415</b></td><td class="colsep0 rowsep0" align="left">0.16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">0.39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">0.10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">0.34</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">0.02</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">0.22</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">NHLF contraction induced by LPA (18:1) @15 μM.</p></div></div></div><div class="NLM_p">The unique LPA1 selectivity determined for compound <b>2</b> prompted us to evaluate this molecule to inhibit LPA-stimulated histamine release in the mouse, an acute PK/PD model to study LPA1 antagonist activity reported in the literature.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>A, LPA dose-dependently caused an acute histamine increase in the plasma following intravenous injection. When mice were orally dosed with compound <b>2</b> (100 mg/kg, aqueous suspension) prior to intravenous LPA injection, the LPA-induced histamine level was significantly blocked (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>B). A clear PK/PD relationship was demonstrated by the correlation between the levels of compound <b>2</b> and LPA-induced histamine concentrations in plasma (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>C). Although AM095 almost completely blocked histamine release (100 mg/kg), analysis of plasma samples revealed more than 65-fold higher concentrations of AM095 than compound <b>2</b> (100 mg/kg). The ability of compound <b>2</b> to block histamine release at much lower plasma concentration suggests that further improvement of pharmacokinetic properties of this chemical class could lower the effective dose.</div><figure id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LPA-induced histamine release in C57BL/6 mice. (A) LPA (intravenous injection) dose-dependently increased plasma histamine levels. (B) Dose-dependent inhibition of LPA-mediated plasma histamine levels by orally dosed compound <b>2</b>. (C) Correlation of histamine levels with compound <b>2</b> concentrations in plasma. Significance is denoted as follows: * <i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">IPF represents a disease of enormous unmet medical need due to the lack of effective treatment options and the dismal prognosis associated with the disease. Preclinical and clinical data exist that support targeting LPA1 for the treatment of organ fibrosis including IPF due to the role of this receptor in mediating the profibrotic effects of LPA in fibroblasts.<a onclick="showRef(event, 'ref7 ref8 ref11'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref11">(7, 8, 11)</a> More recently, it has been reported that LPA acting through the LPA1 receptor isoform may induce apoptosis of human bronchial epithelial cells suggesting that LPA1 may promote lung fibrosis in cell types other than pulmonary fibroblasts.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> In this work, we have used our novel LPA1, LPA1/3 dual, and literature LPA2 antagonists as chemical probes to pharmacologically dissect the function of LPA1/2/3 in driving LPA-mediated profibrotic responses in NHLFs. Our data suggests that the LPA1 receptor is the predominant receptor for mediating LPA-induced NHLF proliferation and contraction, critical cellular responses implicated in the progression of IPF.</div><div class="NLM_p last">Since the first publication of the isoxazole-derived LPAR antagonist, Ki16425 in 2003, the majority of nonlipid LPA1 antagonists disclosed in patent applications or published in the literature are still based on the isoxazole core structure.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> By taking bioisostere approaches, we discovered pyrazole and triazole-derived LPA1 selective and LPA1/3 dual antagonists. Compound <b>2</b> demonstrated the highest LPA1 selectivity and attenuated LPA-induced NHLF proliferation and contraction with high potency. Oral dosing of compound <b>2</b> in mice caused a dose-dependent reduction in serum histamine levels induced following intravenous LPA stimulation. The carboxylic acid-derived LPA1 antagonists from our pyrazole and triazole chemical class showed no liability to CYP, hERG, and other <i>in vitro</i> predictive toxicity assays. The correlation between the inhibition of LPA-induced NHLF proliferation and the inhibition of LPA-induced NHLF contraction by our novel LPA1 antagonists further underscore that LPA1 represents a potentially attractive therapeutic target for the treatment of IPF.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76733" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76733" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were carried out under an argon atmosphere. Solvents were purchased from commercial sources and used without further drying. <sup>1</sup>H NMR spectra were recorded with Mercury 300 and Unityplus 400 MHz spectrometers. All compounds were analyzed by LC/MS (liquid chromatography/mass spectrometry) using a Waters ZQ mass detector and Waters LC system. Ionization was generally achieved via electron spray (ES). The LC fraction detection consisted of both a diode array detector and an evaporative light scattering detector, and all tested compounds had purity greater than 98%.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> [4-(2-Fluoro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic Acid (<i>R</i>)-1-(2-Chloro-phenyl)-ethyl Ester (<b>8</b>)</h3><div class="NLM_p">4-Bromo-1-methyl-1<i>H</i>-pyrazol-5-amine (800 mg, 4.55 mmol), 2-fluorophenylboronic acid (890 mg, 6.36 mmol), X-Phos (217 mg, 0.45 mmol), palladium acetate (51 mg, 0.227 mmol), and potassium phosphate tribasic (1.93 g, 9.09 mmol) were combined in 12 mL of toluene. Degassed water (4 mL) was added, and argon was bubbled through for 3 min. The reaction tube was sealed, and the mixture was stirred at 95 °C overnight. Solvents were evaporated, and the residue was extracted with ethyl acetate and water. The organic layer was washed with brine and dried. Solvents were evaporated, and the residue was purified by flash column chromatography (ethyl acetate containing 3% methanol in hexanes 10% to 80%) to give 4-(2-fluorophenyl)-2-methyl-2<i>H</i>-pyrazole-3-amine as a brown oil (649 mg, 74.7% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 3.60 (s, 3H), 5.30 (br s, 2H), 7.14–7.25 (m, 3H), 7.30 (d, <i>J</i> = 2.5 Hz, 1H), 7.39–7.52 (m, 1H); LC/MS calcd for C<sub>10</sub>H<sub>10</sub>FN<sub>3</sub> (<i>m</i>/<i>e</i>) 191.0; obsd, 192.0 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">4-(2-Fluorophenyl)-2-methyl-2<i>H</i>-pyrazol-3-amine (110 mg, 0.575 mmol) and triphosgene (222 mg, 0.748 mmol) were combined with dichloromethane (4 mL) and toluene (6 mL). The reaction tube was sealed. The mixture was stirred in an ice bath, and triethylamine (0.7 mL) was added. The mixture was stirred at 85 °C for 20 min, and 1-(2-chlorophenyl)ethanol (117 mg, 0.748 mmol) in 1 mL of toluene was added. The mixture was stirred at 90 °C for 1 h. Solvents were evaporated, and the residue was extracted with ethyl acetate and water. The organic layer was dried and concentrated. The residue was purified by flash column chromatography (ethyl acetate in hexanes 0% to 50%) to give [4-(2-fluoro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic acid 1-(2-chloro-phenyl)-ethyl ester as an amorphous powder (134 mg, 62.3% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.06–1.28 (m, 1H), 1.53 (br d, <i>J</i> = 5.6 Hz, 2H), 3.65 (br s, 3H), 5.83–5.98 (m, 1H), 6.83–7.50 (m, 7H), 7.56 (d, <i>J</i> = 6.8 Hz, 1H), 7.65 (br s, 1H), 9.66 (s, 1H); LC/MS calcd for C<sub>19</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 373.0; obsd, 372.0 (M – H, ES<sup>–</sup>). This pure racemic material was separated by supercritical fluid chromatography using a chiral WHELKO column (10% to 65% methanol in CO<sub>2</sub>, 70 mL/min). The second fraction (longer retention time) was concentrated to give a pure enantiomer as compound <b>8</b>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> [4-(2-Fluoro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic Acid (<i>S</i>)-1-(2-Chloro-phenyl)-ethyl Ester (<b>9</b>)</h3><div class="NLM_p last">The first fraction from the chiral SFC separation of [4-(2-fluoro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic acid 1-(2-chloro-phenyl)-ethyl ester as described for the preparation of <b>8</b> gave a pure enantiomer as compound <b>9</b>.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Methyl-4-phenyl-2<i>H</i>-pyrazol-3-yl-carbamic Acid (<i>R</i>)-1-Phenyl-ethyl Ester (<b>3</b>)</h3><div class="NLM_p">Methyl 4-bromo-2-methyl-2<i>H</i>-pyrazole-3-carboxylate (438.1 mg, 2.0 mmol), phenylboronic acid (244 mg, 2.0 mmol), and cesium carbonate (1.3 g, 4.0 mmol) were dissolved in 10 mL of DMF, and the solution was degassed with argon. To this mixture was added Pd(PPh<sub>3</sub>)<sub>4</sub> (139 mg, 0.12 mmol). The mixture was stirred at 80 °C for 12 h. The resulting mixture was cooled to room temperature and filtered. The solid was rinsed with THF. The filtrate was concentrated and purified by ISCO flash column chromatography (0% to 25% ethyl acetate in hexanes) to give an oily material as methyl 2-methyl-4-phenyl-2<i>H</i>-pyrazole-3-carboxylate (388.6 mg, 89.8% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 3.77 (s, 3H), 4.21 (s, 3H), 7.31–7.36 (m, 1H), 7.37–7.42 (m, 4H), 7.52 (s, 1H); LC/MS calcd for C<sub>12</sub>H<sub>12</sub>N<sub>2</sub>O<sub>2</sub> 216.0; obsd, 217.0 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">Methyl 2-methyl-4-phenyl-2<i>H</i>-pyrazole-3-carboxylate (388.6 mg, 1.8 mmol) was dissolved in THF (8 mL), and 0.5 N LiOH solution (4 mL) was added. The mixture was stirred at 60 °C for 2 h and then concentrated. The residue was dissolved in water (30 mL) and filtered. The filtrate was neutralized with 1 N hydrochloric acid, and the white precipitate was filtered and dried in a vacuum oven at 60 °C overnight to provide 2-methyl-4-phenyl-2<i>H</i>-pyrazole-3-carboxylic acid (338.5 mg, 93.1% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 4.06 (s, 3H), 7.25–7.42 (m, 5H), 7.60 (s, 1H), 13.42 (s, 1H); LC/MS calcd for C<sub>11</sub>H<sub>10</sub>N<sub>2</sub>O<sub>2</sub> 202.0; obsd, 201.0 (M – H, ES<sup>–</sup>).</div><div class="NLM_p">2-Methyl-4-phenyl-2<i>H</i>-pyrazole-3-carboxylic acid (100 mg, 0.495 mmol), (<i>R</i>)-1-phenylethanol (60.4 mg, 0.495 mmol), DPPA (136 mg, 0.495 mmol), and TEA (100 mg, 0.989 mmol) were mixed with 3 mL of toluene. The mixture was stirred at 80 °C for 1 h. Solvents were evaporated, and the residue was purified by ISCO flash column chromatography (0% to 55% ethyl acetate in hexanes) to give 2-methyl-4-phenyl-2<i>H</i>-pyrazol-3-yl-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester as a white powder (106 mg, 66.7% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13–1.29 (br, 1 H), 1.52 (d, <i>J</i> = 5.8 Hz, 2 H), 3.60 (s, 3H), 5.58–5.82 (br m, 1H), 6.92–7.53 (m, 10H), 7.74 (s, 1H), 9.55 (s, 1H); LC/MS calcd for C<sub>19</sub>H<sub>19</sub>N<sub>3</sub>O<sub>2</sub> 321.0; obsd, 320.0 (M – H, ES<sup>–</sup>).</div><div class="NLM_p last">Compounds <b>4</b> to <b>7</b> were prepared using the same procedure as that for the preparation of compound <b>3</b>.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> [4-(4-Methoxy-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic Acid (<i>R</i>)-1-Phenyl-ethyl Ester (<b>4</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.15–1.30 (br, 1H), 1.54 (d, <i>J</i> = 5.8 Hz, 2 H), 3.60 (br s, 3H), 3.75 (s, 3H), 5.76 (d, <i>J</i> = 6.1 Hz, 1H), 6.87 (d, <i>J</i> = 7.6 Hz, 2H), 6.97–7.25 (m, 1H), 7.28–7.51 (m, 6H), 7.67 (s, 1H), 9.48 (br s, 1H); LC/MS calcd for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 397; obsd, 398.0 (M + H, ES+); LC/MS calcd for C<sub>20</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub> (<i>m</i>/<i>e</i>) 351; obsd, 350.0 (M – H, ES<sup>–</sup>).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (4-Biphenyl-4-yl-2-methyl-2<i>H</i>-pyrazol-3-yl)-carbamic Acid (<i>R</i>)-1-Phenyl-ethyl Ester (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12–1.30 (br, 1H), 1.57 (d, <i>J</i> = 5.8 Hz, 2 H), 3.64 (br s, 3H), 5.79 (d, <i>J</i> = 5.8 Hz, 1H), 7.29–7.51 (m, 8H), 7.52–7.58 (m, 2H), 7.59–7.65 (m, 2H), 7.68 (d, <i>J</i> = 7.6 Hz, 2H), 7.83 (s, 1H), 9.63 (br s, 1H); LC/MS calcd for C<sub>25</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 397; obsd, 398.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (2-Methyl-4-phenyl-2<i>H</i>-pyrazol-3-yl)-carbamic Acid 1-(2-Chloro-phenyl)-ethyl Ester (<b>6</b>)</h3><div class="NLM_p last">2-Methyl-4-phenyl-2<i>H</i>-pyrazole-3-carboxylic acid (60 mg, 0.297 mmol), 1-(2-chlorophenyl)ethanol (46.5 mg, 0.297 mmol), DPPA (81.7 mg, 0.297 mmol), and triethylamine (0.09 mL) were combined in 2.5 mL of toluene. The mixture was stirred at 85 °C for 3 h. Solvents were evaporated, and the residue was purified by flash column chromatography (0% to 50% ethyl acetate in hexanes) to give (2-methyl-4-phenyl-2<i>H</i>-pyrazol-3-yl)-carbamic acid 1-(2-chloro-phenyl)-ethyl ester as a white fluffy solid (40 mg, 38% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.15–1.28 (br, 1H), 1.55 (d, <i>J</i> = 5.8 Hz, 2H), 3.54–3.78 (m, 3H), 5.82–6.10 (m, 1H), 7.23 (d, <i>J</i> = 6.8 Hz, 1H), 7.28–7.54 (m, 7H), 7.59 (d, <i>J</i> = 6.8 Hz, 1H), 7.76 (br s, 1H), 9.68 (s, 1H). LC/MS calcd for C<sub>19</sub>H<sub>18</sub>ClN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 355.0; obsd, 356.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> [4-(4-Fluoro-phenyl)-2-methyl-2<i>H</i>-pyrazol-3-yl]-carbamic Acid 1-(2-Chloro-phenyl)-ethyl Ester (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.15–1.30 (br, 1H), 1.56 (br d, <i>J</i> = 5.3 Hz, 2H), 3.62 (br s, 3H), 5.86–6.06 (m, 1H), 6.81–7.27 (m, 3H), 7.31–7.65 (m, 5H), 7.76 (br s, 1H), 9.65 (s, 1H); LC/MS calcd for C<sub>19</sub>H<sub>17</sub>ClFN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 373.0; obsd, 374.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> {4-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-Pyrazol-4-yl]-phenyl}-acetic Acid (<b>10</b>)</h3><div class="NLM_p">4-Bromo-2-methyl-2<i>H</i>-pyrazole-3-carboxylic acid (787.2 mg, 3.84 mmol), DPPA (1.16 g, 4.22 mmol), (<i>R</i>)-1-phenylethanol (491 mg, 4.02 mmol), and TEA (1.10 mL, 7.68 mmol) were combined in 15 mL of toluene to give a clear solution. The mixture was heated to 80 °C and stirred for 1 h. Solvents were evaporated, and the residue was extracted with ethyl acetate and sodium bicarbonate solution. The organic layer was dried and evaporated to give an oily material (1.38 g). <sup>1</sup>H NMR of the crude material indicated 75% of the desired compound as 4-bromo-2-methyl-2<i>H</i>-pyrazol-3-yl-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (<b>45</b>). LRMS calcd for C<sub>13</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 324.0; obsd, 323.0 (M – H, ES<sup>–</sup>).</div><div class="NLM_p">4-Bromo-2-methyl-2<i>H</i>-pyrazol-3-yl-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (263.5 mg, 0.61 mmol), ethyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-phenyl)-acetate (354 mg, 1.22 mmol), X-Phos (116 mg, 0.244 mmol), and palladium acetate (27.4 mg, 0.122 mmol) were dissolved in toluene (6 mL), and potassium phosphate tribasic (518 mg, 2.44 mmol) in degassed water (1.5 mL) was added. The mixture was degassed for 5 min and sealed. The mixture was stirred at 100 °C for 4 h and then extracted with ethyl acetate and water. The organic layer was washed with brine and dried. Solvents were evaporated, and the residue was purified by ISCO flash column chromatography using ethyl acetate in hexanes (0% to 50%) to give a waxy pale yellow material as {4-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-phenyl}-acetic acid ethyl ester (134 mg, 54% yield). LC/MS calcd for C<sub>23</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 407.0; obsd, 408.0 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">{4-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-phenyl}-acetic acid ethyl ester (134 mg, 0.33 mmol) was dissolved in THF (4 mL), and aqueous lithium hydroxide solution (0.5N, 1 mL) was added. The reaction was stirred for 6 h. Solvents were evaporated, and the residue was treated with water (15 mL) to give a clear solution followed by the addition of 1 N hydrochloric acid (0.55 mL). The white solid was filtered and rinsed with water and dried in air to give {4-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-phenyl}-acetic acid (90 mg, 72% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.48 (br s, 3H), 3.48 (s, 2H), 3.54 (s, 3H), 5.70 (d, <i>J</i> = 5.6 Hz, 1H), 7.06–7.42 (m, 9H), 7.67 (s, 1H), 9.48 (br s, 1H), 12.28 (br s, 1H); LC/MS calcd for C<sub>21</sub>H<sub>21</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 379.0; obsd, 380.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> {4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-acetic Acid (<b>11</b>)</h3><div class="NLM_p">Ethyl 2-(4-bromophenyl)-acetate (2.43 g, 10 mmol), 4-hydroxyphenylboronic acid (1.65 g, 12 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (693 mg, 0.6 mmol), and potassium carbonate (2.76 g, 20 mmol) were combined in 14 mL of dry DMF. The mixture was bubbled with nitrogen and sealed. The mixture was stirred at 85 °C for 15 h. Solvents were evaporated, and the residue was extracted with ethyl acetate and water. The organic layer was washed with brine and dried over sodium sulfate. Solvents were evaporated, and the residue was purified by flash column chromatography (5% to 50% ethyl acetate in hexanes). The pure fraction was combined and concentrated. The residue was dissolved in ethyl acetate (4 mL), and hot hexanes were added. The white solid was filtered and dried to give 4′-hydroxy-biphenyl-4-yl-acetic acid ethyl ester (1.68 g, 65.6% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.29 (t, <i>J</i> = 7.1 Hz, 3H), 3.66 (s, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 4.95 (br. s., 1 H), 6.87 (d, <i>J</i> = 8.6 Hz, 2H), 7.33 (d, <i>J</i> = 8.3 Hz, 2H), 7.47 (m, 4H); LC/MS calcd for C<sub>16</sub>H<sub>16</sub>O<sub>3</sub> (<i>m</i>/<i>e</i>) 256.0; obsd, 257.1 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">4′-Hydroxy-biphenyl-4-yl-acetic acid ethyl ester (641 mg, 2.5 mmol) was dissolved in dichloromethane (15 mL). To this solution was added trifluoromethanesulfonic anhydride (706 mg, 2.5 mmol) at −78 °C. Triethylamine (0.35 mL, 2.5 mmol) was added. The mixture was stirred at −78 °C for 10 min and warmed to room temperature. After 30 min, the mixture was extracted with water and methylene chloride. The organic layer was washed with diluted hydrochloric acid and concentrated sodium bicarbonate solution. Solvents were evaporated, and the residue was treated with hexanes. The gray crystalline material was filtered to give 4′-trifluoromethanesulfonyloxy-biphenyl-4-yl-acetic acid ethyl ester (812 mg, 83.6% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.29 (t, <i>J</i> = 7.1 Hz, 3H), 3.68 (s, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 7.35 (d, <i>J</i> = 8.1 Hz, 2H), 7.39 (d, <i>J</i> = 8.1 Hz, 2H), 7.53 (d, <i>J</i> = 8.0 Hz, 2H), 7.64 (d, <i>J</i> = 8.0 Hz, 2H).</div><div class="NLM_p">4′-Trifluoromethanesulfonyloxy-biphenyl-4-yl-acetic acid ethyl ester (800 mg, 2.06 mmol), 4,4,4′,4′,5,5,5′,5′-octamethyl-2,2′-bi(1,3,2-dioxaborolane) (628 mg, 2.47 mmol), potassium acetate (607 mg, 6.18 mmol), and Pd(dppf)Cl<sub>2</sub> (90.4 mg, 0.124 mmol) were combined in dry dioxane (15 mL). The mixture was stirred with argon bubbled through for 5 min. The mixture was heated to 90 °C and stirred for 4 h. The resulting material was filtered through a layer of silica gel and rinsed with ethyl acetate. Solvents were evaporated, and the residue was purified by flash column chromatography (0% to 30% ethyl acetate in hexanes) to give [4′-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-biphenyl-4-yl]-acetic acid ethyl ester as a white solid (728 mg, 96.5% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.28 (t, <i>J</i> = 7.1 Hz, 3H), 1.37 (s, 12H), 3.67 (s, 2H), 4.18 (q, <i>J</i> = 7.1 Hz, 2H), 7.37 (d, <i>J</i> = 8.1 Hz, 2H), 7.60 (dd, <i>J</i> = 8.0, 6.4 Hz, 4H), 7.88 (d, <i>J</i> = 8.1 Hz, 2H).</div><div class="NLM_p last">In a 50 mL round-bottom flask, palladium acetate (12.5 mg, 0.055 mmol), X-Phos (52.9 mg, 0.11 mmol), and potassium phosphate tribasic (236 mg, 1.11 mmol) were mixed in 0.5 mL of degassed water and 1 mL of toluene and stirred for 1 min. Then 4-bromo-2-methyl-2<i>H</i>-pyrazol-3-yl-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (180 mg, 0.55 mmol) in 2 mL of toluene was added followed by the addition of [4′-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-biphenyl-4-yl]-acetic acid ethyl ester (203 mg, 0.55 mmol) and 1 mL of toluene. The mixture was degassed with argon and sealed. The mixture was stirred at 95 °C overnight. The resulting mixture was extracted with ethyl acetate and water. The organic layer was dried and evaporated. The residue was purified by flash column chromatography (ethyl acetate with 5% methanol in hexanes) to give {4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-acetic acid ethyl ester (78.0 mg, 29.1% yield) as an amorphous material. LC/MS calcd for C<sub>29</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 483.0; obsd, 484.1 (M + H, ES<sup>+</sup>). This material was dissolved in 6 mL of THF, and lithium hydroxide solution (1 mL, 0.5 N) was added followed by 0.2 mL of methanol. The mixture was stirred at room temperature for 4 h and concentrated. Warm water (35 mL) was added, and the mixture was filtered. The filtrate was acidified with 1 N hydrochloric acid (0.6 mL) and filtered. The solid was dried under vacuum overnight to give a pale yellow solid as {4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-acetic acid (30 mg, 40.8% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.15–1.32 (br, 1H), 1.56 (d, <i>J</i> = 5.8 Hz, 2H), 3.62 (s, 2H), 3.63 (s, 3H), 5.66–5.83 (br m, 1H), 7.03 (br, 0.5H), 7.18 (br, 0.5H), 7.28–7.38 (m, 3H), 7.38–7.48 (m, 3H), 7.49–7.56 (m, 1H), 7.57–7.68 (m, 5H), 7.81 (s, 1H), 9.62 (s, 1H), 12.38 (s, 1H); LC/MS calcd for C<sub>27</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 455.0; obsd, 456.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-{4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid Ethyl Ester (<b>12</b>)</h3><div class="NLM_p">Ethyl 1-(4′-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-biphenyl-4-yl)-cyclopropanecarboxylate (100 mg, 0.255 mmol), 4-bromo-1-methyl-1<i>H</i>-pyrazol-5-amine (67.3 mg, 0.38 mmol), X-Phos (36.5 mg, 0.077 mol), potassium phosphate tribasic (162 mg, 0.76 mmol), and palladium acetate (8.6 mg, 0.038 mmol) were mixed in 4 mL of toluene. The mixture was stirred, and degassed water (0.8 mL) was added. The mixture was degassed with nitrogen and sealed. The mixture was stirred at 100 °C overnight and then extracted with ethyl acetate and water. Solvents were evaporated, and the residue was purified by flash column chromatography (methanol in methylene chloride 0% to 10%) to give a pale gray solid as 1-[4′-(5-amino-1-methyl-1<i>H</i>-pyrazol-4-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid ethyl ester (48 mg, 52.1% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.19–1.25 (m, 5H), 1.64 (m, 2H), 3.77 (s, 3H), 3.81(br s, 2H), 4.13 (q, <i>J</i> = 7.1 Hz, 2H), 7.44 (t, <i>J</i> = 8.8 Hz, 4H), 7.53 (s, 1H), 7.56 (d, <i>J</i> = 8.1 Hz, 2H), 7.64 (d, <i>J</i> = 8.1 Hz, 2H); LC/MS calcd for C<sub>22</sub>H<sub>23</sub>N<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 361.0; obsd, 362.1 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">1-[4′-(5-Amino-1-methyl-1<i>H</i>-pyrazol-4-yl)-biphenyl-4-yl]-cyclopropanecarboxylic acid ethyl ester (100 mg, 0.277 mmol) and triphosgene (123 mg, 0.415 mmol) were dissolved in methylene chloride (2 mL) to give a solution. Toluene (6 mL) was added, and the mixture was stirred followed by the addition of TEA (0.16 mL). The mixture was sealed and stirred at 90 °C for 10 min. (<i>R</i>)-(+)-1-Phenylethanol (68 mg, 0.553 mmol) in toluene (2 mL) was added. The mixture was stirred at 85 °C for 2 h. This material was extracted with ethyl acetate and ammonium chloride solution. The organic layer was dried over sodium sulfate and filtered. Solvents were evaporated, and the residue was purified by flash column chromatography (0% to 60% ethyl acetate in hexanes) to give a gray powder as 1-{4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid ethyl ester (101 mg, 71.6% yield). <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.20–1.34 (m, 6H), 1.49–1.75 (m, 4H), 3.80 (s, 3H), 4.14 (q, <i>J</i> = 7.1 Hz, 2H), 5.93 (m, 1H), 6.25 (br s, 1H), 7.35–7.48 (m, 9H), 7.53–7.64 (m, 4H), 7.72 (s, 1H); LC/MS calcd for C<sub>31</sub>H<sub>31</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 509.0; obsd, 510.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-{4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid (<b>13</b>)</h3><div class="NLM_p">1-{4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid ethyl ester (80 mg, 0.157 mmol) was dissolved in 4 mL of THF, and lithium hydroxide solution (0.5N, 2 mL) was added. The mixture was stirred at room temperature for 5 min. Methanol (1 mL) was added to give a clear solution. The mixture was stirred at 65 °C for 5 h and then at 30 °C overnight. Solvents were evaporated, and the residue was dissolved in water (12 mL). Hydrochloric acid (1 N, 1.3 mL) was added, and the solid was filtered to give a white solid (65 mg). LC/MS indicated 85% purity with the major impurity as the cleavage of carbamate. This solid was dissolved in acetonitrile/methylene chloride (containing 5% methanol) and purified by flash column chromatography (methanol in dichloromethane 0% to 5%) to give a white solid as 1-{4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-pyrazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid (45 mg, 59.5% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.19–1.25 (m, 2H), 1.49–1.57 (m, 5H), 3.64 (s, 3H), 5.65–5.83 (m, 1H), 6.95–7.25 (br m, 1H), 7.27–7.48 (m, 6H), 7.49–7.67 (m, 6H), 7.82 (br s, 1H), 9.25 (br s, 0.2H), 9.57 (s, 0.8H), 12.35 (s, 1H); LC/MS calcd for C<sub>29</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 481.0; obsd, 482.1 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">Compounds <b>14</b>–<b>20</b> were prepared with the same method described for the preparation of compound <b>13</b>.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-1-{4′-[5-((1-(2-Fluorophenyl)ethoxy)carbonylamino)-1-methyl-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>14</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.37 (br. s., 1H), 9.67 (s, 1H), 7.80 (s, 2H), 7.45–7.70 (m, 8H), 7.39 (d, 2H), 7.19–7.33 (m, 1H), 5.97 (d, <i>J</i> = 5.7 Hz, 1H), 3.62 (s, 3H), 1.57 (m, 2H), 1.38–1.52 (m, 2H), 1.22 (s, 1H), 1.15 (d, 2H); LC/MS calcd for C<sub>29</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 499.0; obsd, 500.1 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 1-{4′-[5-((1-(4-Fluorophenyl)ethoxy)carbonylamino)-1-methyl-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.36 (br. s., 1H), 9.62 (br. s., 1H), 7.82 (s, 1H), 7.60 (d, <i>J</i> = 8.1 Hz, 4H), 7.51 (d, <i>J</i> = 7.8 Hz, 3H), 7.35–7.44 (m, 2H), 7.26 (t, <i>J</i> = 7.8 Hz, 2H), 6.94–7.18 (m, 1H), 5.79 (d, <i>J</i> = 5.8 Hz, 1H), 3.68 (br. s., 3H), 1.56 (d, <i>J</i> = 5.8 Hz, 2H), 1.42–1.51 (m, 2H), 1.21–1.33 (br.m, 1H), 1.11–1.21 (m, 2H); LC/MS calcd for C<sub>29</sub>H<sub>26</sub>FN<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 499.0; obsd, 498.0 (M – H, ES<sup>–</sup>).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>R</i>)-1-{4′-[1-Methyl-5-((1-(3-(trifluoromethyl)phenyl)ethoxy)carbonylamino)-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.34 (br. s., 1H), 9.71 (br. s., 1H), 7.45–7.85 (m, 10H), 7.39 (d, <i>J</i> = 8.3 Hz, 3H), 5.87 (d, <i>J</i> = 6.0 Hz, 1H), 3.65 (s, 3H), 1.57 (d, <i>J</i> = 6.0 Hz, 2H), 1.39–1.51 (m, 2H), 1.22 (br. s., 1H), 1.09–1.19 (m, 2H); LC/MS calcd for C<sub>30</sub>H<sub>26</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 549.0; obsd, 550.1 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>R</i>)-1-{4′-[5-(<i>sec</i>-Butoxycarbonylamino)-1-methyl-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.32 (br. s., 1H), 9.38 (br. s., 1H), 7.80 (s, 1H), 7.50–7.69 (m, 6H), 7.38 (d, <i>J</i> = 8.3 Hz, 2H), 4.69 (br. s., 1H), 3.65 (s, 3H), 1.58 (br. s., 2H), 1.33–1.52 (m, <i>J</i> = 2.6 Hz, 2H), 1.22 (br. s., 3H), 1.14 (m, <i>J</i> = 2.6 Hz, 2H), 0.91 (br. s., 3H); LC/MS calcd for C<sub>25</sub>H<sub>27</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 433.0; obsd, 434.1 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-1-{4′-[5-(1,2-Dimethyl-propoxycarbonylamino)-1-methyl-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.34 (br. s., 1H), 9.37 (br. s., 1H), 7.81 (s, 1H), 7.49–7.68 (m, 6H), 7.38 (d, <i>J</i> = 8.3 Hz, 2H), 4.58 (br. s., 1H), 3.65 (s, 3H), 1.82 (br. s., 1H), 1.44 (br. s., 2H), 1.03–1.30 (m, 5H), 0.92 (br. s., 6H); LC/MS calcd for C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 447.0; obsd, 448.2 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 1-{4′-[5-(Cyclobutoxycarbonylamino)-1-methyl-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (Methanol-d<sub>4</sub>) δ ppm 7.77 (s, 1H), 7.52–7.72 (m, 5H), 7.44 (d, <i>J</i> = 8.3 Hz, 2H), 5.01 (br. s., 1H), 3.79 (s, 3H), 2.40 (br.s., 2H), 2.05–2.29 (m, 2H), 1.78–1.94 (m, 1H), 1.46–1.76 (m, 3H), 1.12–1.42 (m, 2H); LC/MS calcd for C<sub>25</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 431.0; obsd, 432.0 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-{4′-[1-Methyl-5-((oxetan-3-yloxy)carbonylamino)-1<i>H</i>-pyrazol- 4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.33 (br. s., 1H), 7.93 (s, 1H), 7.66–7.73 (m, <i>J</i> = 8.3 Hz, 2H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.53–7.59 (m, <i>J</i> = 8.1 Hz, 2H), 7.42 (d, <i>J</i> = 8.1 Hz, 2H), 5.41 (br. s., 1H), 4.85–4.94 (m, 1H), 3.90 (t, 1H), 3.66–3.83 (m, 6H), 3.57 (br. d., 1H), 1.42–1.62 (m, 2H), 1.13–1.22 (m, 2H); LC/MS calcd for C<sub>24</sub>H<sub>23</sub>N<sub>3</sub>O<sub>5</sub> (<i>m</i>/<i>e</i>) 433.0; obsd, 434.1 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 1-{4′-[4-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>2</b>)</h3><div class="NLM_p">In a 350 mL reaction vial, 4-bromo-phenylboronic acid (21.17 g, 105 mmol), sodium azide (10.3 g, 158 mmol), and copper(II) acetate (1.91 g, 10.5 mmol) were combined with methanol (200 mL) to give a brown suspension. The reaction was stirred at room temperature open to the atmosphere for 23 h. The resulting mixture was concentrated, diluted with ethyl ether/hexanes, and washed with water, saturated ammonium chloride, and ammonium hydroxide solution. The organic layer was dried over MgSO<sub>4</sub> and stored in the refrigerator overnight. The crude material was warmed to room temperature, filtered, concentrated to give a red/yellow oil which was dissolved in hexanes (20 mL), and purified by flash column chromatography eluted with hexanes to obtain 1-azido-4-bromo-benzene (19.5 g, 93.4% yield) as a yellow oil. LC/MS calcd for C<sub>6</sub>H<sub>4</sub>BrN<sub>3</sub> (<i>m</i>/<i>e</i>) 197/199; obsd, 170/172 (M-N<sub>2</sub>+H, ES<sup>+</sup>).</div><div class="NLM_p">In a 350 mL reaction vial, 1-azido-4-bromo-benzene (10 g, 50.5 mmol) and methyl but-2-ynoate (5.45 g, 5.56 mL, 55.5 mmol) were combined with toluene (106 mL) to give a yellow suspension. The vial was sealed and heated in an oil bath at 150 °C for 4.5 h. The mixture was cooled and stored at room temperature. The reaction was filtered, and the solid was washed with toluene and ethyl acetate (3 × 15 mL). The filtrate was concentrated, dissolved in minimal dichloromethane, and purified by flash column chromatography (0% to 50% ethyl acetate in hexanes) to give 3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid methyl ester (4.5 g, 30.1% yield) as a light brown solid. LC/MS calcd for C<sub>11</sub>H<sub>10</sub>BrN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 295/297; obsd, 296/298 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">To a 1 L round-bottom flask containing 3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid methyl ester (4.5 g, 15.2 mmol) dissolved in THF (200 mL) was added LiOH (2.77 g, 120 mmol) dissolved in water (75 mL, with heat). The solution was stirred at room temperature for 16 h. The reaction was concentrated, diluted with water, and extracted with ethyl ether. The aqueous layer was acidified with 1 N HCl, and the resulting precipitate was filtered, washed with water and hexanes, and dried over an in-house vacuum to provide 3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid (4.25 g, 99% yield) as an off-white solid. LC/MS calcd for C<sub>10</sub>H<sub>8</sub>N<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 281/283; obsd, 282/284 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">In a 350 mL reaction vial, 3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid (3.6 g, 12.8 mmol), (<i>R</i>)-1-phenylethanol (3.04 g, 3 mL, 24.9 mmol), and triethylamine (3.27 g, 4.5 mL, 32.3 mmol) were combined with toluene (100 mL) to give a yellow solution. To this solution was added diphenylphosphoryl azide (8.94 g, 7 mL, 32.5 mmol). The mixture was heated in an oil bath at 65 °C for 2 h and cooled to room temperature overnight. The reaction was concentrated as a yellow viscous oil, diluted with dichloromethane, and purified by flash column chromatography (0–50% ethyl acetate in hexanes) to give [3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (4.07 g, 79.5% yield) as a white solid. LC/MS calcd for C<sub>18</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 400/402; obsd, 401/403 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">In a 350 mL vial, 1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarboxylic acid methyl ester (2.49 g, 8.22 mmol, prepared from 1-(4-bromophenyl)-cyclopropanecarboxylic acid methyl ester), [3-(4-bromo-phenyl)-5-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (3.0 g, 7.48 mmol), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (S-Phos) (921 mg, 2.24 mmol), and palladium(II) acetate (252 mg, 1.12 mmol) were combined with toluene (120 mL) to give a light yellow solution. To this was added tripotassium phosphate (4.76 g, 22.4 mmol) dissolved in water (30.0 mL). The mixture was bubbled with nitrogen, and the vial was sealed, heated in an oil bath at 100 °C for 4 h, and cooled to room temperature overnight. The reaction was diluted with ethyl acetate (50 mL) and water (100 mL), filtered, and rinsed with water (30 mL) and ethyl acetate (50 mL). The filtrate was separated and the organic layer was dried over MgSO<sub>4</sub>, filtered, concentrated, dissolved in minimal dichloromethane, and purified by flash column chromatography (0% to 50% ethyl acetate in hexanes) to give 1-{4′-[4-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid methyl ester (2.65 g, 71.4% yield) as a white solid. LC/MS calcd for C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 496; obsd, 497 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">{4′-[4-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid methyl ester (2.65 g, 5.34 mmol) was combined with THF (50 mL) to give a yellow solution. To this was added LiOH (1.28 g, 53.4 mmol) dissolved in water (12.5 mL, heated to partially dissolve). The reaction flask was sealed and heated in an oil bath at 60 °C for 5 h. The reaction was cooled to room temperature overnight. The mixture was diluted with water (100 mL), concentrated, diluted with more water (500 mL), and acidified with 1 N HCl. The resulting precipitate was filtered, washed with water and hexanes, and dried. The crude product (2.8 g) was purified by reverse phase chromatography (C18 Silicycle 120 g, 60 mL/min, 20–100% acetonitrile/H<sub>2</sub>O) to give 1.65 g of a white solid. This solid was crystallized from acetonitrile to provide pure compound <b>2</b> (1.48 g, 57.5% yield). LC/MS calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 482; obsd, 483 (M + H, ES<sup>+</sup>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ 12.40 (br. s., 1H), 9.69 (br. s., 1H), 7.83 (d, <i>J</i> = 7.0 Hz, 2H), 7.67 (d, <i>J</i> = 8.3 Hz, 2H), 7.58 (d, <i>J</i> = 8.0 Hz, 2H), 7.47 (d, <i>J</i> = 8.5 Hz, 2H), 7.00–7.42 (m, 5H), 5.71 (br. s., 1H), 2.18 (s, 3H), 1.29–1.69 (m, 5H), 1.13–1.26 (m, 2H).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> {4′-[4-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-acetic Acid (<b>21</b>)</h3><div class="NLM_p">In a 350 mL reaction vial, ethyl 2-(4-bromophenyl)acetate (25 g, 103 mmol), bis(pinacolato)diboron (31.3 g, 123 mmol), and potassium acetate (20.2 g, 206 mmol) were combined with 1,4-dioxane (190 mL) to give a white suspension. The mixture was purged with nitrogen for 5 min, PdCl<sub>2</sub>(dppf) (4.2 g, 5.74 mmol) was added, and the vial was sealed and heated in an oil bath at 80 °C for 3 h. The reaction was filtered, rinsed with ethyl ether, concentrated, diluted with water (500 mL), and extracted with ethyl ether (2 × 300 mL), and the organic layers were washed with brine (250 mL). The ethyl ether layers were combined, dried over MgSO<sub>4</sub>, filtered, and concentrated as red oil. The crude material was purified by flash column chromatography (0% to 20% EtOAc in hexanes) to give [4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-acetic acid ethyl ester (25.14 g, 84.2% yield) as an oil. LC/MS calcd for C<sub>16</sub>H<sub>23</sub>BO<sub>4</sub> (<i>m</i>/<i>e</i>) 290; obsd, 291 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">In a 20 mL vial, [4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-acetic acid ethyl ester (79.5 mg, 0.274 mmol), [1-(4-bromo-phenyl)-5-methyl-1<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (100 mg, 0.249 mmol), tripotassium phosphate (159 mg, 0.748 mmol), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (S-Phos) (30.7 mg, 0.0748 mmol), and palladium(II) acetate (8.4 mg, 0.037 mmol) were combined with toluene (2 mL) and water (0.5 mL) (previously purged with nitrogen for 20 min) to give a light yellow suspension. The mixture was bubbled with nitrogen, and the vial was sealed, heated in a dry block at 100 °C for 6 h, and cooled to room temperature overnight. The reaction was diluted with ethyl acetate (50 mL) and washed with water (50 mL) and brine. The aqueous layers were extracted with ethyl acetate (50 mL). The organic layers were combined, dried over MgSO<sub>4</sub>, filtered, concentrated, dissolved in minimal dichloromethane, and purified by flash column chromatography (0% to 60% ethyl acetate in hexanes) to give {4′-[4-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-acetic acid ethyl ester (40 mg, 33.1% yield) as a colorless waxy solid. LC/MS calcd for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 484; obsd, 485 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">In a 200 mL round-bottomed flask, {4′-[4-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-acetic acid ethyl ester (34 mg, 0.0702 mmol) was combined with THF (2 mL) to give a yellow solution. To this was dripped in LiOH (16.8 mg, 0.702 mmol) dissolved in water (0.5 mL, heated to partially dissolve). The mixture was stirred for 11 h. The reaction was diluted with water, and acidified with 1 N HCl. The resulting precipitate was filtered, washed with water and hexanes, and dried to provide compound <b>21</b> as an off-white solid. LC/MS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> (me) 456; obsd, 457 (M + H, ES<sup>+</sup>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.42 (br. s., 1H), 9.19–9.80 (m, 1H), 7.83 (d, <i>J</i> = 6.5 Hz, 2H), 7.69 (d, <i>J</i> = 8.0 Hz, 2H), 7.57 (d, <i>J</i> = 7.3 Hz, 2H), 7.08–7.47 (m, 7H), 5.69 (br. s., 1H), 3.65 (s, 2H), 2.16 (s, 3H), 1.13–1.64 (m, 3H).</div><div class="NLM_p last">Compounds <b>22</b>–<b>29</b> and <b>31</b>–<b>32</b> were prepared with the same method described for the preparation of compound <b>2</b>.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 1-(4′-{5-[(<i>R</i>)-1-(2-Fluoro-phenyl)-ethoxycarbonylamino]-4-methyl-[1,2,3]triazol-1-yl}-biphenyl-4-yl)-cyclopropanecarboxylic Acid (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.39 (br. s., 1H), 9.74 (br. s., 1H), 7.84 (d, <i>J</i> = 6.5 Hz, 2H), 7.67 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (d, <i>J</i> = 8.0 Hz, 2H), 7.47 (d, <i>J</i> = 8.0 Hz, 2H), 6.69–7.42 (m, 4H), 5.89 (br. s., 1H), 2.17 (br. s., 3H), 1.26–1.74 (m, 5H), 1.14–1.24 (m, 2H); LC/MS calcd for C<sub>28</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 500; obsd, 501 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 1-(4′-{4-Methyl-5-[(<i>R</i>)-1-(2-trifluoromethyl-phenyl)-ethoxycarbonylamino]-[1,2,3]triazol-1-yl}-biphenyl-4-yl)-cyclopropanecarboxylic Acid (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.40 (br. s., 1H), 9.77 (br. s., 1H), 7.83 (d, <i>J</i> = 7.3 Hz, 2H), 7.63–7.78 (m, 5H), 7.39–7.62 (m, 5H), 5.96 (br. s., 1H), 2.15 (br. s., 3H), 1.50 (d, <i>J</i> = 2.3 Hz, 5H), 1.20 (d, <i>J</i> = 2.0 Hz, 2H); LC/MS calcd for C<sub>29</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 550; obsd, 551 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 1-(4′-{4-Methyl-5-[(<i>R</i>)-1-(3-trifluoromethyl-phenyl)-ethoxycarbonylamino]-[1,2,3]triazol-1-yl}-biphenyl-4-yl)-cyclopropanecarboxylic Acid (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.39 (br. s., 1H), 9.47 (br. s., 1H), 7.88 (d, <i>J</i> = 7.8 Hz, 2H), 7.64 (dd, <i>J</i> = 18.7, 8.2 Hz, 4H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 4.67 (br. s., 1H), 2.36 (br. s., 1H), 2.20 (s, 3H), 1.54–2.02 (m, 6H), 1.43–1.53 (m, 2H), 1.17–1.31 (m, 2H), 1.05 (br. s., 3H); LC/MS calcd for C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 460; obsd, 461 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 1-{4′-[5-((<i>R</i>)-1,2-Dimethyl-propoxycarbonylamino)-4-methyl-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.37 (br. s., 1H), 9.43 (br. s., 1H), 7.88 (d, <i>J</i> = 8.0 Hz, 2H), 7.57–7.73 (m, 4H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 4.50 (br. s., 1H), 2.21 (s, 3H), 1.71 (br. s., 1H), 1.40–1.57 (m, 2H), 1.00–1.32 (m, 5H), 0.84 (br. s., 6H); LC/MS calcd for C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 448; obsd, (M + H, ES<sup>+</sup>).</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 1-{4′-[5-((<i>R</i>)-<i>sec</i>-Butoxycarbonylamino)-4-methyl-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.37 (br. s., 1H), 9.44 (br. s., 1H), 7.88 (d, <i>J</i> = 8.5 Hz, 2H), 7.56–7.72 (m, 4H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 4.61 (br. s., 1H), 2.21 (s, 3H), 1.38–1.66 (m, 4H), 1.03–1.34 (m, 5H), 0.85 (dd, <i>J</i> = 10.7, 6.9 Hz, 3H); LC/MS calcd for C<sub>24</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 434; obsd, 435 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-{4′-[5-(1-Cyclobutyl-ethoxycarbonylamino)-4-methyl-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.39 (br. s., 1H), 9.47 (br. s., 1H), 7.88 (d, <i>J</i> = 7.8 Hz, 2H), 7.64 (dd, <i>J</i> = 18.7, 8.2 Hz, 4H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 4.67 (br. s., 1H), 2.36 (br. s., 1H), 2.20 (s, 3H), 1.54–2.02 (m, 6H), 1.43–1.53 (m, 2H), 1.17–1.31 (m, 2H), 1.05 (br. s., 3H); LC/MS calcd for C<sub>26</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 460; obsd, 461 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-[4′-(5-<i>tert</i>-Butoxycarbonylamino-4-methyl-[1,2,3]triazol-1-yl)-biphenyl-4-yl]-cyclopropanecarboxylic Acid (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.40 (br. s., 1H), 9.24 (br. s., 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 2H), 7.58–7.71 (m, 4H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 2.20 (s, 3H), 1.16–1.55 (m, 13H); LC/MS calcd for C<sub>24</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 434; obsd, 435 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> {3-[4′-(1-Methanesulfonylaminocarbonyl-cyclopropyl)-biphenyl-4-yl]-5-methyl-3<i>H</i>-[1,2,3]triazol-4-yl}-carbamic Acid (<i>R</i>)-1-Phenyl-ethyl Ester (<b>29</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 11.24 (br. s., 1H), 9.68 (br. s., 1H), 7.85 (d, <i>J</i> = 7.0 Hz, 2H), 7.72 (d, <i>J</i> = 8.3 Hz, 2H), 7.59 (d, <i>J</i> = 7.8 Hz, 2H), 7.45 (d, <i>J</i> = 8.3 Hz, 2H), 7.34 (br. s., 5H), 5.70 (br. s., 1H), 3.23 (s, 3H), 2.17 (s, 3H), 1.29–1.73 (m, 5H), 1.23 (br. s., 2H); LC/MS calcd for C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>5</sub>S (<i>m</i>/<i>e</i>) 559; obsd, 560 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>)-1-Phenyl-ethyl-1-(4′-(1-(1<i>H</i>-tetrazol-5-yl)cyclopropyl)biphenyl-4-yl)-4-methyl-1<i>H</i>-1,2,3-triazol-5-ylcarbamate (<b>30</b>)</h3><div class="NLM_p">To a mixture of (<i>R</i>)-1-phenylethyl 4-methyl-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-1<i>H</i>-1,2,3-triazol-5-ylcarbamate (485 mg, 1.08 mmol), 1-(4-bromophenyl)cyclopropanecarbonitrile (360 mg, 1.62 mmol), palladium(II) acetate (36.4 mg, 0.16 mmol), 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (133 mg, 0.33 mmol), and potassium phosphate tribasic (689 mg, 3.25 mmol) in a vial were added toluene (9 mL) and water (2.0 mL) at room temperature under nitrogen atmosphere. The vial was sealed, and the resulting light brown suspension was heated to 105 °C and stirred for 3 h. The reaction mixture was cooled and diluted with water. The organic compound was extracted into ethyl acetate (2 × 50 mL), and the combined extracts were washed with brine solution and dried over anhydrous MgSO<sub>4</sub>. Filtration and concentration gave the crude residue, which was purified by flash column chromatography eluting with 0–100% ethyl acetate in hexanes to give (<i>R</i>)-1-phenyl-ethyl-1-(4′-(1-cyanocyclopropyl)biphenyl-4-yl)-4-methyl-1<i>H</i>-1,2,3-triazol-5-ylcarbamate (190 mg, 38% yield) as a white solid. LC/MS calcd for C<sub>28</sub>H<sub>25</sub>N<sub>5</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 463; obsd, 464.8 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">To a solution of (<i>R</i>)-1-phenylethyl-1-(4′-(1-cyanocyclopropyl)biphenyl-4-yl)-4-methyl-1<i>H</i>-1,2,3-triazol-5-ylcarbamate (50 mg, 0.11 mmol) in toluene (5 mL) were added di-<i>n</i>-butyltin oxide (5.37 mg, 0.22 mmol) and azidotrimethylsilane (12.4 mg, 14.3 μL, 0.11 mmol) at room temperature under nitrogen atmosphere. The resulting cloudy solution was heated to 100 °C and stirred for 15 h. The mixture was cooled to room temperature, poured into brine solution, and extracted with ethyl acetate. The organic layer was washed with brine solution and dried over anhydrous MgSO<sub>4</sub>. Filtration and concentration gave the crude product which was purified by flash column chromatography eluting with 0–100% ethyl acetate in hexanes and 10% methanol in dichloromethane to give compound <b>30</b> as a white solid (25 mg, 46% yield). LC/MS calcd for C<sub>28</sub>H<sub>26</sub>N<sub>8</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 506; obsd, 507.1 (M + H, ES<sup>+</sup>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 16.08 (br. s., 1H), 9.20–9.84 (m, 1H), 7.85 (d, <i>J</i> = 7.0 Hz, 2H), 7.73 (d, <i>J</i> = 8.3 Hz, 2H), 7.52–7.65 (m, 2H), 7.46 (d, <i>J</i> = 8.3 Hz, 2H), 7.34 (br. s., 5H), 5.52–5.84 (m, 1H), 2.17 (s, 3H), 1.51–1.63 (m, 4H), 1.15–1.35 (m, 3H).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-{4′-[4-Ethyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>31</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.40 (br. s., 1H), 9.66 (br. s., 1H), 7.83 (d, <i>J</i> = 6.5 Hz, 2H), 7.67 (d, <i>J</i> = 8.0 Hz, 2H), 7.58 (d, <i>J</i> = 7.3 Hz, 2H), 7.47 (d, <i>J</i> = 8.0 Hz, 2H), 7.34 (br. s., 5H), 5.71 (br. s., 1H), 2.56 (d, <i>J</i> = 7.5 Hz, 2H), 1.36–1.60 (m, 5H), 1.16–1.23 (m, 5H); LC/MS calcd for C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 496; obsd, 497.1 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 1-{4′-[5-((<i>R</i>)-1-Phenyl-ethoxycarbonylamino)-[1,2,3]triazol-1-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>32</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.38 (br. s., 1H), 10.04 (br. s., 1H), 7.87 (d, <i>J</i> = 8.3 Hz, 2H), 7.82 (s, 1H), 7.68 (d, <i>J</i> = 8.3 Hz, 2H), 7.62 (d, <i>J</i> = 8.3 Hz, 2H), 7.48 (d, <i>J</i> = 8.0 Hz, 2H), 7.17–7.41 (m, 5H), 5.74 (d, <i>J</i> = 5.8 Hz, 1H), 1.34–1.62 (m, 5H), 1.21 (d, <i>J</i> = 2.5 Hz, 2H); LC/MS calcd for C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 468; obsd, 469 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-{4′-[3-((<i>R</i>)-1-Phenyl-ethoxycarbonylamino)-[1,2,4]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>33</b>)</h3><div class="NLM_p">In a 250 mL round-bottomed flask, calcium carbonate (6.11 g, 61.0 mmol) and 4-bromoaniline (5 g, 29.1 mmol) were combined with dichloromethane (25 mL) and water (25.0 mL) to give a light brown suspension. The reaction mixture was cooled to 0 °C, and thiophosgene (3.68 g, 2.45 mL, 32.0 mmol) was added dropwise over 4 min. The reaction was stirred at 0 °C for 30 min then at 25 °C for 19 h. The reaction mixture was filtered through Celite, and the filter cake was washed with dichloromethane. The aqueous layer was back-extracted with dichloromethane (1 × 25 mL). The organic layers were combined, washed with water (1 × 25 mL) and saturated NaCl (1 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo</i>. The light brown solid was dried under vacuum to give 1-bromo-4-isothiocyanatobenzene (5.43 g, 87%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 7.55–7.74 (m, 2H), 7.28–7.50 (m, 2H).</div><div class="NLM_p">In a 500 mL round-bottomed flask, 1-bromo-4-isothiocyanatobenzene (1.5 g, 7.01 mmol) was combined with 0.4 M ammonia in THF (52.5 mL, 21.0 mmol) to give a yellow solution. The reaction was stirred at 25 °C overnight. The crude reaction mixture was concentrated <i>in vacuo</i> to afford 1-(4-bromophenyl)thiourea (1.63 g, quantitative) as a light brown solid. (M + H)<sup>+</sup> = 230.9/233.0 (<i>m</i>/<i>e</i>).</div><div class="NLM_p">In a 250 mL round-bottomed flask, 1-(4-bromophenyl)thiourea (1.62 g, 7.01 mmol) was combined with methanol (50 mL) to give a light brown suspension. Methyl iodide (1.09 g, 482 μL, 7.71 mmol) was added, and the reaction mixture was stirred at 25 °C for 17 h. The crude reaction mixture was concentrated <i>in vacuo</i> to yield 1-(4-bromophenyl)-2-methyl-isothiourea hydroiodide (2.61 g, 100%) as a light brown powder. The material was used without further purification.</div><div class="NLM_p">In a 250 mL round-bottomed flask, 1-(4-bromophenyl)-2-methyl-isothiourea hydroiodide (2.61 g, 7.00 mmol) was combined with water (10 mL) and ethanol (10.0 mL) to give a light brown solution. Hydrazine monohydrate (525 mg, 509 μL, 10.5 mmol) was added and the reaction was stirred at 25 °C for 20 h. The crude reaction mixture was concentrated <i>in vacuo</i> to about half volume, and silver nitrate (1.19 g, 7.00 mmol) was added with vigorous stirring. The gray/brown solid was filtered through Celite, and the filter cake was washed twice with boiling water. The filtrate was concentrated <i>in vacuo</i> to give a yellow oil. The oily material was dried under vacuum with slight heating (2.27 g). This material (2.27 g, 7.77 mmol) and formic acid (715 mg, 596 μL, 15.5 mmol) were combined to give a yellow solution. The reaction mixture was heated to 120 °C for 3.5 h. The reaction was cooled and neutralized with 3 M NaOH. The mixture was diluted with 150 mL of dichloromethane and stirred vigorously. The insoluble solid was filtered, and the phases were separated. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub> and filtered. The filtered solid was combined with the dried organic phase and concentrated <i>in vacuo</i>. The residue was taken up in refluxing ethanol and filtered hot to remove a small amount of white insoluble solid. The light brown filtrate was stripped to a tan powder and dried under vacuum to afford 4-(4-bromophenyl)-4<i>H</i>-1,2,4-triazol-3-amine (1.665 g, 90%). (M + H)<sup>+</sup> = 239.0/240.9 (<i>m</i>/<i>e</i>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 8.20 (s, 1H), 7.66–7.81 (m, 2H), 7.34–7.54 (m, 2H), 5.86 (s, 2H).</div><div class="NLM_p">In a 20 mL sealed tube, 4-(4-bromophenyl)-4<i>H</i>-1,2,4-triazol-3-amine (349 mg, 1.46 mmol), 4-(1-(methoxycarbonyl)cyclopropyl)phenylboronic acid (450 mg, 2.04 mmol) and 2 M Na<sub>2</sub>CO<sub>3</sub> (2.19 mL, 4.38 mmol) were combined with dioxane (6 mL) to give a light yellow suspension. PdCl<sub>2</sub>(dppf) (95.4 mg, 117 μmol) was added, and the reaction was purged with argon. The reaction mixture was sealed and heated to 100 °C for 24 h under argon. The reaction was cooled and diluted with ethyl acetate and water. The mixture was filtered, and the filtrate was washed with water and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, combined with the filtered solid, and concentrated <i>in vacuo</i>. Celite was added to the residue, and the mixture was triturated with refluxing methanol. The mixture was filtered, and the filter cake was washed twice with refluxing methanol. The filtrate was stripped <i>in vacuo</i>, and the crude material was purified by flash chromatography (0% to 10% methanol in dichloromethane) to afford methyl 1-(4′-(3-amino-4<i>H</i>-1,2,4-triazol-4-yl)biphenyl-4-yl)cyclopropanecarboxylate (257 mg, 53%) as a light brown powder. (M + H)<sup>+</sup> = 335.1 (<i>m</i>/<i>e</i>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 8.24 (s, 1H), 7.79–7.86 (m, 2H), 7.62–7.70 (m, 2H), 7.53–7.60 (m, 2H), 7.41–7.49 (m, 2H), 5.86 (s, 2H), 3.58 (s, 3H), 1.42–1.61 (m, 2H), 1.16–1.35 (m, 2H).</div><div class="NLM_p">In a 250 mL round-bottomed flask, (<i>R</i>)-1-phenylethanol (2.01 g, 16.5 mmol) and carbonyl diimidazole (2.67 g, 16.5 mmol) were combined with ethyl acetate (40 mL) to give a colorless solution. The reaction mixture was refluxed for 20 h under argon, cooled, and diluted with ethyl acetate. The mixture was washed with water (2 × 40 mL) and saturated NaCl (1 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated <i>in vacuo.</i> The material crystallized upon standing to afford (<i>R</i>)-1-phenylethyl 1<i>H</i>-imidazole-1-carboxylate (3.42 g, 96%) as off white needles. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 8.42 (s, 1H), 7.65 (dd, <i>J</i> = 1.8, 1.3 Hz, 1H), 7.45–7.54 (m, 2H), 7.22–7.45 (m, 3H), 7.09 (dd, <i>J</i> = 1.6, 0.9 Hz, 1H), 6.05 (q, <i>J</i> = 6.6 Hz, 1H), 1.66 (d, <i>J</i> = 6.6 Hz, 3H).</div><div class="NLM_p last">In a 250 mL round-bottomed flask, methyl 1-(4′-(3-amino-4<i>H</i>-1,2,4-triazol-4-yl)biphenyl-4-yl)cyclopropanecarboxylate (115 mg, 344 μmol) was combined with THF (6 mL) to give a light brown suspension. LiHMDS (1 M) in THF (447 μL, 447 μmol) was added, and the brown solution was stirred at 25 °C under argon for 15 min. (<i>R</i>)-1-phenylethyl 1<i>H</i>-imidazole-1-carboxylate (112 mg, 516 μmol) in 1 mL of THF was added, and the reaction mixture was stirred for 15 min at 25 °C. The reaction was quenched with water and diluted with 10% methanol in dichloromethane. Sodium sulfate was added, and the mixture was filtered through Celite, and the brown filtrate was concentrated <i>in vacuo</i>. The crude material was purified by flash column chromatography (0% to 10% methanol in dichloromethane) to afford 1-{4′-[3-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-[1,2,4]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid methyl ester (85 mg, 51%) as an off white solid. (M + H)<sup>+</sup> = 483.1 (<i>m</i>/<i>e</i>). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 10.01 (s, 1H), 8.87 (s, 1H), 7.76–7.93 (m, 2H), 7.58–7.75 (m, 2H), 7.38–7.57 (m, 4H), 7.12–7.38 (m, 5H), 5.62 (d, <i>J</i> = 6.8 Hz, 1H), 3.58 (s, 3H), 1.47–1.60 (m, 2H), 1.34 (d, <i>J</i> = 5.6 Hz, 2H), 1.15–1.31 (m, 3H). This material (110 mg, 228 μmol) was combined with THF (5 mL) and methanol (1 mL) to give a yellow solution. LiOH (1 M) (2 mL, 2.00 mmol) was added, and the reaction was stirred at 25 °C for 17 h. The crude reaction mixture was concentrated <i>in vacuo</i>, acidified with 1 M HCl, and diluted with ethyl acetate. The organic layer was washed with water (1 × 15 mL) and saturated NaCl (1 × 15 mL), dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated <i>in vacuo</i>. The crude material was purified by flash column chromatography (0% to 10% methanol in dichloromethane) to afford compound <b>33</b> (86 mg, 80%) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.39 (br. s., 1H), 10.01 (br. s., 1H), 8.87 (br. s., 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 2H), 7.65 (d, <i>J</i> = 8.3 Hz, 2H), 7.39–7.59 (m, 4H), 7.10–7.39 (m, 5H), 5.62 (d, <i>J</i> = 6.3 Hz, 1H), 1.45–1.54 (m, 2H), 1.40 (br. s., 1H), 1.09–1.37 (m, 4H); LC/MS calcd for C<sub>27</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 468; obsd, 469 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> {4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-acetic Acid (<b>34</b>)</h3><div class="NLM_p">LDA solution (2 M) in THF (20.71 mL, 41.436 mmol) was added to a stirred solution of 1-bromo-4-ethynyl-benzene (3 g, 16.57 mmol) in dry THF (40 mL) at −70 °C and stirred for 30 min. Ethyl chloroformate (11.81 mL, 74.58 mmol) was added, and the mixture was allowed to warm to ambient temperature. Stirring was continued for 2 h. The mixture was cooled and quenched with saturated NH<sub>4</sub>Cl solution. THF was evaporated under reduced pressure, and the aqueous layer was extracted with ethyl acetate. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, concentrated, and purified by flash column chromatography using ethyl acetate and hexane as eluting solvent to give (4-bromo-phenyl)-propyonic acid ethyl ester (2.9 g, 69.13% yield) as a light yellow liquid. GC-MS (M + H)<sup>+</sup> 253 (<i>m</i>/<i>e</i>); <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.32 (t, <i>J</i> = 7.0 Hz, 3H). 4.28 (q, <i>J</i> = 7.0 Hz, 2H), 7.43 (d, <i>J</i> = 8.4 Hz, 2H), 7.51 (d, <i>J</i> = 8.4 Hz, 2H).</div><div class="NLM_p">To a stirred solution of (4-bromo-phenyl)-propynoic acid ethyl ester (2.5 g, 9.881 mmol) in benzene (4 mL), was added trimethylsilylmethyl azide (5.108 g, 39.52 mmol). The reaction mixture was refluxed for 4 h, then cooled to rt and concentrated under reduced pressure. Crude mass was purified by normal silica gel column chromatography using ethyl acetate–hexane as eluting solvent to get two major fractions. One fraction is 5-(4-bromo-phenyl)-3-trimethylsilanylmethyl-3<i>H</i>-[1,2,3] triazole-4-carboxylic acid ethyl ester (1.7 g, 45%) as a light yellow liquid. LC-MS (M + H)<sup>+</sup> 382 (<i>m</i>/<i>e</i>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.10 (s, 9H), 1.21 (t, <i>J</i> = 7.2 Hz, 3H), 4.31 (m, 4H), 7.66 (s, 4H). The regio-chemistry was assigned by the <sup>1</sup>H-NOE study. The other major fraction gave 5-(4-bromo-phenyl)-1-trimethylsilanylmethyl-1<i>H</i>-[1,2,3] triazole-4-carboxylic acid ethyl ester (1.8 g, 47.7% yield) as a light yellow liquid. LC-MS (M + H)<sup>+</sup> 382 (<i>m</i>/<i>e</i>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.02 (s, 9H), 1.13 (t, <i>J</i> = 7.2 Hz, 3H), 3.76 (s, 2H), 4.16 (q, <i>J</i> = 7.2 Hz, 2H), 7.46 (d, <i>J</i> = 8.4 Hz, 2H), 7.74 (d, <i>J</i> = 8.4 Hz, 2H). The regio-chemistry was also assigned by the <sup>1</sup>H-NOE study.</div><div class="NLM_p">To a stirred solution of 5-(4-bromo-phenyl)-3-trimethylsilanylmethyl-3<i>H</i>-[1,2,3] triazole-4-carboxylic acid ethyl ester (1.9 g, 4.974 mmol) in THF (40 mL) was added water (0.18 mL, 9.948 mmol) and cooled to 0 °C. Then TBAF (1 M) solution in THF (5.9 mL, 5.9 mmol) was added, and the mixture was stirred at 0 °C for 10 min. Volatiles were distilled off, and crude mass was purified by normal silica gel column chromatography using ethyl acetate–hexane as eluting solvent to get 5-(4-bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3] triazole-4-carboxylic acid ethyl ester (0.7 g, 45.4% yield) as an off white solid. LC-MS (M + H)<sup>+</sup> 310 (<i>m</i>/<i>e</i>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.23 (t, <i>J</i> = 7.0 Hz, 3H), 4.27 (s, 3H), 4.31 (q, <i>J</i> = 7.0 Hz, 2H), 7.68 (s, 4H). 5-(4-Bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3] triazole-4-carboxylic acid ethyl ester (1.2 g, 3.87 mmol) was dissolved in THF (15 mL), and lithium hydroxide solution (0.5 N, 10 mL) was added. The mixture was stirred at room temperature for 3 h. The mixture was concentrated, and the residue was dissolved in water (20 mL) and filtered. The filtrate was acidified with 2 N hydrochloric acid (3 mL). The white solid was filtered and dried to give 5-(4-bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3] triazole-4-carboxylic acid as a white solid (1.03 g, 94.4% yield). Mp 209–210 °C; LC-MS calcd for C<sub>10</sub>H<sub>8</sub>BrN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 283.0; obsd, 284.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 4.26 (s, 3H), 7.66–7.72 (m, 4H), 14.20 (br s, 1H).</div><div class="NLM_p">5-(4-Bromophenyl)-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid (500 mg, 1.77 mmol), (<i>R</i>)-1-phenylethanol (260 mg, 2.13 mmol), DPPA (537 mg, 1.95 mmol), and TEA (179 mg, 1.7 mmol) were combined in toluene (10 mL). The mixture was stirred at 90 °C for 2 h, and solvents were evaporated. The residue was extracted with ethyl acetate and water. The organic layer was washed with sodium bicarbonate solution and dried. Solvents were evaporated, and the residue was purified by flash column chromatography (ethyl acetate in hexanes 0% to 50%) to give [5-(4-bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester as an amorphous powder (440 mg, 61.9% yield). LC/MS calcd for C<sub>18</sub>H<sub>17</sub>BrN<sub>4</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 402; obsd, 402.9 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.55 (br, 3H), 3.83 (s, 3H), 5.76 (br s, 1H), 7.20–7.50 (m, 5H), 7.57–7.70 (m, 4H), 9.95 (br s, 1H).</div><div class="NLM_p">[5-(4-Bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (120 mg, 0.30 mmol), ethyl 2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)acetate (130 mg, 0.45 mmol), X-Phos (43 mg, 0.09 mmol), palladium acetate (10 mg, 0.045 mmol), and potassium phosphate (190 mg, 0.90 mmol) were combined in 5 mL of toluene. Deionized water (1 mL) was added, and the mixture was degassed with argon for 2 min. The mixture was sealed and stirred at 100 °C for 2 h. The mixture was extracted with ethyl acetate and water, washed with brine, and dried. Solvents were evaporated, and the residue was purified by flash column chromatography (0% to 70% ethyl acetate in hexanes) to give {4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-acetic acid ethyl ester as an amorphous powder (70 mg, 48.3% yield). LC/MS calcd for C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 484.0; obsd, 485.1 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.31 (t, <i>J</i> = 7.2 Hz, 3H), 1.53–1.76 (m, 3H), 3.69 (s, 2H), 3.95 (s, 3H), 4.21 (q, <i>J</i> = 7.2 Hz, 2H), 5.93 (m, 1H), 6.40 (br s, 1H), 7.31–7.49 (m, 7H), 7.56–7.66 (m, 4H), 7.80 (d, J-6.8 Hz, 2H).</div><div class="NLM_p last">{4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-acetic acid ethyl ester (60 mg, 0.124 mmol) was dissolved in 3 mL of THF, and lithium hydroxide solution (0.5 N, 1.0 mL) was added. The mixture was stirred at room temperature for 3 h, concentrated, and dissolved in water (8 mL). The clear solution was treated with hydrochloric acid (1 N, 0.6 mL). The mixture was filtered, and the white solid was dried to give compound <b>34</b> (51 mg, 90.2% yield). LC/MS calcd for C<sub>26</sub>H<sub>24</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 456.0; obsd, 457.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.12–1.32 (m, 1H), 1.59 (br, 2H), 3.64 (s, 2H), 3.89 (s, 3H), 5.80 (br m, 1H), 6.96–7.54 (m, 7H), 7.61–7.74 (m, 4H), 7.80 (d, <i>J</i> = 7.6 Hz, 2H), 9.54 and 9.95 (br s, 1H), 12.38 (br s, 1H).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 1-{4′-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>35</b>)</h3><div class="NLM_p">[5-(4-Bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (566 mg, 1.41 mmol), methyl 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)cyclopropanecarboxylate (511 mg, 1.69 mmol), X-Phos (134 mg, 0.28 mmol), palladium acetate (31.7 mg, 0.14 mmol), and potassium phosphate (898 mg, 4.23 mmol) were combined in toluene (12 mL), and degassed water (3 mL) was added. The mixture was degassed and sealed. The mixture was stirred at 95 °C for 3 h and cooled to room temperature. The mixture was extracted with ethyl acetate and water. The organic layer was washed with brine and dried. Solvents were evaporated, and the residue was purified by flash column chromatography (ethyl acetate in hexanes 10% to 70%) to give 1-{4′-[1-methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic acid methyl ester as a pale yellow solid (370 mg, 52.8% yield). LC/MS calcd for C<sub>29</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 496.0; obsd, 497.0 (M + H); <sup>1</sup>H NMR (CDCl<sub>3</sub>) δ ppm 1.25 (m, 3H), 1.66 (m, 4H), 3.67 (s, 3H), 3.93 (s, 3H), 5.91 (m, 1H), 6.44 (br, 1H), 7.29–7.40 (m, 5H), 7.44 (d, <i>J</i> = 8.1 Hz, 2H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.61 (d, <i>J</i> = 8.3 Hz, 2H), 7.78 (br d, <i>J</i> = 6.6 Hz, 2H). This material (50 mg) was dissolved in 1 mL of THF and 1 mL of ethanol. To this mixture was added 1 N sodium hydroxide solution (1 mL). The clear solution was stirred at room temperature for 12 h. Solvents were evaporated, and the residue was treated with 2 N hydrochloric acid (1.4 mL). The solid was filtered and rinsed with water and dried in air to give compound <b>35</b> (47.5 mg, 97.8% yield). LC/MS calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 482.0; obsd, 483.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.14–1.24 (m, 3H), 1.49 (m, 2H), 1.59 (m, 2H), 3.86 (s, 3H), 5.80 (m, 1H), 7.28–7.50 (m, 7H), 7.63 (d, <i>J</i> = 8.1 Hz, 2H), 7.71 (m, 2H), 7.80 (d, <i>J</i> = 7.6 Hz, 2H), 9.95 and 9.62 (br s, 1H), 12.35 (s, 1H).</div><div class="NLM_p last">Compounds <b>36</b>–<b>39</b> were prepared with the same method described in the preparation of compound <b>35</b>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 1-{3′-Fluoro-4′-[1-methyl-5-((<i>R</i>)-1- phenyl-ethoxycarbonylamino)-1<i>H</i>-[1,2,3]triazole-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>36</b>)</h3><div class="NLM_p last">LC/MS calcd for C<sub>28</sub>H<sub>25</sub>FN<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 500.0; obsd, 501.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.39 (br. s., 1H), 9.92 (br. s., 1H), 7.64–7.78 (m, 3H), 7.59 (d, <i>J</i> = 7.8 Hz, 2H), 7.37–7.50 (m, 5H), 7.02–7.37 (m, 2H), 5.74 (br. s., 1H), 3.89 (s, 3H), 1.41–1.60 (m, 4H), 1.09–1.32 (m, 3H).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 1-{4′-[5-((<i>R</i>)-1,2-Dimethyl-propoxycarbonylamino)-1-methyl-1<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>37</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 0.52 (br, 1H), 0.88 (br, 5H), 1.04–1.25 (m, 5H), 1.35–1.43 (m, 2H), 1.62–1.85 (br, 1H), 3.80 (s, 3H), 4.55 (br, 1H), 7.35 (d, <i>J</i> = 8.3 Hz, 2H), 7.57 (d, <i>J</i> = 8.3 Hz, 2H), 7.68 (d, <i>J</i> = 8.3 Hz, 2H), 7.78 (d, <i>J</i> = 8.3 Hz, 2H), 9.34 and 9.67 (br s, 1H), 12.30 (br s, 1H); LC/MS calcd for C<sub>25</sub>H<sub>28</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 448.0; obsd, 449.2 (M + H).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 1-(4′-{1-Methyl-5-[(<i>R</i>)-1-(3-trifluoromethyl-phenyl)-ethoxycarbonylamino]-1<i>H</i>-[1,2,3]triazol-4-yl}-biphenyl-4-yl)-cyclopropanecarboxylic Acid (<b>38</b>)</h3><div class="NLM_p last">This compound was obtained from the chiral separation of the racemate by super critical fluid chromatography on Waters/Berger Multigram II using a Whelk-O1 (R,R)-column (3 × 25 cm) eluted with 50% isopropanol in CO<sub>2</sub> at 70 mL/min (detection at 220 nM, 100 bar backpressure, and 35 °C oven). The second fraction gave compound <b>38</b> as a white solid. LC/MS calcd for C<sub>29</sub>H<sub>25</sub>F<sub>3</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 550.0; obsd, 551.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.13–1.29 (m, 3H), 1.44–1.52 (m, 2H), 1.60 (br d, 2H), 3.86 (s, 3H), 5.75–5.95 (br m, 1H), 7.43 (d, <i>J</i> = 8.1 Hz, 2.5H), 7.61 (d, <i>J</i> = 8.1 Hz, 2.5H), 7.69 (br m, 3.5H), 7.79 (d, <i>J</i> = 7.6 Hz, 3.5H), 9.65 and 10.05 (br s, 1H), 12.35 (s, 1H).</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 1-(4′-{1-Methyl-5-[(<i>S</i>)-1-(3-trifluoromethyl-phenyl)-ethoxycarbonylamino]-1<i>H</i>-[1,2,3]triazol-4-yl}-biphenyl-4-yl)-cyclopropanecarboxylic Acid (<b>39</b>)</h3><div class="NLM_p last">The first fraction from the chiral separation (conditions described in the preparation of <b>38</b>) gave compound <b>39</b> as a white solid.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 1-{4′-[3-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-3<i>H</i>-[1,2,3]triazol-4-yl]-biphenyl-4-yl}-cyclopropanecarboxylic Acid (<b>40</b>)</h3><div class="NLM_p last">This compound was prepared using the same method as that described for the preparation of compound <b>35</b>, except that 5-(4-bromo-phenyl)-1-methyl-1<i>H</i>-[1,2,3] triazole-4-carboxylic acid was used. LC/MS calcd for C<sub>28</sub>H<sub>26</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 482.0; obsd, 483.0 (M + H); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 1.15–1.30 (m, 2H), 1.32–1.62 (m, 5H), 4.05 (s, 3H), 5.69 (br m, 1H), 7.20–7.40 (br m, 5H), 7.46 (d, <i>J</i> = 8.1 Hz, 2H), 7.59 (d, <i>J</i> = 8.1 Hz, 2H), 7.66 (d, <i>J</i> = 8.1 Hz, 2H), 7.77 (d, <i>J</i> = 7.6 Hz, 2H), 9.34 (br s, 1H), 12.39 (s, 1H).</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> {5-[4′-(1-Methanesulfonylaminocarbonyl-cyclopropyl)-biphenyl-4-yl]-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl}-carbamic acid (<i>R</i>)-1-phenyl-ethyl Ester (<b>41</b>)</h3><div class="NLM_p">In a 100 mL round-bottomed flask, 1-(4-bromo-phenyl)-cyclopropanecarboxylic acid (4 g, 16.6 mmol) was combined with dichloromethane (15 mL) and 3 drops of DMF to give a white suspension. To this was added dropwise a clear solution of oxalyl chloride (6.96 g, 4.8 mL, 54.8 mmol) dissolved in dichloromethane (6 mL). After 10 min, the mixture became clear, and the reaction was stirred at room temperature for 2 h. The reaction was concentrated, diluted with toluene and hexanes, concentrated, and stored in a freezer overnight. In a 200 mL round-bottomed flask, NaH (60% mineral dispersion, 876 mg, 36.5 mmol) was washed with hexanes, and the resulting solid was diluted with DMF (6 mL) to give a white suspension. The suspension was cooled in an ice bath, and methanesulfonamide (3.16 g, 33.2 mmol) dissolved in DMF (6 mL) was added dropwise under nitrogen. After addition (5 min), the ice bath was removed, and the reaction was warmed to room temperature overnight. The reaction was cooled in an ice bath, the acid chloride previously prepared and dissolved in DMF (6 mL) was added dropwise, and the reaction was warmed to room temperature overnight. The reaction was diluted with 0.2 N HCl (200 mL) and extracted with ethyl acetate (2 × 100 mL). The organic layers were washed with brine, combined, dried over MgSO<sub>4</sub>, and concentrated. The crude material was dissolved in minimal dichloromethane and purified by flash column chromatography (0% to 60% ethyl acetate in hexanes, 0.5% acetic acid) to give <i>N</i>-[1-(4-bromo-phenyl)-cyclopropanecarbonyl]-methanesulfonamide (2.74 g, 51.9% yield) as a white solid. LC/MS calcd for C<sub>11</sub>H<sub>12</sub>BrNO<sub>3</sub>S (<i>m</i>/<i>e</i>) 317/319; obsd, 318/320 (M + H, ES<sup>+</sup>). This material (2.71 g, 8.52 mmol) was combined with bis-pinacolatodiboron (3.24 g, 12.8 mmol), potassium acetate (2.51 g, 25.6 mmol), and 1,4-dioxane (63.8 mL) to give a white suspension. The mixture was purged with nitrogen for 20 min, and then PdCl<sub>2</sub>(dppf)CH<sub>2</sub>Cl<sub>2</sub> (701 mg, 859 μmol) was added. The vial was sealed and heated in an oil bath at 80 °C for 16 h. The reaction was diluted with ethyl acetate (150 mL), filtered, and rinsed with 0.2 M HCl (200 mL) and ethyl acetate (50 mL). The combined filtrate was mixed vigorously, filtered, and separated. The aqueous layer was extracted once with EtOAc (150 mL). The organic layers were washed with brine, combined, dried over MgSO<sub>4</sub>, filtered, concentrated, and dried from dichloromethane/hexanes to give a brown solid (4 g). The crude material was supported on Celite and purified by flash column chromatography (0 to 60% EtOAc in hexanes, 0.5% AcOH) to give <i>N</i>-{1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonyl}-methanesulfonamide (2.75 g, 88.4% yield) as a white solid. LC/MS calcd for C<sub>17</sub>H<sub>24</sub>BNO<sub>5</sub>S (<i>m</i>/<i>e</i>) 365; obsd, 366 (M + H, ES<sup>+</sup>).</div><div class="NLM_p last">In a 20 mL vial, [5-(4-bromo-phenyl)-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl]-carbamic acid (<i>R</i>)-1-phenyl-ethyl ester (110.3 mg, 275 μmol), <i>N</i>-{1-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-cyclopropanecarbonyl}-methanesulfonamide (112 mg, 307 μmol), DPPF (38 mg, 68.5 μmol), and PdCl<sub>2</sub>(dppf)CH<sub>2</sub>Cl<sub>2</sub> (39 mg, 47.8 μmol) were combined with DMF (5 mL), and the mixture was bubbled with nitrogen for 20 min to give a light brown/red solution. To this was added 2 N Na<sub>2</sub>CO<sub>3</sub> (550 μL, 1.1 mmol), and the red mixture had nitrogen bubbled through for 1 min. The vial was sealed, placed in a dry block, and heated at 80 °C for 4 h. The reaction was diluted with ethyl acetate (75 mL) and 0.1 M HCl (100 mL), and the layers were separated. The aqueous layer was extracted with ethyl acetate (75 mL). The organic layers were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to give a crude material (311 mg). The crude material was dissolved in minimal dichloromethane and purified by flash column chromatography (0% to 100% EtOAc in hexanes, 0.5% AcOH) to provide compound <b>41</b> (98.5 mg, 64% yield). LC/MS calcd for C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>5</sub>S (<i>m</i>/<i>e</i>) 559; obsd, 560 (M + H, ES<sup>+</sup>); <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 11.16 (br. s., 1H), 9.93 (br. s., 1H), 7.80 (d, <i>J</i> = 7.8 Hz, 2H), 7.62–7.76 (m, 4H), 7.06–7.57 (m, 7H), 5.65–5.93 (m, 1H), 3.85 (s, 3H), 3.20 (s, 3H), 1.38–1.76 (m, 5H), 1.20 (br. s., 2H).</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> {5-[4′-(1-Methanesulfonylaminocarbonyl-cyclopropyl)-biphenyl-4-yl]-3-methyl-3<i>H</i>-[1,2,3]triazol-4-yl}-carbamic Acid (<i>R</i>)-1-(3-trifluoromethyl-phenyl)-ethyl Ester (<b>42</b>)</h3><div class="NLM_p last">This compound was prepared with the same method described in the preparation of <b>41</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 11.16 (br. s., 1H), 9.47–10.15 (m, 1H), 7.53–7.94 (m, 10H), 7.41 (d, <i>J</i> = 8.3 Hz, 2H), 5.89 (br. s., 1H), 3.86 (br. s., 3H), 3.20 (s, 3H), 1.60 (br. s., 3H), 1.47–1.53 (m, 2H), 1.20 (d, <i>J</i> = 1.8 Hz, 2H); LC/MS calcd for C<sub>30</sub>H<sub>28</sub>F<sub>3</sub>N<sub>5</sub>O<sub>5</sub>S (<i>m</i>/<i>e</i>) 627; obsd, 628 (M + H, ES<sup>+</sup>).</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (4-{4-[1-Methyl-5-((<i>R</i>)-1-phenyl-ethoxycarbonylamino)-1H-[1,2,3]triazol-4-yl]-phenyl}-cyclohexyl)-acetic Acid (<b>43</b>)</h3><div class="NLM_p">To a suspension of 5-(4-bromophenyl)-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid (209 mg, 0.74 mmol) and sodium bicarbonate (187 mg, 2.22 mmol) in DMF (10 mL) was added an excess of benzyl bromide (380 mg, 264 μL, 2.22 mmol) at room temperature under nitrogen atmosphere. The resulting colorless reaction mixture was stirred for 15 h and then diluted with water and extracted with ethyl acetate (2 × 70 mL). The combined extracts were washed with brine solution and dried over anhydrous MgSO<sub>4</sub>. Filtration and concentration gave the crude colorless oil which was purified by column chromatography eluting with ethyl acetate in hexanes (0–60%) to give 5-(4-bromophenyl)-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid benzyl ester as a viscous oil (275 mg, 99% yield). LC/MS calcd for C<sub>17</sub>H<sub>14</sub>BrN<sub>3</sub>O<sub>2</sub> (<i>m</i>/<i>e</i>) 373; obsd, 373.8 (M + H, ES<sup>+</sup>).</div><div class="NLM_p">To a mixture of 2-(4-hydroxycyclohexyl)acetic acid ethyl ester (3 g, 16.1 mmol), iodine (6.13 g, 24.2 mmol), imidazole (1.64 g, 24.2 mmol), and triphenylphosphine (6.34 g, 24.2 mmol) was added dichloromethane (100 mL) at room temperature under nitrogen atmosphere. The resulting brown suspension was stirred for 15 h, and the solvent was removed under vacuum. The residue was extracted with ethyl acetate, washed twice with a solution of water and methanol (3:1), and then washed with brine solution. The organic layer was dried over anhydrous MgSO<sub>4</sub>, filtered, and concentrated to give the crude residue, which was purified by column chromatography eluting with ethyl acetate in hexanes (0–50%) to give 2-(4-iodocyclohexyl)acetic acid ethyl ester (3.39 g, 71.1% yield) as a viscous light yellow oil. <sup>1</sup>H NMR of this product indicated that it contained ∼30–40% of elimination product (olefin), which was not separable on TLC.</div><div class="NLM_p">To a 3-neck 50 mL round-bottom flask, equipped with an additional funnel and thermometer, was added zinc dust (490 mg, 7.5 mmol) at room temperature under nitrogen atmosphere. THF (2 mL) was added to cover the zinc dust followed by the addition of 1,2-dibromoethane (60.6 mg, 27.8 μL, 0.322 mmol). The mixture was heated with a heat gun until evolution of ethylene gas ceased. The suspension was cooled to room temperature, chlorotrimethylsilane (35.0 mg, 40.8 μL, 0.322 mmol) was added, and the mixture was stirred for 15 min at room temperature. Then, a solution of 2-(4-iodocyclohexyl)acetic acid ethyl ester (740 mg, 2.5 mmol) in THF (2 and 1 mL for rinsing) was added dropwise for 5 min. After addition, the reaction mixture was heated to 60 °C in an oil bath, and stirred for 3 h. The excess zinc dust was allowed to settle (15 h) to give a colorless solution. In another 2-neck 25 mL round-bottom flask, palladium(II) acetate (18.1 mg, 0.081 mmol) and 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (66.2 mg, 0.162 mmol) were charged, and the flask was purged with nitrogen gas. Then, THF (1 mL) was added, and the resulting light brown suspension was stirred for 5 min before the addition of a solution of 5-(4-bromophenyl)-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid benzyl ester (120 mg, 0.322 mmol) in THF (3 mL) at room temperature under nitrogen atmosphere. The above prepared colorless zinc solution was added to this mixture. The mixture was heated to 60 °C and stirred for 5 h. The reaction was cooled to room temperature and diluted with saturated ammonium chloride solution and ethyl acetate. The organic extracts were washed with brine and dried over anhydrous MgSO<sub>4</sub>. Filtration and evaporation of solvents gave a crude light yellow residue, which was purified by column chromatography eluting with ethyl acetate in hexanes (0–100%) to provide 5-[4-(4-ethoxycarbonylmethyl-cyclohexyl)-phenyl]-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid benzyl ester (55 mg, 37.0% yield) as a light brown oil. LC/MS calcd for C<sub>27</sub>H<sub>31</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 461; obsd, 462.1 (M + H, ES<sup>+</sup>). This material (51 mg, 0.11 mmol) and 10% Pd/C (58.8 mg, 0.552 mmol) were combined with ethyl acetate (5 mL) at room temperature and hydrogenated with a hydrogen balloon overnight. The reaction mixture was filtered, and the charcoal was washed with hot ethyl acetate (50 mL), THF (25 mL), CH<sub>3</sub>CN (75 mL), and ethanol (25 mL). The filtrate was concentrated, and the residue was dried under high vacuum to obtain 5-[4-(4-ethoxycarbonylmethyl-cyclohexyl)-phenyl]-3-methyl-3<i>H</i>-[1,2,3]triazole-4-carboxylic acid (40 mg, 97.5% yield) as a white solid. LC/MS calcd for C<sub>20</sub>H<sub>25</sub>N<sub>3</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 371; obsd, 372.3 (M + H, ES<sup>+</sup>). This material was converted to the desired carbamate followed by saponification (2 steps) to afford compound <b>43</b>. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ ppm 12.04 (br. s., 1H), 9.85 (br. s., 1H), 7.62 (d, <i>J</i> = 7.3 Hz, 2H), 6.84–7.54 (m, 7H), 5.78 (br. s., 1H), 3.83 (s, 3H), 2.16 (d, <i>J</i> = 6.8 Hz, 2H), 1.65–1.93 (m, 5H), 1.39–1.64 (m, 5H), 1.01–1.35 (m, 3H). LC/MS calcd for C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>4</sub> (<i>m</i>/<i>e</i>) 462; obsd, 463.3 (M + H, ES<sup>+</sup>).</div><div id="sec4_42_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Calculations of Torsion Angle Preferences</h4><div class="NLM_p last">Truncated models of compounds <b>32</b>, <b>33</b>, and <b>2</b> were built using Maestro version 9.1 (Schrodinger, LLC, New York, NY). Specifically, the biaryl substitutions linked to the triazole were truncated to contain only a single phenyl group. All potential energies were calculated using Jaguar (Schrodinger, LLC, New York, NY) using the Density Functional Theory (DFT) method with the B3LYP hybrid functional and the 6-31G** basis set. The torsion angle was defined using the atom at the 4-position (in <b>32</b> and <b>2</b>) or the 2-position (in <b>33</b>) of the triazole, the carbon of the triazole bonded to the carbamate, the nitrogen of the carbamate, and the carbonyl carbon of the carbamate. The triazole-carbamate torsion angle was scanned in 20° increments, with up to 50 rounds of geometry optimization of the remaining degrees of freedom at each torsion angle.</div></div><div id="sec4_42_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> LPA1/3 Calcium Flux Assay Using a Fluorometric Imaging Plate Reader (FLIPR Assay)</h4><div class="NLM_p last">The ChemiScreen Calcium-optimized stable cell lines containing the human recombinant LPA1 or LPA3 Lysophospholipid receptors along with the parental line were purchased from Chemicon International, Inc./Millipore. One day prior to assay, cells were harvested and seeded at 10,000 cells per well into 384 well black/clear tissue culture treated plates. On the day of the assay, a calcium loading dye (Calcium-4, Molecular Devices) in Hank’s Balanced Salt Solution containing 20 mM HEPES and 2.5 mM probenecid was added to each well, and plates were then incubated for 30 min at 37 °C. After incubation, 20 μL of test compound in assay buffer with 2.2% DMSO was transferred to the cell plate by the FLIPR. Compound addition was monitored by the FLIPR to detect any agonist activity of the compounds. Plates were then incubated for 30 min at room temperature protected from light. After incubation, plates were returned to the FLIPR, and 20 μL of 4.5 μM LPA (18:1) or ionomycin (for parental line) was added to the cell plates. The fluorescence was continuously monitored before, during, and after sample addition for a total elapsed time of 100 s. Responses (increase in peak fluorescence) in each well following agonist addition is determined. The initial fluorescence reading from each well, prior to ligand stimulation, was used as zero baseline value for the data from that well. The responses are expressed as % inhibition of the buffer control. The IC<sub>50</sub> value, defined as the concentration of a compound that is required for 50% inhibition of the buffer control, was calculated by fitting the percent inhibition data for 10 concentrations to a sigmoidal dose–response (4 parameter logistic) model using the Genedata Condoseo program [ model 205, <i>F</i>(<i>x</i>) = (<i>A</i> + (<i>B</i> – <i>A</i>)/(1+((<i>C</i>/<i>x</i>)<sup>D</sup>)))].</div></div><div id="sec4_42_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> Cell Culture of NHLFs</h4><div class="NLM_p last">NHLFs obtained from healthy, nonsmoking donors, (Lonza Rockland Inc., Rockland, ME, USA) were grown at 37 °C in a humidified 5% CO<sub>2</sub> atmosphere in complete medium (FGM fibroblast basal medium supplemented with 0.5 mL of recombinant human fibroblast growth factor-B, 0.5 mL of insulin, 0.5 mL of gentamicin sulfate amphotericin-B, and 2% (v/v) fetal bovine serum (FBS) according to the manufacturer’s instructions). Where indicated, NHLFs were serum-starved in basal medium (FGM fibroblast basal medium supplemented with 0.5 mL of recombinant human fibroblast growth factor-B, 0.5 mL of insulin, 0.5 mL of gentamicin sulfate amphotericin-B, 0.1% (v/v) FBS, and 0.1% (v/v) fatty acid-free BSA). For all experiments, NHLFs were used between passages 5 and 9.</div></div><div id="sec4_42_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> Assessment of Proliferation Using BrdU Incorporation</h4><div class="NLM_p last">NHLFs were seeded in BioCoat Collagen I 96-well clear black plates (BD Biosciences, Franklin Lakes, NJ, USA) at a density of 5 × 10<sup>3</sup> cells/well and incubated overnight in complete medium after which the cells were starved with basal media containing 0.1% (v/v) FBS and 0.1% (v/v) fatty acid-free BSA for 24 h. The cells were incubated with vehicle or LPAR antagonists for 1 h at the concentrations indicated and were then stimulated with LPA (18:1) at the indicated concentration for 48 h. Proliferation was assessed by determining the incorporation of BrdU using a BrdU proliferation assay kit (Calbiochem, San Diego, CA, USA) in accordance with the manufacturer’s protocol. The degree of BrdU incorporation was assessed using an EnVision Multilabel Reader (Perkin-Elmer Inc., San Jose, CA, USA).</div></div><div id="sec4_42_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> Three-Dimensional Collagen Gel Contraction Assay</h4><div class="NLM_p last">Lung fibroblast contraction was assessed using a commercially available three-dimensional collagen gel contraction kit (Cell Biolabs, San Diego, CA, USA) and performed according to the manufacturer’s instructions. Briefly, NHLFs (2.5 × 10<sup>5</sup> cells/well) were mixed 1:4 with a collagen gel lattice mixture using the volumes indicated in the manufacturer’s instructions and 0.5 mL plated per well in a 24-well plate, which was incubated for 2 h at 37 °C to allow gel polymerization. Following gel polymerization, 1 mL of basal media containing 0.1% (v/v) FBS, 0.1% (v/v) fatty acid-free BSA, and either vehicle or LPAR antagonists was added to each well. The gels were detached, and then vehicle or LPA (18:1) at the concentrations indicated was added. Then, 18 h later the images of the contracted gel discs were obtained and quantitation performed by assessing the weight of the gel discs.</div></div><div id="sec4_42_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> LPA-Induced Histamine Release in Mice</h4><div class="NLM_p">Male C57BL6/J mice (7–9 weeks old) were purchased from the Jackson Laboratory (Bar Harbor, ME) and housed under pathogen-free conditions with food and water <i>ad libitum</i>. All animal care and experimental procedures were approved by the Roche Animal Care and Use Committee, which is a facility accredited by the American Association for the Accreditation of Laboratory Animal Care (AAALAC).</div><div class="NLM_p">For dose–response studies, mice received intravenous LPA challenge (0–1000 μg/mouse in 0.1% fatty acid-free bovine serum albumin) and then were sacrificed 3 min after LPA administration with 4% isoflurane. Blood was collected into EDTA-coated tubes, centrifuged 10,000<i>g</i> for 10 min at 4 °C, and frozen on dry ice. The plasma was stored at −80 °C before analysis. Histamine concentrations were measured by ELISA (Oxford Biomedical Research) based on the manufacturer’s instructions. Data are presented as the mean ± SEM of <i>n</i> = 5–6 mice.</div><div class="NLM_p last">For the compound efficacy studies, mice received compound <b>2</b> (1–100 mg/kg), the LPA1R antagonist AM095 (100 mg/kg) as a positive control, or vehicle per os (p.o.) 2 h prior to the intravenous administration of LPA (100 μg/mouse). Histamine levels in the plasma were determined as described above. The plasma concentrations of compound <b>2</b> were analyzed by liquid chromatography/mass spectrometry. Data are expressed as the mean ± SEM of <i>n</i> = 5–8 mice. Significance (relative to the LPA vehicle control) was determined using a one-way ANOVA and Dunnet’s posthoc test. The relationship between plasma histamine and compound <b>2</b> concentrations was determined using a Spearman’s rank correlation coefficient.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm301022v" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yimin Qian</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6019090d090e4e1109010e20120f0308054e030f0d"><span class="__cf_email__" data-cfemail="641d0d090d0a4a150d050a24160b070c014a070b09">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Hamilton</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achyutharao Sidduri</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Gabriel</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yonglin Ren</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruoqi Peng</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rama Kondru</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Arjun Narayanan</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry Truitt</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachid Hamid</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yun Chen</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Zhang</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adrian J. Fretland</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruben Alvarez Sanchez</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kung-Ching Chang</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew Lucas</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ryan C. Schoenfeld</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dramane Laine</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria E. Fuentes</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher S. Stevenson</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David C. Budd</span> - <span class="hlFld-Affiliation affiliation">†Discovery
Chemistry, ‡Discovery Inflammation and Respiratory Diseases, §Discovery Technology, ∥Pharmaceutical and
Analytical Research, and ⊥Drug Metabolism and Pharmacokinetics, Small Molecule Research, Pharmaceutical Research and Early Drug
Development, Hoffmann-La Roche, 340 Kingsland
Street, Nutley, New Jersey 07110, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d336e6353-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i64">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28060" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28060" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Paul Gillespie, Karen Lackey, and Satwant Narula for constructive discussion, Ted Lambros for SFC chiral separation, and Gino Sasso for the <sup>1</sup>H NMR NOE study.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i65" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i65"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i66" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i66"> Abbreviations Used</h2><tr><td class="NLM_term">LPA</td><td class="NLM_def"><p class="first last">lysophosphatidic acid</p></td></tr><tr><td class="NLM_term">LPAR</td><td class="NLM_def"><p class="first last">lysophosphatidic acid receptor</p></td></tr><tr><td class="NLM_term">LPA1</td><td class="NLM_def"><p class="first last">lysophosphatidic acid receptor-1</p></td></tr><tr><td class="NLM_term">IPF</td><td class="NLM_def"><p class="first last">idiopathic pulmonary fibrosis</p></td></tr><tr><td class="NLM_term">ECM</td><td class="NLM_def"><p class="first last">extracellular matrix</p></td></tr><tr><td class="NLM_term">BALF</td><td class="NLM_def"><p class="first last">bronchoalveolar lavage fluid</p></td></tr><tr><td class="NLM_term">UUO</td><td class="NLM_def"><p class="first last">unilateral ureteral obstruction</p></td></tr><tr><td class="NLM_term">NHLF</td><td class="NLM_def"><p class="first last">normal human lung fibroblast</p></td></tr><tr><td class="NLM_term">BrdU</td><td class="NLM_def"><p class="first last">bromodeoxyuridine</p></td></tr><tr><td class="NLM_term">FLIPR</td><td class="NLM_def"><p class="first last">fluorometric imaging plate reader</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42807" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42807" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Datta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, R. C.</span><span> </span><span class="NLM_article-title">Novel therapeutic approaches for pulmonary fibrosis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2011.01247.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21265830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=141-172&issue=1&author=A.+Dattaauthor=C.+J.+Scottonauthor=R.+C.+Chambers&title=Novel+therapeutic+approaches+for+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Novel therapeutic approaches for pulmonary fibrosis</span></div><div class="casAuthors">Datta, Arnab; Scotton, Chris J.; Chambers, Rachel C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Pulmonary fibrosis represents the end stage of a no. of heterogeneous conditions and is, to a greater or lesser degree, the hallmark of the interstitial lung diseases.  It is characterized by the excessive deposition of extracellular matrix proteins within the pulmonary interstitium leading to the obliteration of functional alveolar units and in many cases, respiratory failure.  While a small no. of interstitial lung diseases have known etiologies, most are idiopathic in nature, and of these, idiopathic pulmonary fibrosis is the most common and carries with it an appalling prognosis - median survival from the time of diagnosis is less than 3 years.  This reflects the lack of any effective therapy to modify the course of the disease, which in turn is indicative of our incomplete understanding of the pathogenesis of this condition.  Current prevailing hypotheses focus on dysregulated epithelial-mesenchymal interactions promoting a cycle of continued epithelial cell injury and fibroblast activation leading to progressive fibrosis.  However, it is likely that multiple abnormalities in a myriad of biol. pathways affecting inflammation and wound repair - including matrix regulation, epithelial reconstitution, the coagulation cascade, neovascularization and antioxidant pathways - modulate this defective crosstalk and promote fibrogenesis.  This review aims to offer a pathogenetic rationale behind current therapies, briefly outlining previous and ongoing clin. trials, but will focus on recent and exciting advancements in our understanding of the pathogenesis of idiopathic pulmonary fibrosis, which may ultimately lead to the development of novel and effective therapeutic interventions for this devastating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZh6zcVDUa7Vg90H21EOLACvtfcHk0lh1k5BSMn3yFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GjtLc%253D&md5=a161ebe75b90c742137e12b92fbeee42</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01247.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01247.x%26sid%3Dliteratum%253Aachs%26aulast%3DDatta%26aufirst%3DA.%26aulast%3DScotton%26aufirst%3DC.%2BJ.%26aulast%3DChambers%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520therapeutic%2520approaches%2520for%2520pulmonary%2520fibrosis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26issue%3D1%26spage%3D141%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Scotton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, R. C.</span><span> </span><span class="NLM_article-title">Molecular targets in pulmonary fibrosis: the myofibroblast in focus</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=1311-1321&issue=4&author=C.+J.+Scottonauthor=R.+C.+Chambers&title=Molecular+targets+in+pulmonary+fibrosis%3A+the+myofibroblast+in+focus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScotton%26aufirst%3DC.%2BJ.%26aulast%3DChambers%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520targets%2520in%2520pulmonary%2520fibrosis%253A%2520the%2520myofibroblast%2520in%2520focus%26jtitle%3DChest%26date%3D2007%26volume%3D132%26issue%3D4%26spage%3D1311%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1619</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1517%2F13543776.2010.533658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21047298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1619-1625&issue=12&author=A.+L.+Parrillauthor=D.+L.+Baker&title=Autotaxin+inhibitors%3A+a+perspective+on+initial+medicinal+chemistry+efforts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts</span></div><div class="casAuthors">Parrill, Abby L.; Baker, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1619-1625</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The lysophospholipase D enzyme, autotaxin (ATX), has been linked to numerous human diseases including cancer, neurophatic pain, obesity and Alzheimer's disease.  Although the ATX protein was initially purified and characterized in 1992, a link to bioactive lipid metab. was not made until 2002.  In the past decade, metal chelators, lysophospholipid product analogs, and more recently, small non-lipid inhibitors of the enzyme were successfully identified.  The majority of these inhibitors have been characterized using recombinant purified ATX in vitro, with very few examples studied in more complex systems.  Translation of ATX inhibitors from the hands of medicinal chemists to clin. use will require substantially expanded characterization of ATX inhibitors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWuFyKHNmQC7Vg90H21EOLACvtfcHk0lh1k5BSMn3yFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7fN&md5=5aed6b92b1ccd459bfe0546e282c2d9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.533658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.533658%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520perspective%2520on%2520initial%2520medicinal%2520chemistry%2520efforts%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D1619%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&issue=3%E2%80%934&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+signaling+properties+and+disease+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0lgnQqkqXPi8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26issue%3D3%25E2%2580%25934%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptors: subtypes and biological actions</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1146%2Fannurev.pharmtox.010909.105753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20055701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=157-186&author=J.+W.+Choiauthor=D.+R.+Herrauthor=K.+Noguchiauthor=Y.+C.+Yungauthor=C.+W.+Leeauthor=T.+Mutohauthor=M.+E.+Linauthor=S.+T.+Teoauthor=K.+E.+Parkauthor=A.+N.+Mosleyauthor=J.+Chun&title=LPA+receptors%3A+subtypes+and+biological+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptors: subtypes and biological actions</span></div><div class="casAuthors">Choi, Ji Woong; Herr, Deron R.; Noguchi, Kyoko; Yung, Yun C.; Lee, Chang-Wook; Mutoh, Tetsuji; Lin, Mu-En; Teo, Siew T.; Park, Kristine E.; Mosley, Alycia N.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-186</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling mol. by binding to and activating at least 5 known G protein-coupled receptors (GPCRs): LPA1-LPA5.  They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice.  The biol. roles of LPA are diverse and include developmental, physiol., and pathophysiol. effects.  This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors.  Studies using cloned receptors and genetic knockout mice were instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ systems such as the nervous system.  This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru4MuMgWgZ7LVg90H21EOLACvtfcHk0lgnQqkqXPi8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D&md5=995861e6d3dcc7193eba9b4948b4811d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.010909.105753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.010909.105753%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DPark%26aufirst%3DK.%2BE.%26aulast%3DMosley%26aufirst%3DA.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptors%253A%2520subtypes%2520and%2520biological%2520actions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D157%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&issue=4&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0lgnQqkqXPi8XQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D4%26spage%3D829%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shiomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padem, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drazen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschumperlin, D. J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts</span> <span class="citation_source-journal">Wound Repair Regener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1524-475X.2010.00655.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21362091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ivF2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=229-240&issue=2&author=T.+Shiomiauthor=F.+Boudreaultauthor=N.+Pademauthor=S.+Higashiyamaauthor=J.+M.+Drazenauthor=D.+J.+Tschumperlin&title=Lysophosphatidic+acid+stimulates+epidermal+growth+factor-family+ectodomain+shedding+and+paracrine+signaling+from+human+lung+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts</span></div><div class="casAuthors">Shiomi Tetsuya; Boudreault Francis; Padem Nurcicek; Higashiyama Shigeki; Drazen Jeffrey M; Tschumperlin Daniel J</div><div class="citationInfo"><span class="NLM_cas:title">Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysophospatidic acid (LPA) is a bioactive lipid mediator implicated in tissue repair and wound healing.  It mediates diverse functional effects in fibroblasts, including proliferation, migration and contraction, but less is known about its ability to evoke paracrine signaling to other cell types involved in wound healing.  We hypothesized that human pulmonary fibroblasts stimulated by LPA would exhibit ectodomain shedding of epidermal growth factor receptor (EGFR) ligands that signal to lung epithelial cells.  To test this hypothesis, we used alkaline phosphatase-tagged EGFR ligand plasmids transfected into lung fibroblasts, and enzyme-linked immunosorbent assays to detect shedding of native ligands.  LPA induced shedding of alkaline phosphatase-tagged heparin-binding epidermal growth factor (HB-EGF), amphiregulin, and transforming growth factor-a; non-transfected fibroblasts shed amphiregulin and HBEGF under baseline conditions, and increased shedding of HB-EGF in response to LPA.  Treatment of fibroblasts with LPA resulted in elevated phosphorylation of extracellular signal-regulated kinase 1/2, enhanced expression of mRNA for c-fos, HB-EGF and amphiregulin, and enhanced proliferation at 96 hours.  However, none of these fibroblast responses to LPA required ectodomain shedding or EGFR activity.  To test the ability of LPA to stimulate paracrine signaling from fibroblasts, we transferred conditioned medium from LPA-stimulated cells, and found enhanced EGFR and extracellular signal-regulated kinase 1/2 phosphorylation in reporter A549 cells in excess of what could be accounted for by transferred LPA alone.  These data show that LPA mediates EGF-family ectodomain shedding, resulting in enhanced paracrine signaling from lung fibroblasts to epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStZlLCCqCSB3thwrmtH4OBfW6udTcc2eYHl52YVx0zK7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ivF2iuw%253D%253D&md5=daab9ffaae21bf4b386fd812f5520167</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-475X.2010.00655.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-475X.2010.00655.x%26sid%3Dliteratum%253Aachs%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DBoudreault%26aufirst%3DF.%26aulast%3DPadem%26aufirst%3DN.%26aulast%3DHigashiyama%26aufirst%3DS.%26aulast%3DDrazen%26aufirst%3DJ.%2BM.%26aulast%3DTschumperlin%26aufirst%3DD.%2BJ.%26atitle%3DLysophosphatidic%2520acid%2520stimulates%2520epidermal%2520growth%2520factor-family%2520ectodomain%2520shedding%2520and%2520paracrine%2520signaling%2520from%2520human%2520lung%2520fibroblasts%26jtitle%3DWound%2520Repair%2520Regener.%26date%3D2011%26volume%3D19%26issue%3D2%26spage%3D229%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, M. A.</span><span> </span><span class="NLM_article-title">Chloride channel activity in human lung fibroblasts and myofibroblasts</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">L1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=L1110-1116&issue=6&author=Z.+Yinauthor=M.+A.+Watsky&title=Chloride+channel+activity+in+human+lung+fibroblasts+and+myofibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DWatsky%26aufirst%3DM.%2BA.%26atitle%3DChloride%2520channel%2520activity%2520in%2520human%2520lung%2520fibroblasts%2520and%2520myofibroblasts%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2005%26volume%3D288%26issue%3D6%26spage%3DL1110%26epage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=20-27&issue=1&author=T.+Mioauthor=X.+Liuauthor=M.+L.+Toewsauthor=S.+I.+Rennard&title=Lysophosphatidic+acid+augments+fibroblast-mediated+contraction+of+released+collagen+gels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMio%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26atitle%3DLysophosphatidic%2520acid%2520augments%2520fibroblast-mediated%2520contraction%2520of%2520released%2520collagen%2520gels%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2002%26volume%3D139%26issue%3D1%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Pradere, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guigne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bascands, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schanstra, J. P.</span><span> </span><span class="NLM_article-title">LPA1 receptor activation promotes renal interstitial fibrosis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1681%2FASN.2007020196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=18003779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGgu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3110-3118&issue=12&author=J.+P.+Pradereauthor=J.+Kleinauthor=S.+Gresauthor=C.+Guigneauthor=E.+Neauauthor=P.+Valetauthor=D.+Caliseauthor=J.+Chunauthor=J.+L.+Bascandsauthor=J.+S.+Saulnier-Blacheauthor=J.+P.+Schanstra&title=LPA1+receptor+activation+promotes+renal+interstitial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">LPA1 receptor activation promotes renal interstitial fibrosis</span></div><div class="casAuthors">Pradere, Jean-Philippe; Klein, Julie; Gres, Sandra; Guigne, Charlotte; Neau, Eric; Valet, Philippe; Calise, Denis; Chun, Jerold; Bascands, Jean-Loup; Saulnier-Blache, Jean-Sebastien; Schanstra, Joost P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3110-3118</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Tubulointerstitial fibrosis in chronic renal disease is strongly assocd. with progressive loss of renal function.  We studied the potential involvement of lysophosphatidic acid (LPA), a growth factor-like phospholipid, and its receptors LPA1-4 in the development of tubulointerstitial fibrosis (TIF).  Renal fibrosis was induced in mice by unilateral ureteral obstruction (UUO) for up to 8 d, and kidney explants were prepd. from the distal poles to measure LPA release into conditioned media.  After obstruction, the extracellular release of LPA increased approx. 3-fold.  Real-time reverse transcription PCR (RT-PCR) anal. demonstrated significant upregulation in the expression of the LPA1 receptor subtype, downregulation of LPA3, and no change of LPA2 or LPA4.  TIF was significantly attenuated in LPA1 (-/-) mice compared to wild-type littermates, as measured by expression of collagen III, α-smooth muscle actin (α-SMA), and F4/80.  Furthermore, treatment of wild-type mice with the LPA1 antagonist Ki16425 similarly reduced fibrosis and significantly attenuated renal expression of the profibrotic cytokines connective tissue growth factor (CTGF) and transforming growth factor β (TGFβ).  In vitro, LPA induced a rapid, dose-dependent increase in CTGF expression that was inhibited by Ki16425.  In conclusion, LPA, likely acting through LPA1, is involved in obstruction-induced TIF.  Therefore, the LPA1 receptor might be a pharmaceutical target to treat renal fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfduq2hWxxr7Vg90H21EOLACvtfcHk0lhNr5xLhfUhWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGgu73J&md5=6d212bb8e2ea41a78e0f8f7140c87423</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1681%2FASN.2007020196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2007020196%26sid%3Dliteratum%253Aachs%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DGres%26aufirst%3DS.%26aulast%3DGuigne%26aufirst%3DC.%26aulast%3DNeau%26aufirst%3DE.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DCalise%26aufirst%3DD.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBascands%26aufirst%3DJ.%2BL.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DSchanstra%26aufirst%3DJ.%2BP.%26atitle%3DLPA1%2520receptor%2520activation%2520promotes%2520renal%2520interstitial%2520fibrosis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2007%26volume%3D18%26issue%3D12%26spage%3D3110%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&issue=1&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lgVSvovbAFpKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26issue%3D1%26spage%3D45%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">Effects of lysophosphatidic acid and its receptors LPA(1/3) on radiation pneumonitis</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21042747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sit7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1515-1520&issue=6&author=J.+Xueauthor=L.+Ganauthor=X.+Liauthor=J.+Liauthor=G.+Qiauthor=Y.+Wuauthor=X.+Fuauthor=Q.+Maoauthor=R.+Aoauthor=J.+Langauthor=Y.+Lu&title=Effects+of+lysophosphatidic+acid+and+its+receptors+LPA%281%2F3%29+on+radiation+pneumonitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis</span></div><div class="casAuthors">Xue, Jianxin; Gan, Lu; Li, Xin; Li, Jian; Qi, Guohai; Wu, Yalan; Fu, Xiaoyue; Mao, Qing; Ao, Rui; Lang, Jingyi; Lu, You</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1515-1520</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Radiation pneumonitis (RP) is a serious complication of radiation therapy for thoracic tumors.  Lyso-phosphatidic acid (LPA) and its receptors LPA1/3 were reported to participate in the processes of inflammation.  We tested the hypothesis that LPA and its receptors LPA1/3, take part in the pathogenesis of RP.  In our study, irradn. increased LPA levels in the lung and expression of LPA1/3.  To further det. the role of LPA1/3, we performed pharmacol. knockout of LPA1/3 by a specific antagonist, VPC-12249.  On day 60 post-irradn., RP was significantly alleviated in a dose-dependent manner in mice treated with VPC-12249, as shown by H&E staining, malondialdehyde (MDA, an indicator of oxidative damage) assay in lung, and concns. of proinflammatory and profibrotic cytokines in plasma, including IL-1β, TNF-α, and TGF-β1.  Addnl., VPC-12249 administration decreased the phosphorylation of IκB-α (the initial event that activates the NF-κB signal way), and expression of TGF-β1, CTGF, and α-SMA mRNA.  Our findings suggest that LPA and LPA1/3 may play a pivotal role in RP, and LPA-LPA1/3 may serve as novel therapeutic targets for the treatment of RP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopubf3UJxFCLVg90H21EOLACvtfcHk0lgVSvovbAFpKg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sit7zO&md5=6105ad83f62414458f4a80d7533e4c61</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DR.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEffects%2520of%2520lysophosphatidic%2520acid%2520and%2520its%2520receptors%2520LPA%25281%252F3%2529%2520on%2520radiation%2520pneumonitis%26jtitle%3DOncol.%2520Rep.%26date%3D2010%26volume%3D24%26issue%3D6%26spage%3D1515%26epage%3D1520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Rancoule, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradere, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bascands, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schanstra, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid-1-receptor targeting agents for fibrosis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=657-667&issue=5&author=C.+Rancouleauthor=J.+P.+Pradereauthor=J.+Gonzalezauthor=J.+Kleinauthor=P.+Valetauthor=J.+L.+Bascandsauthor=J.+P.+Schanstraauthor=J.+S.+Saulnier-Blache&title=Lysophosphatidic+acid-1-receptor+targeting+agents+for+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRancoule%26aufirst%3DC.%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DBascands%26aufirst%3DJ.%2BL.%26aulast%3DSchanstra%26aufirst%3DJ.%2BP.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26atitle%3DLysophosphatidic%2520acid-1-receptor%2520targeting%2520agents%2520for%2520fibrosis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26issue%3D5%26spage%3D657%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Structure-based drug design identifies novel LPA3 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7457</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7457-7464&issue=21&author=J.+I.+Fellsauthor=R.+Tsukaharaauthor=J.+Liuauthor=G.+Tigyiauthor=A.+L.+Parrill&title=Structure-based+drug+design+identifies+novel+LPA3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DStructure-based%2520drug%2520design%2520identifies%2520novel%2520LPA3%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D21%26spage%3D7457%26epage%3D7464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Heasley, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2735-2740&issue=11&author=B.+H.+Heasleyauthor=R.+Jaroszauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Initial+structure-activity+relationships+of+lysophosphatidic+acid+receptor+antagonists%3A+discovery+of+a+high-affinity+LPA1%2FLPA3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DJarosz%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DInitial%2520structure-activity%2520relationships%2520of%2520lysophosphatidic%2520acid%2520receptor%2520antagonists%253A%2520discovery%2520of%2520a%2520high-affinity%2520LPA1%252FLPA3%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D11%26spage%3D2735%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">East, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=325-330&issue=4&author=J.+E.+Eastauthor=K.+M.+Carterauthor=P.+C.+Kennedyauthor=N.+A.+Schulteauthor=M.+L.+Toewsauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Development+of+a+phosphatase-resistant%2C+L-tyrosine+derived+LPA1%2FLPA3+dual+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DJ.%2BE.%26aulast%3DCarter%26aufirst%3DK.%2BM.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DSchulte%26aufirst%3DN.%2BA.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520phosphatase-resistant%252C%2520L-tyrosine%2520derived%2520LPA1%252FLPA3%2520dual%2520antagonist%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D325%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damirin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchinkhuu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishitoba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okajima, F.</span><span> </span><span class="NLM_article-title">Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=994-1005&issue=4&author=H.+Ohtaauthor=K.+Satoauthor=N.+Murataauthor=A.+Damirinauthor=E.+Malchinkhuuauthor=J.+Konauthor=T.+Kimuraauthor=M.+Toboauthor=Y.+Yamazakiauthor=T.+Watanabeauthor=M.+Yagiauthor=M.+Satoauthor=R.+Suzukiauthor=H.+Murookaauthor=T.+Sakaiauthor=T.+Nishitobaauthor=D.+S.+Imauthor=H.+Nochiauthor=K.+Tamotoauthor=H.+Tomuraauthor=F.+Okajima&title=Ki16425%2C+a+subtype-selective+antagonist+for+EDG-family+lysophosphatidic+acid+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DN.%26aulast%3DDamirin%26aufirst%3DA.%26aulast%3DMalchinkhuu%26aufirst%3DE.%26aulast%3DKon%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTobo%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYagi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DNishitoba%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.%2BS.%26aulast%3DNochi%26aufirst%3DH.%26aulast%3DTamoto%26aufirst%3DK.%26aulast%3DTomura%26aufirst%3DH.%26aulast%3DOkajima%26aufirst%3DF.%26atitle%3DKi16425%252C%2520a%2520subtype-selective%2520antagonist%2520for%2520EDG-family%2520lysophosphatidic%2520acid%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26issue%3D4%26spage%3D994%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span> </span><span class="NLM_article-title">A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2010.00828.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20649573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlejsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1699-1713&issue=7&author=J.+S.+Swaneyauthor=C.+Chapmanauthor=L.+D.+Correaauthor=K.+J.+Stebbinsauthor=R.+A.+Bundeyauthor=P.+C.+Prodanovichauthor=P.+Faganauthor=C.+S.+Bacceiauthor=A.+M.+Santiniauthor=J.+H.+Hutchinsonauthor=T.+J.+Seidersauthor=T.+A.+Parrauthor=P.+Prasitauthor=J.+F.+Evansauthor=D.+S.+Lorrain&title=A+novel%2C+orally+active+LPA%281%29+receptor+antagonist+inhibits+lung+fibrosis+in+the+mouse+bleomycin+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model</span></div><div class="casAuthors">Swaney, J. S.; Chapman, C.; Correa, L. D.; Stebbins, K. J.; Bundey, R. A.; Prodanovich, P. C.; Fagan, P.; Baccei, C. S.; Santini, A. M.; Hutchinson, J. H.; Seiders, T. J.; Parr, T. A.; Prasit, P.; Evans, J. F.; Lorrain, D. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1699-1713</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The aim of this study was to assess the potential of an antagonist selective for the lysophosphatidic acid receptor, LPA1, in treating lung fibrosis.  We evaluated the in vitro and in vivo pharmacol. properties of the high affinity, selective, oral LPA1-antagonist (4'-{4-[(R)-1-(2-chloro-phenyl)-ethoxycarbonylamino]-3-methyl-isoxazol-5-yl}-biphenyl-4-yl)-acetic acid (AM966).  The potency and selectivity of AM966 for LPA1 receptors was detd. in vitro by calcium flux and cell chemotaxis assays using recombinant and native cell cultures.  The in vivo efficacy of AM966 to reduce tissue injury, vascular leakage, inflammation and fibrosis was assessed at several time points in the mouse bleomycin model.  AM966 was a potent antagonist of LPA1 receptors, with selectivity for this receptor over the other LPA receptors.  In vitro, AM966 inhibited LPA-stimulated intracellular calcium release (IC50 = 17 nM) from Chinese hamster ovary cells stably expressing human LPA1 receptors and inhibited LPA-induced chemotaxis (IC50 = 181 nM) of human IMR-90 lung fibroblasts expressing LPA1 receptors.  AM966 demonstrated a good pharmacokinetic profile following oral dosing in mice.  In the mouse, AM966 reduced lung injury, vascular leakage, inflammation and fibrosis at multiple time points following intratracheal bleomycin instillation.  AM966 also decreased lactate dehydrogenase activity and tissue inhibitor of metalloproteinase-1, transforming growth factor β1, hyaluronan and matrix metalloproteinase-7, in bronchoalveolar lavage fluid.  These findings demonstrate that AM966 is a potent, selective, orally bioavailable LPA1 receptor antagonist that may be beneficial in treating lung injury and fibrosis, as well as other diseases that are characterized by pathol. inflammation, edema and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0rImMbkAWbVg90H21EOLACvtfcHk0lghrpm-QbJfJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlejsbzJ&md5=73f26734408141d8b0350d7488b54a6c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00828.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00828.x%26sid%3Dliteratum%253Aachs%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DStebbins%26aufirst%3DK.%2BJ.%26aulast%3DBundey%26aufirst%3DR.%2BA.%26aulast%3DProdanovich%26aufirst%3DP.%2BC.%26aulast%3DFagan%26aufirst%3DP.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DParr%26aufirst%3DT.%2BA.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26atitle%3DA%2520novel%252C%2520orally%2520active%2520LPA%25281%2529%2520receptor%2520antagonist%2520inhibits%2520lung%2520fibrosis%2520in%2520the%2520mouse%2520bleomycin%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26issue%3D7%26spage%3D1699%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1124%2Fjpet.110.175901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21159750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=693-700&issue=3&author=J.+S.+Swaneyauthor=C.+Chapmanauthor=L.+D.+Correaauthor=K.+J.+Stebbinsauthor=A.+R.+Broadheadauthor=G.+Bainauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+S.+Bacceiauthor=C.+Leeauthor=T.+A.+Parrauthor=J.+R.+Roppeauthor=T.+J.+Seidersauthor=J.+Ziffauthor=P.+Prasitauthor=J.+H.+Hutchinsonauthor=J.+F.+Evansauthor=D.+S.+Lorrain&title=Pharmacokinetic+and+pharmacodynamic+characterization+of+an+oral+lysophosphatidic+acid+type+1+receptor-selective+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist</span></div><div class="casAuthors">Swaney, J. S.; Chapman, C.; Correa, L. D.; Stebbins, K. J.; Broadhead, A. R.; Bain, G.; Santini, A. M.; Darlington, J.; King, C. D.; Baccei, C. S.; Lee, C.; Parr, T. A.; Roppe, J. R.; Seiders, T. J.; Ziff, J.; Prasit, P.; Hutchinson, J. H.; Evans, J. F.; Lorrain, D. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-700</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive phospholipid that signals through a family of at least six G protein-coupled receptors designated LPA1-6.  LPA type 1 receptor (LPA1) exhibits wide-spread tissue distribution and regulates a variety of physiol. and pathol. cellular functions.  Here, we evaluated the in vitro pharmacol., pharmacokinetic, and pharmacodynamic properties of the LPA1-selective antagonist AM095 (sodium, {4'-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-acetate) and assessed the effects of AM095 in rodent models of lung and kidney fibrosis and dermal wound healing.  In vitro, AM095 was a potent LPA1 receptor antagonist because it inhibited GTPγS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA1 with IC50 values of 0.98 and 0.73 μM, resp., and exhibited no LPA1 agonism.  In functional assays, AM095 inhibited LPA-driven chemotaxis of CHO cells overexpressing mouse LPA1 (IC50 = 778 nM) and human A2058 melanoma cells (IC50 = 233 nM).  In vivo, we demonstrated that AM095: (1) had high oral bioavailability and a moderate half-life and was well tolerated at the doses tested in rats and dogs after oral and i.v. dosing, (2) dose-dependently reduced LPA-stimulated histamine release, (3) attenuated bleomycin-induced increases in collagen, protein, and inflammatory cell infiltration in bronchalveolar lavage fluid, and (4) decreased kidney fibrosis in a mouse unilateral ureteral obstruction model.  Despite its antifibrotic activity, AM095 had no effect on normal wound healing after incisional and excisional wounding in rats.  These data demonstrate that AM095 is an LPA1 receptor antagonist with good oral exposure and antifibrotic activity in rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVYo8MBYXos7Vg90H21EOLACvtfcHk0liPPC9z9t_rXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqtr4%253D&md5=72388f534912ad0e440a6fff949d7710</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175901%26sid%3Dliteratum%253Aachs%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DStebbins%26aufirst%3DK.%2BJ.%26aulast%3DBroadhead%26aufirst%3DA.%2BR.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DParr%26aufirst%3DT.%2BA.%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520characterization%2520of%2520an%2520oral%2520lysophosphatidic%2520acid%2520type%25201%2520receptor-selective%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D3%26spage%3D693%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1002%2Fart.30262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21305523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1405-1415&issue=5&author=F.+V.+Castelinoauthor=J.+Seidersauthor=G.+Bainauthor=S.+F.+Brooksauthor=C.+D.+Kingauthor=J.+S.+Swaneyauthor=D.+S.+Lorrainauthor=J.+Chunauthor=A.+D.+Lusterauthor=A.+M.+Tager&title=Amelioration+of+dermal+fibrosis+by+genetic+deletion+or+pharmacologic+antagonism+of+lysophosphatidic+acid+receptor+1+in+a+mouse+model+of+scleroderma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma</span></div><div class="casAuthors">Castelino, Flavia V.; Seiders, Jon; Bain, Gretchen; Brooks, Sarah F.; King, Christopher D.; Swaney, James S.; Lorrain, Daniel S.; Chun, Jerold; Luster, Andrew D.; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1405-1415</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Scleroderma (systemic sclerosis [SSc]), is characterized by progressive multiorgan fibrosis.  We recently implicated lysophosphatidic acid (LPA) in the pathogenesis of pulmonary fibrosis.  The purpose of the present study was to investigate the roles of LPA and two of its receptors, LPA1 and LPA2, in dermal fibrosis in a mouse model of SSc.  Methods : Wild type (WT), and LPA1-knockout (KO) and LPA2-KO mice were injected s.c. with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.  Dermal thickness, collagen content, and nos. of cells pos. for α-smooth muscle actin (α-SMA) or phospho-Smad2 were detd. in bleomycin-injected and PBS-injected skin.  In sep. expts., a novel selective LPA1 antagonist AM095 or vehicle alone was administered by oral gavage to C57BL/6 mice that were challenged with 28 daily injections of bleomycin or PBS.  AM095 or vehicle treatments were initiated concurrently with, or 7 or 14 days after, the initiation of bleomycin and PBS injections and continued to the end of the expts.  Dermal thickness and collagen content were detd. in injected skin.  Results : The LPA1-KO mice were markedly resistant to bleomycin-induced increases in dermal thickness and collagen content, whereas the LPA2-KO mice were as susceptible as the WT mice.  Bleomycin-induced increases in dermal α-SMA+ and phospho-Smad2+ cells were abrogated in LPA1-KO mice.  Pharmacol. antagonism of LPA1 with AM095 significantly attenuated bleomycin-induced dermal fibrosis when administered according to either a preventive regimen or two therapeutic regimens.  Conclusion : These results suggest that LPA/LPA1 pathway inhibition has the potential to be an effective new therapeutic strategy for SSc, and that LPA1 is an attractive pharmacol. target in dermal fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR6SISG5m67LVg90H21EOLACvtfcHk0liPPC9z9t_rXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGhtrY%253D&md5=a13b1f9f7826b3075728ed13e533102c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.30262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.30262%26sid%3Dliteratum%253Aachs%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DSeiders%26aufirst%3DJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DS.%2BF.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAmelioration%2520of%2520dermal%2520fibrosis%2520by%2520genetic%2520deletion%2520or%2520pharmacologic%2520antagonism%2520of%2520lysophosphatidic%2520acid%2520receptor%25201%2520in%2520a%2520mouse%2520model%2520of%2520scleroderma%26jtitle%3DArthritis%2520Rheum.%26date%3D2011%26volume%3D63%26issue%3D5%26spage%3D1405%26epage%3D1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Xu, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnulty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, G.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q)</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.2353%2Fajpath.2009.080160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=19147812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=1264-1279&issue=4&author=M.+Y.+Xuauthor=J.+Porteauthor=A.+J.+Knoxauthor=P.+H.+Weinrebauthor=T.+M.+Maherauthor=S.+M.+Violetteauthor=R.+J.+McAnultyauthor=D.+Sheppardauthor=G.+Jenkins&title=Lysophosphatidic+acid+induces+alphavbeta6+integrin-mediated+TGF-beta+activation+via+the+LPA2+receptor+and+the+small+G+protein+G+alpha%28q%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span></div><div class="casAuthors">Xu, Ming Yan; Porte, Joanne; Knox, Alan J.; Weinreb, Paul H.; Maher, Toby M.; Violette, Shelia M.; McAnulty, Robin J.; Sheppard, Dean; Jenkins, Gisli</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1264-1279</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Activation of latent transforming growth factor β (TGF-β) by αvβ6 integrin is crit. in the pathogenesis of lung injury and fibrosis.  We have previously demonstrated that the stimulation of protease activated receptor 1 promotes αvβ6 integrin-mediated TGF-β activation via RhoA, which is known to modulate cell contraction.  However, whether other G protein-coupled receptors can also induce αvβ6 integrin-mediated TGF-β activation is unknown; in addn., the αvβ6 integrin signaling pathway has not yet been fully characterized.  In this study, we show that lysophosphatidic acid (LPA) induces αvβ6-mediated TGF-β activation in human epithelial cells via both RhoA and Rho kinase.  Furthermore, we demonstrate that LPA-induced αvβ6 integrin-mediated TGF-β activity is mediated via the LPA2 receptor, which signals via Gαq.  Finally, we show that the expression levels of both the LPA2 receptor and αvβ6 integrin are up-regulated and are spatially and temporally assocd. following bleomycin-induced lung injury.  Furthermore, both the LPA2 receptor and αvβ6 integrin are up-regulated in the overlying epithelial areas of fibrosis in patients with usual interstitial pneumonia.  These studies demonstrate that LPA induces αvβ6 integrin-mediated TGF-β activation in epithelial cells via LPA2, Gαq, RhoA, and Rho kinase, and that this pathway might be clin. relevant to the development of lung injury and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLfe65xAfj7Vg90H21EOLACvtfcHk0liPPC9z9t_rXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D&md5=0b9c319e5b3e4f6794333d2810edd958</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080160%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%2BY.%26aulast%3DPorte%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DViolette%26aufirst%3DS.%2BM.%26aulast%3DMcAnulty%26aufirst%3DR.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DG.%26atitle%3DLysophosphatidic%2520acid%2520induces%2520alphavbeta6%2520integrin-mediated%2520TGF-beta%2520activation%2520via%2520the%2520LPA2%2520receptor%2520and%2520the%2520small%2520G%2520protein%2520G%2520alpha%2528q%2529%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26issue%3D4%26spage%3D1264%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwandner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasslinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span> </span><span class="NLM_article-title">Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1037-1041&issue=3&author=H.+P.+Beckauthor=T.+Kohnauthor=S.+Rubensteinauthor=C.+Hedbergauthor=R.+Schwandnerauthor=K.+Hasslingerauthor=K.+Daiauthor=C.+Liauthor=L.+Liangauthor=H.+Wescheauthor=B.+Frankauthor=S.+Anauthor=D.+Wickramasingheauthor=J.+Jaenauthor=J.+Medinaauthor=R.+Hungateauthor=W.+Shen&title=Discovery+of+potent+LPA2+%28EDG4%29+antagonists+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DRubenstein%26aufirst%3DS.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DHasslinger%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520potent%2520LPA2%2520%2528EDG4%2529%2520antagonists%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D3%26spage%3D1037%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Lukyanov, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliznets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorshnev, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleksandrov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepanov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasil’ev, A. A.</span><span> </span><span class="NLM_article-title">Microve-assisted synthesis and transformations of sterically hindered 3-(5-tetrazolyl)pyridines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1849-1863&author=S.+M.+Lukyanovauthor=I.+V.+Bliznetsauthor=S.+V.+Shorshnevauthor=G.+G.+Aleksandrovauthor=A.+E.+Stepanovauthor=A.+A.+Vasil%E2%80%99ev&title=Microve-assisted+synthesis+and+transformations+of+sterically+hindered+3-%285-tetrazolyl%29pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukyanov%26aufirst%3DS.%2BM.%26aulast%3DBliznets%26aufirst%3DI.%2BV.%26aulast%3DShorshnev%26aufirst%3DS.%2BV.%26aulast%3DAleksandrov%26aufirst%3DG.%2BG.%26aulast%3DStepanov%26aufirst%3DA.%2BE.%26aulast%3DVasil%25E2%2580%2599ev%26aufirst%3DA.%2BA.%26atitle%3DMicrove-assisted%2520synthesis%2520and%2520transformations%2520of%2520sterically%2520hindered%25203-%25285-tetrazolyl%2529pyridines%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D1849%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhuZWKlz86rmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Sardar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Molecular basis for lysophosphatidic acid receptor antagonist selectivity</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=309-317&issue=1%E2%80%933&author=V.+M.+Sardarauthor=D.+L.+Bautistaauthor=D.+J.+Fischerauthor=K.+Yokoyamaauthor=N.+Nusserauthor=T.+Viragauthor=D.+A.+Wangauthor=D.+L.+Bakerauthor=G.+Tigyiauthor=A.+L.+Parrill&title=Molecular+basis+for+lysophosphatidic+acid+receptor+antagonist+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSardar%26aufirst%3DV.%2BM.%26aulast%3DBautista%26aufirst%3DD.%2BL.%26aulast%3DFischer%26aufirst%3DD.%2BJ.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DNusser%26aufirst%3DN.%26aulast%3DVirag%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DMolecular%2520basis%2520for%2520lysophosphatidic%2520acid%2520receptor%2520antagonist%2520selectivity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1582%26issue%3D1%25E2%2580%25933%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span> </span><span class="NLM_article-title">CH-O and CH-N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492249" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1278-1281&author=A.+C.+Pierceauthor=E.+ter+Haarauthor=H.+M.+Binchauthor=D.+P.+Kayauthor=S.+R.+Patelauthor=P.+Li&title=CH-O+and+CH-N+hydrogen+bonds+in+ligand+design%3A+a+novel+quinazolin-4-ylthiazol-2-ylamine+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0492249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492249%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBinch%26aufirst%3DH.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DCH-O%2520and%2520CH-N%2520hydrogen%2520bonds%2520in%2520ligand%2520design%253A%2520a%2520novel%2520quinazolin-4-ylthiazol-2-ylamine%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1278%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujiuchi, T.</span><span> </span><span class="NLM_article-title">Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1016%2Fj.canlet.2011.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=22079467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkslamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2012&pages=91-96&issue=1&author=M.+Hayashiauthor=K.+Okabeauthor=K.+Katoauthor=M.+Okumuraauthor=R.+Fukuiauthor=N.+Fukushimaauthor=T.+Tsujiuchi&title=Differential+function+of+lysophosphatidic+acid+receptors+in+cell+proliferation+and+migration+of+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells</span></div><div class="casAuthors">Hayashi, Mai; Okabe, Kyoko; Kato, Kohei; Okumura, Mai; Fukui, Rie; Fukushima, Nobuyuki; Tsujiuchi, Toshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid mediator that induces diverse cellular biol. effects and interacts with G protein-coupled transmembrane LPA receptors.  In the present study, to assess biol. roles of LPA receptors in the pathogenesis of tumor cells, each LPA receptor (Lpar1, Lpar2 or Lpar3)-expressing rat neuroblastoma B103 cells (lpa1-1, lpa2-2 or lpa3-3-2 cells, resp.) were used.  In cell motility and invasion assay, lpa2-2 and lpa3-3-2 cells showed significant higher intrinsic activity without LPA treatment than LPA receptor-unexpressing AB2-1bf cells.  LPA treatment further increased cell motility of these cells, which was suppressed by the pretreatment with inhibitors of Gi, Gq protein, or ROCK.  By contrast, lpa1-1 cells markedly decreased intrinsic cell motility and invasion, compared with AB2-1bf cells.  Constitutively active mutant Lpar1-expressing cells (lpa1Δ-1) showed significant high motility, comparable with those of lpa2-2 and lpa3-3-2.  In soft agar assay, lpa3-3-2 and lpa1Δ-1 cells showed colony formation, but other cells failed.  These results suggest that LPA receptors may play different roles in cell proliferation and migration of rat neuroblastoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl00AWhJHObVg90H21EOLACvtfcHk0lgLq4ysd5Q2eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkslamug%253D%253D&md5=eaa74a58ace52d38c66fc7663776ee14</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2011.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2011.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DTsujiuchi%26aufirst%3DT.%26atitle%3DDifferential%2520function%2520of%2520lysophosphatidic%2520acid%2520receptors%2520in%2520cell%2520proliferation%2520and%2520migration%2520of%2520neuroblastoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2012%26volume%3D316%26issue%3D1%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagood, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerril, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span> </span><span class="NLM_article-title">Absence of Thy-1 results in TGF-beta induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1206-1218&issue=8&author=G.+Ramirezauthor=J.+S.+Hagoodauthor=Y.+Sandersauthor=R.+Ramirezauthor=C.+Becerrilauthor=L.+Seguraauthor=L.+Barreraauthor=M.+Selmanauthor=A.+Pardo&title=Absence+of+Thy-1+results+in+TGF-beta+induced+MMP-9+expression+and+confers+a+profibrotic+phenotype+to+human+lung+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DG.%26aulast%3DHagood%26aufirst%3DJ.%2BS.%26aulast%3DSanders%26aufirst%3DY.%26aulast%3DRamirez%26aufirst%3DR.%26aulast%3DBecerril%26aufirst%3DC.%26aulast%3DSegura%26aufirst%3DL.%26aulast%3DBarrera%26aufirst%3DL.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DA.%26atitle%3DAbsence%2520of%2520Thy-1%2520results%2520in%2520TGF-beta%2520induced%2520MMP-9%2520expression%2520and%2520confers%2520a%2520profibrotic%2520phenotype%2520to%2520human%2520lung%2520fibroblasts%26jtitle%3DLab.%2520Invest.%26date%3D2011%26volume%3D91%26issue%3D8%26spage%3D1206%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Funke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1165%2Frcmb.2010-0155OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=22021336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=355-364&issue=3&author=M.+Funkeauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Chunauthor=A.+M.+Tager&title=The+lysophosphatidic+acid+receptor+LPA1+promotes+epithelial+cell+apoptosis+after+lung+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span></div><div class="casAuthors">Funke, Manuela; Zhao, Zhenwen; Xu, Yan; Chun, Jerold; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the mol. pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified.  Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types.  We now show that LPA signaling through its receptor LPA1 promotes epithelial cell apoptosis induced by bleomycin injury.  The no. of apoptotic cells present in the alveolar and bronchial epithelia of LPA1-deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity.  Consistent with these in vivo results, we found that LPA signaling through LPA1 induced apoptosis in normal human bronchial epithelial cells in culture.  LPA-LPA1 signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment.  Similarly, LPA neg. regulated attachment of R3/1 rat alveolar epithelial cell line cells.  In contrast, LPA signaling through LPA1 promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF.  The ability of LPA-LPA1 signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_okuklehf2bVg90H21EOLACvtfcHk0lgLq4ysd5Q2eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D&md5=ae97ec6b86cb2006ed7c3ce6b7d35c0b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2010-0155OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2010-0155OC%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520promotes%2520epithelial%2520cell%2520apoptosis%2520after%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26issue%3D3%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijichi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3736</span><span class="NLM_x">–</span> <span class="NLM_lpage">3740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3736-3740&issue=13&author=T.+Yamamotoauthor=K.+Fujitaauthor=S.+Asariauthor=A.+Chibaauthor=Y.+Katabaauthor=K.+Ohsumiauthor=N.+Ohmutaauthor=Y.+Iidaauthor=C.+Ijichiauthor=S.+Iwayamaauthor=N.+Fukuchiauthor=M.+Shoji&title=Synthesis+and+evaluation+of+isoxazole+derivatives+as+lysophosphatidic+acid+%28LPA%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DAsari%26aufirst%3DS.%26aulast%3DChiba%26aufirst%3DA.%26aulast%3DKataba%26aufirst%3DY.%26aulast%3DOhsumi%26aufirst%3DK.%26aulast%3DOhmuta%26aufirst%3DN.%26aulast%3DIida%26aufirst%3DY.%26aulast%3DIjichi%26aufirst%3DC.%26aulast%3DIwayama%26aufirst%3DS.%26aulast%3DFukuchi%26aufirst%3DN.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520isoxazole%2520derivatives%2520as%2520lysophosphatidic%2520acid%2520%2528LPA%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D13%26spage%3D3736%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31a"><span><span class="NLM_contrib-group">Hutchinson, J. H.; Seiders, T. J.; Wang, B.</span><span> </span><span class="NLM_article-title">Compounds as Lysophosphatidic Acid Receptor Antagonists</span>. Patent application WO2011/017350.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchinson%2C+J.+H.%3B+Seiders%2C+T.+J.%3B+Wang%2C+B.+Compounds+as+Lysophosphatidic+Acid+Receptor+Antagonists.+Patent+application+WO2011%2F017350."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DCompounds%2520as%2520Lysophosphatidic%2520Acid%2520Receptor%2520Antagonists" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutchinson, J. H.; DeArmond, I. M.; Seiders, T. J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic Acid Receptor Antagonist for the Treatment of Dermal Conditions</span>. Patent application WO2011/159635.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchinson%2C+J.+H.%3B+DeArmond%2C+I.+M.%3B+Seiders%2C+T.+J.+Lysophosphatidic+Acid+Receptor+Antagonist+for+the+Treatment+of+Dermal+Conditions.+Patent+application+WO2011%2F159635."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DLysophosphatidic%2520Acid%2520Receptor%2520Antagonist%2520for%2520the%2520Treatment%2520of%2520Dermal%2520Conditions" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit31c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brittain, J. E.; Seiders, T. J.; Hutchinson, J. H.; King, C. D.; Rosso, V. W.</span> Patent application WO2012/078805.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brittain%2C+J.+E.%3B+Seiders%2C+T.+J.%3B+Hutchinson%2C+J.+H.%3B+King%2C+C.+D.%3B+Rosso%2C+V.+W.+Patent+application+WO2012%2F078805."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrittain%26aufirst%3DJ.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31a','cit31b','cit31c']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 33 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lucienne Juillerat-Jeanneret, John-David Aubert, Josip Mikulic, <span class="NLM_string-name hlFld-ContribAuthor">Dela Golshayan</span>. </span><span class="cited-content_cbyCitation_article-title">Fibrogenic Disorders in Human Diseases: From Inflammation to Organ Dysfunction. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (22)
                                     , 9811-9840. <a href="https://doi.org/10.1021/acs.jmedchem.8b00294" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00294</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00294%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFibrogenic%252BDisorders%252Bin%252BHuman%252BDiseases%25253A%252BFrom%252BInflammation%252Bto%252BOrgan%252BDysfunction%26aulast%3DJuillerat-Jeanneret%26aufirst%3DLucienne%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D21022018%26date%3D17072018%26date%3D03072018%26volume%3D61%26issue%3D22%26spage%3D9811%26epage%3D9840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian A.  Kuttruff</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Tom  Bretschneider</span>, <span class="hlFld-ContribAuthor ">Stefan  Hoerer</span>, <span class="hlFld-ContribAuthor ">Sandra  Handschuh</span>, <span class="hlFld-ContribAuthor ">Bernd  Nosse</span>, <span class="hlFld-ContribAuthor ">Helmut  Romig</span>, <span class="hlFld-ContribAuthor ">Paul  Nicklin</span>, and <span class="hlFld-ContribAuthor ">Gerald J.  Roth</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly Reduces LPA Levels in Vivo. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1252-1257. <a href="https://doi.org/10.1021/acsmedchemlett.7b00312" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00312</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00312%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BBI-2545%25253A%252BA%252BNovel%252BAutotaxin%252BInhibitor%252BThat%252BSignificantly%252BReduces%252BLPA%252BLevels%252Bin%252BVivo%26aulast%3DKuttruff%26aufirst%3DChristian%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D05082017%26date%3D08112017%26date%3D14112017%26date%3D14122017%26date%3D08112017%26volume%3D8%26issue%3D12%26spage%3D1252%26epage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiko  Terakado</span>, <span class="hlFld-ContribAuthor ">Hidehiro  Suzuki</span>, <span class="hlFld-ContribAuthor ">Kazuya  Hashimura</span>, <span class="hlFld-ContribAuthor ">Motoyuki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Ueda</span>, <span class="hlFld-ContribAuthor ">Keisuke  Hirai</span>, <span class="hlFld-ContribAuthor ">Masaki  Asada</span>, <span class="hlFld-ContribAuthor ">Masahiro  Ikura</span>, <span class="hlFld-ContribAuthor ">Naoki  Matsunaga</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Saga</span>, <span class="hlFld-ContribAuthor ">Koji  Shinozaki</span>, <span class="hlFld-ContribAuthor ">Naoko  Karakawa</span>, <span class="hlFld-ContribAuthor ">Yuka  Takada</span>, <span class="hlFld-ContribAuthor ">Masashi  Minami</span>, <span class="hlFld-ContribAuthor ">Hiromu  Egashira</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Sugiura</span>, <span class="hlFld-ContribAuthor ">Masanori  Yamada</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakade</span>, and <span class="hlFld-ContribAuthor ">Yoshikazu  Takaoka</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Slow Tight Binding LPA1 Antagonist (ONO-0300302) for the Treatment of Benign Prostatic Hyperplasia. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (12)
                                     , 1281-1286. <a href="https://doi.org/10.1021/acsmedchemlett.7b00383" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00383</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00383&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00383%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BSlow%252BTight%252BBinding%252BLPA1%252BAntagonist%252B%252528ONO-0300302%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BBenign%252BProstatic%252BHyperplasia%26aulast%3DTerakado%26aufirst%3DMasahiko%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D19092017%26date%3D20112017%26date%3D22112017%26date%3D14122017%26date%3D20112017%26volume%3D8%26issue%3D12%26spage%3D1281%26epage%3D1286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wangze  Song</span> and <span class="hlFld-ContribAuthor ">Nan  Zheng</span>  . </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed Highly Regioselective Azide–Ynamide Cycloaddition to Access 5-Amido Fully Substituted 1,2,3-Triazoles under Mild, Air, Aqueous, and Bioorthogonal Conditions. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (22)
                                     , 6200-6203. <a href="https://doi.org/10.1021/acs.orglett.7b03123" title="DOI URL">https://doi.org/10.1021/acs.orglett.7b03123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.7b03123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.7b03123%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIridium-Catalyzed%252BHighly%252BRegioselective%252BAzide%2525E2%252580%252593Ynamide%252BCycloaddition%252Bto%252BAccess%252B5-Amido%252BFully%252BSubstituted%252B1%25252C2%25252C3-Triazoles%252Bunder%252BMild%25252C%252BAir%25252C%252BAqueous%25252C%252Band%252BBioorthogonal%252BConditions%26aulast%3DSong%26aufirst%3DWangze%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D06102017%26date%3D07112017%26date%3D17112017%26volume%3D19%26issue%3D22%26spage%3D6200%26epage%3D6203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yi-Min  Liu</span>, <span class="hlFld-ContribAuthor ">Kunal  Nepali</span>, and <span class="hlFld-ContribAuthor ">Jing-Ping  Liou</span>  . </span><span class="cited-content_cbyCitation_article-title">Idiopathic Pulmonary Fibrosis: Current Status, Recent Progress, and Emerging Targets. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 527-553. <a href="https://doi.org/10.1021/acs.jmedchem.6b00935" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00935%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdiopathic%252BPulmonary%252BFibrosis%25253A%252BCurrent%252BStatus%25252C%252BRecent%252BProgress%25252C%252Band%252BEmerging%252BTargets%26aulast%3DLiu%26aufirst%3DYi-Min%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D22062016%26date%3D29112016%26date%3D26012017%26date%3D14112016%26volume%3D60%26issue%3D2%26spage%3D527%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masahiko  Terakado</span>, <span class="hlFld-ContribAuthor ">Hidehiro  Suzuki</span>, <span class="hlFld-ContribAuthor ">Kazuya  Hashimura</span>, <span class="hlFld-ContribAuthor ">Motoyuki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Ueda</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kohno</span>, <span class="hlFld-ContribAuthor ">Taku  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Saga</span>, <span class="hlFld-ContribAuthor ">Shinji  Nakade</span>, <span class="hlFld-ContribAuthor ">Hiromu  Habashita</span>, <span class="hlFld-ContribAuthor ">Yoshikazu  Takaoka</span>, and <span class="hlFld-ContribAuthor ">Takuya  Seko</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (10)
                                     , 913-918. <a href="https://doi.org/10.1021/acsmedchemlett.6b00225" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.6b00225</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.6b00225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.6b00225%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BONO-7300243%252Bfrom%252Ba%252BNovel%252BClass%252Bof%252BLysophosphatidic%252BAcid%252BReceptor%252B1%252BAntagonists%25253A%252BFrom%252BHit%252Bto%252BLead%26aulast%3DTerakado%26aufirst%3DMasahiko%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D19082016%26date%3D23082016%26date%3D13102016%26date%3D19082016%26volume%3D7%26issue%3D10%26spage%3D913%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Castagna</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>, <span class="hlFld-ContribAuthor ">Simon J. F.  Macdonald</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, and <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Autotaxin Inhibitors: An Overview of the Patent and Primary Literature. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5604-5621. <a href="https://doi.org/10.1021/acs.jmedchem.5b01599" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01599</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01599&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01599%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BAutotaxin%252BInhibitors%25253A%252BAn%252BOverview%252Bof%252Bthe%252BPatent%252Band%252BPrimary%252BLiterature%26aulast%3DCastagna%26aufirst%3DDiana%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D13102015%26date%3D28012016%26date%3D23062016%26date%3D08012016%26volume%3D59%26issue%3D12%26spage%3D5604%26epage%3D5621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bhagyalalitha  Meduri</span>, <span class="hlFld-ContribAuthor ">Gurubasavaraj Veeranna  Pujar</span>, <span class="hlFld-ContribAuthor ">T.  Durai Ananda Kumar</span>, <span class="hlFld-ContribAuthor ">H.S.  Akshatha</span>, <span class="hlFld-ContribAuthor ">Arun Kumar  Sethu</span>, <span class="hlFld-ContribAuthor ">Manisha  Singh</span>, <span class="hlFld-ContribAuthor ">Abhinav  Kanagarla</span>, <span class="hlFld-ContribAuthor ">Bijo  Mathew</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid (LPA) receptor modulators: Structural features and recent development. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113574. <a href="https://doi.org/10.1016/j.ejmech.2021.113574" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113574</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113574%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLysophosphatidic%252Bacid%252B%252528LPA%252529%252Breceptor%252Bmodulators%25253A%252BStructural%252Bfeatures%252Band%252Brecent%252Bdevelopment%26aulast%3DMeduri%26aufirst%3DBhagyalalitha%26date%3D2021%26volume%3D222%26spage%3D113574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel S.  Gribanov</span>, <span class="hlFld-ContribAuthor ">Edita M.  Atoian</span>, <span class="hlFld-ContribAuthor ">Anna N.  Philippova</span>, <span class="hlFld-ContribAuthor ">Maxim A.  Topchiy</span>, <span class="hlFld-ContribAuthor ">Andrey F.  Asachenko</span>, <span class="hlFld-ContribAuthor ">Sergey N.  Osipov</span>. </span><span class="cited-content_cbyCitation_article-title">One‐Pot Synthesis of 5‐Amino‐1,2,3‐triazole Derivatives via Dipolar Azide−Nitrile Cycloaddition and Dimroth Rearrangement under Solvent‐Free Conditions. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em>2021 </em>
                                    (9)
                                     , 1378-1384. <a href="https://doi.org/10.1002/ejoc.202001620" title="DOI URL">https://doi.org/10.1002/ejoc.202001620</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.202001620&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.202001620%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DOne%2525E2%252580%252590Pot%252BSynthesis%252Bof%252B5%2525E2%252580%252590Amino%2525E2%252580%2525901%25252C2%25252C3%2525E2%252580%252590triazole%252BDerivatives%252Bvia%252BDipolar%252BAzide%2525E2%252588%252592Nitrile%252BCycloaddition%252Band%252BDimroth%252BRearrangement%252Bunder%252BSolvent%2525E2%252580%252590Free%252BConditions%26aulast%3DGribanov%26aufirst%3DPavel%2BS.%26date%3D2021%26date%3D2021%26volume%3D2021%26issue%3D9%26spage%3D1378%26epage%3D1384" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Badr  Jismy</span>, <span class="hlFld-ContribAuthor ">Gérald  Guillaumet</span>, <span class="hlFld-ContribAuthor ">Mohamed  Akssira</span>, <span class="hlFld-ContribAuthor ">Abdellatif  Tikad</span>, <span class="hlFld-ContribAuthor ">Mohamed  Abarbri</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient microwave-assisted Suzuki–Miyaura cross-coupling reaction of 3-bromo pyrazolo[1,5-
              a
              ]pyrimidin-5(4
              H
              )-one: towards a new access to 3,5-diarylated 7-(trifluoromethyl)pyrazolo[1,5-
              a
              ]pyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (3)
                                     , 1287-1302. <a href="https://doi.org/10.1039/D0RA07959F" title="DOI URL">https://doi.org/10.1039/D0RA07959F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA07959F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA07959F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DEfficient%252Bmicrowave-assisted%252BSuzuki%2525E2%252580%252593Miyaura%252Bcross-coupling%252Breaction%252Bof%252B3-bromo%252Bpyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidin-5%2525284%252BH%252B%252529-one%25253A%252Btowards%252Ba%252Bnew%252Baccess%252Bto%252B3%25252C5-diarylated%252B7-%252528trifluoromethyl%252529pyrazolo%25255B1%25252C5-%252Ba%252B%25255Dpyrimidine%252Bderivatives%26aulast%3DJismy%26aufirst%3DBadr%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D3%26spage%3D1287%26epage%3D1302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria C.  Olianas</span>, <span class="hlFld-ContribAuthor ">Simona  Dedoni</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Onali</span>. </span><span class="cited-content_cbyCitation_article-title">Antidepressants induce profibrotic responses via the lysophosphatidic acid receptor LPA1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2020,</strong> <em>873 </em>, 172963. <a href="https://doi.org/10.1016/j.ejphar.2020.172963" title="DOI URL">https://doi.org/10.1016/j.ejphar.2020.172963</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2020.172963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2020.172963%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DAntidepressants%252Binduce%252Bprofibrotic%252Bresponses%252Bvia%252Bthe%252Blysophosphatidic%252Bacid%252Breceptor%252BLPA1%26aulast%3DOlianas%26aufirst%3DMaria%2BC.%26date%3D2020%26volume%3D873%26spage%3D172963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarina  Zmajkovicova</span>, <span class="hlFld-ContribAuthor ">Yasmina  Bauer</span>, <span class="hlFld-ContribAuthor ">Katalin  Menyhart</span>, <span class="hlFld-ContribAuthor ">Marie  Schnoebelen</span>, <span class="hlFld-ContribAuthor ">Diego  Freti</span>, <span class="hlFld-ContribAuthor ">Maxime  Boucher</span>, <span class="hlFld-ContribAuthor ">Bérengère  Renault</span>, <span class="hlFld-ContribAuthor ">Rolf  Studer</span>, <span class="hlFld-ContribAuthor ">Magdalena  Birker-Robaczewska</span>, <span class="hlFld-ContribAuthor ">Axel  Klenk</span>, <span class="hlFld-ContribAuthor ">Oliver  Nayler</span>, <span class="hlFld-ContribAuthor ">John  Gatfield</span>, . </span><span class="cited-content_cbyCitation_article-title">GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2020,</strong> <em>15 </em>
                                    (2)
                                     , e0228195. <a href="https://doi.org/10.1371/journal.pone.0228195" title="DOI URL">https://doi.org/10.1371/journal.pone.0228195</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0228195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0228195%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DGPCR-induced%252BYAP%252Bactivation%252Bsensitizes%252Bfibroblasts%252Bto%252Bprofibrotic%252Bactivity%252Bof%252BTGF%2525CE%2525B21%26aulast%3DZmajkovicova%26aufirst%3DKatarina%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D2%26spage%3De0228195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hao  Zeng</span>, <span class="hlFld-ContribAuthor ">Johnny  Castillo-Cabrera</span>, <span class="hlFld-ContribAuthor ">Mika  Manser</span>, <span class="hlFld-ContribAuthor ">Bo  Lu</span>, <span class="hlFld-ContribAuthor ">Zinger  Yang</span>, <span class="hlFld-ContribAuthor ">Vaik  Strande</span>, <span class="hlFld-ContribAuthor ">Damien  Begue</span>, <span class="hlFld-ContribAuthor ">Raffaella  Zamponi</span>, <span class="hlFld-ContribAuthor ">Shumei  Qiu</span>, <span class="hlFld-ContribAuthor ">Frederic  Sigoillot</span>, <span class="hlFld-ContribAuthor ">Qiong  Wang</span>, <span class="hlFld-ContribAuthor ">Alicia  Lindeman</span>, <span class="hlFld-ContribAuthor ">John S  Reece-Hoyes</span>, <span class="hlFld-ContribAuthor ">Carsten  Russ</span>, <span class="hlFld-ContribAuthor ">Debora  Bonenfant</span>, <span class="hlFld-ContribAuthor ">Xiaomo  Jiang</span>, <span class="hlFld-ContribAuthor ">Youzhen  Wang</span>, <span class="hlFld-ContribAuthor ">Feng  Cong</span>. </span><span class="cited-content_cbyCitation_article-title">Genome-wide CRISPR screening reveals genetic modifiers of mutant EGFR dependence in human NSCLC. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2019,</strong> <em>8 </em><a href="https://doi.org/10.7554/eLife.50223" title="DOI URL">https://doi.org/10.7554/eLife.50223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.50223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.50223%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DGenome-wide%252BCRISPR%252Bscreening%252Breveals%252Bgenetic%252Bmodifiers%252Bof%252Bmutant%252BEGFR%252Bdependence%252Bin%252Bhuman%252BNSCLC%26aulast%3DZeng%26aufirst%3DHao%26date%3D2019%26date%3D2019%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maria C.  Olianas</span>, <span class="hlFld-ContribAuthor ">Simona  Dedoni</span>, <span class="hlFld-ContribAuthor ">Pierluigi  Onali</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of TNF-α-induced neuronal apoptosis by antidepressants acting through the lysophosphatidic acid receptor LPA1. </span><span class="cited-content_cbyCitation_journal-name">Apoptosis</span><span> <strong>2019,</strong> <em>24 </em>
                                    (5-6)
                                     , 478-498. <a href="https://doi.org/10.1007/s10495-019-01530-2" title="DOI URL">https://doi.org/10.1007/s10495-019-01530-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10495-019-01530-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10495-019-01530-2%26sid%3Dliteratum%253Aachs%26jtitle%3DApoptosis%26atitle%3DInhibition%252Bof%252BTNF-%2525CE%2525B1-induced%252Bneuronal%252Bapoptosis%252Bby%252Bantidepressants%252Bacting%252Bthrough%252Bthe%252Blysophosphatidic%252Bacid%252Breceptor%252BLPA1%26aulast%3DOlianas%26aufirst%3DMaria%2BC.%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D5-6%26spage%3D478%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexios N.  Matralis</span>, <span class="hlFld-ContribAuthor ">Antreas  Afantitis</span>, <span class="hlFld-ContribAuthor ">Vassilis  Aidinis</span>. </span><span class="cited-content_cbyCitation_article-title">Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 976-1013. <a href="https://doi.org/10.1002/med.21551" title="DOI URL">https://doi.org/10.1002/med.21551</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21551%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DDevelopment%252Band%252Btherapeutic%252Bpotential%252Bof%252Bautotaxin%252Bsmall%252Bmolecule%252Binhibitors%25253A%252BFrom%252Bbench%252Bto%252Badvanced%252Bclinical%252Btrials%26aulast%3DMatralis%26aufirst%3DAlexios%2BN.%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D976%26epage%3D1013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonathan  Ellery</span>, <span class="hlFld-ContribAuthor ">Louise  Dickson</span>, <span class="hlFld-ContribAuthor ">Toni  Cheung</span>, <span class="hlFld-ContribAuthor ">Loredana  Ciuclan</span>, <span class="hlFld-ContribAuthor ">Peter  Bunyard</span>, <span class="hlFld-ContribAuthor ">Stephen  Mack</span>, <span class="hlFld-ContribAuthor ">William J.  Buffham</span>, <span class="hlFld-ContribAuthor ">William  Farnaby</span>, <span class="hlFld-ContribAuthor ">Philip  Mitchell</span>, <span class="hlFld-ContribAuthor ">Daniel  Brown</span>, <span class="hlFld-ContribAuthor ">Richard  Isaacs</span>, <span class="hlFld-ContribAuthor ">Matt  Barnes</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of compounds acting as negative allosteric modulators of the LPA1 receptor. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Pharmacology</span><span> <strong>2018,</strong> <em>833 </em>, 8-15. <a href="https://doi.org/10.1016/j.ejphar.2018.05.040" title="DOI URL">https://doi.org/10.1016/j.ejphar.2018.05.040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejphar.2018.05.040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejphar.2018.05.040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Pharmacology%26atitle%3DIdentification%252Bof%252Bcompounds%252Bacting%252Bas%252Bnegative%252Ballosteric%252Bmodulators%252Bof%252Bthe%252BLPA1%252Breceptor%26aulast%3DEllery%26aufirst%3DJonathan%26date%3D2018%26volume%3D833%26spage%3D8%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Cooper</span>, <span class="hlFld-ContribAuthor ">Sameek  Singh</span>, <span class="hlFld-ContribAuthor ">Sarah  Hook</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>, <span class="hlFld-ContribAuthor ">Andrea J.  Vernall</span>, . </span><span class="cited-content_cbyCitation_article-title">Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Reviews</span><span> <strong>2017,</strong> <em>69 </em>
                                    (3)
                                     , 316-353. <a href="https://doi.org/10.1124/pr.116.013243" title="DOI URL">https://doi.org/10.1124/pr.116.013243</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/pr.116.013243&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fpr.116.013243%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Reviews%26atitle%3DChemical%252BTools%252Bfor%252BStudying%252BLipid-Binding%252BClass%252BA%252BG%252BProtein%2525E2%252580%252593Coupled%252BReceptors%26aulast%3DCooper%26aufirst%3DAnna%26date%3D2017%26date%3D2017%26volume%3D69%26issue%3D3%26spage%3D316%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hui Ying  Li</span>, <span class="hlFld-ContribAuthor ">Yoon Sin  Oh</span>, <span class="hlFld-ContribAuthor ">Ji-Woong  Choi</span>, <span class="hlFld-ContribAuthor ">Ji Yong  Jung</span>, <span class="hlFld-ContribAuthor ">Hee-Sook  Jun</span>. </span><span class="cited-content_cbyCitation_article-title">Blocking lysophosphatidic acid receptor 1 signaling inhibits diabetic nephropathy in db/db mice. </span><span class="cited-content_cbyCitation_journal-name">Kidney International</span><span> <strong>2017,</strong> <em>91 </em>
                                    (6)
                                     , 1362-1373. <a href="https://doi.org/10.1016/j.kint.2016.11.010" title="DOI URL">https://doi.org/10.1016/j.kint.2016.11.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.kint.2016.11.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.kint.2016.11.010%26sid%3Dliteratum%253Aachs%26jtitle%3DKidney%2520International%26atitle%3DBlocking%252Blysophosphatidic%252Bacid%252Breceptor%252B1%252Bsignaling%252Binhibits%252Bdiabetic%252Bnephropathy%252Bin%252Bdb%25252Fdb%252Bmice%26aulast%3DLi%26aufirst%3DHui%2BYing%26date%3D2017%26volume%3D91%26issue%3D6%26spage%3D1362%26epage%3D1373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lukáš  Jedinák</span>, <span class="hlFld-ContribAuthor ">Petr  Cankař</span>. </span><span class="cited-content_cbyCitation_article-title">4-Arylation of
              N
              -Acylamino- and Aminopyrazoles by the Suzuki-Miyaura Cross-Coupling Reaction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (11)
                                     , 2013-2023. <a href="https://doi.org/10.1002/ejoc.201600072" title="DOI URL">https://doi.org/10.1002/ejoc.201600072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D4-Arylation%252Bof%252BN%252B-Acylamino-%252Band%252BAminopyrazoles%252Bby%252Bthe%252BSuzuki-Miyaura%252BCross-Coupling%252BReaction%26aulast%3DJedin%25C3%25A1k%26aufirst%3DLuk%25C3%25A1%25C5%25A1%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D11%26spage%3D2013%26epage%3D2023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. H.  Shim</span>, <span class="hlFld-ContribAuthor ">H.-S.  Kim</span>, <span class="hlFld-ContribAuthor ">E. S.  Kim</span>, <span class="hlFld-ContribAuthor ">K.-Y.  Lee</span>, <span class="hlFld-ContribAuthor ">E.-K.  Kim</span>, <span class="hlFld-ContribAuthor ">J.-H.  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Expression of autotaxin and lysophosphatidic acid receptors 1 and 3 in the developing rat lung and in response to hyperoxia. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Research</span><span> <strong>2015,</strong> <em>49 </em>
                                    (11)
                                     , 1362-1370. <a href="https://doi.org/10.3109/10715762.2015.1073850" title="DOI URL">https://doi.org/10.3109/10715762.2015.1073850</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/10715762.2015.1073850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F10715762.2015.1073850%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Research%26atitle%3DExpression%252Bof%252Bautotaxin%252Band%252Blysophosphatidic%252Bacid%252Breceptors%252B1%252Band%252B3%252Bin%252Bthe%252Bdeveloping%252Brat%252Blung%252Band%252Bin%252Bresponse%252Bto%252Bhyperoxia%26aulast%3DShim%26aufirst%3DG.%2BH.%26date%3D2015%26date%3D2015%26volume%3D49%26issue%3D11%26spage%3D1362%26epage%3D1370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dong-Soon  Im</span>. </span><span class="cited-content_cbyCitation_article-title">Translational research on autotaxin-LPA-LPA receptors and drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Clinical Lipidology</span><span> <strong>2015,</strong> <em>10 </em>
                                    (2)
                                     , 177-190. <a href="https://doi.org/10.2217/clp.15.4" title="DOI URL">https://doi.org/10.2217/clp.15.4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/clp.15.4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fclp.15.4%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Lipidology%26atitle%3DTranslational%252Bresearch%252Bon%252Bautotaxin-LPA-LPA%252Breceptors%252Band%252Bdrug%252Bdiscovery%26aulast%3DIm%26aufirst%3DDong-Soon%26date%3D2015%26volume%3D10%26issue%3D2%26spage%3D177%26epage%3D190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sabin  Llona-Minguez</span>, <span class="hlFld-ContribAuthor ">Artin  Ghassemian</span>, <span class="hlFld-ContribAuthor ">Thomas  Helleday</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid receptor (LPAR) modulators: The current pharmacological toolbox. </span><span class="cited-content_cbyCitation_journal-name">Progress in Lipid Research</span><span> <strong>2015,</strong> <em>58 </em>, 51-75. <a href="https://doi.org/10.1016/j.plipres.2015.01.004" title="DOI URL">https://doi.org/10.1016/j.plipres.2015.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.plipres.2015.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.plipres.2015.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DProgress%2520in%2520Lipid%2520Research%26atitle%3DLysophosphatidic%252Bacid%252Breceptor%252B%252528LPAR%252529%252Bmodulators%25253A%252BThe%252Bcurrent%252Bpharmacological%252Btoolbox%26aulast%3DLlona-Minguez%26aufirst%3DSabin%26date%3D2015%26volume%3D58%26spage%3D51%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Inés  González-Gil</span>, <span class="hlFld-ContribAuthor ">Debora  Zian</span>, <span class="hlFld-ContribAuthor ">Henar  Vázquez-Villa</span>, <span class="hlFld-ContribAuthor ">Silvia  Ortega-Gutiérrez</span>, <span class="hlFld-ContribAuthor ">María L.  López-Rodríguez</span>. </span><span class="cited-content_cbyCitation_article-title">The status of the lysophosphatidic acid receptor type 1 (LPA
              1
              R). </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (1)
                                     , 13-23. <a href="https://doi.org/10.1039/C4MD00333K" title="DOI URL">https://doi.org/10.1039/C4MD00333K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MD00333K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MD00333K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DThe%252Bstatus%252Bof%252Bthe%252Blysophosphatidic%252Bacid%252Breceptor%252Btype%252B1%252B%252528LPA%252B1%252BR%252529%26aulast%3DGonz%25C3%25A1lez-Gil%26aufirst%3DIn%25C3%25A9s%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D1%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diana  Castagna</span>, <span class="hlFld-ContribAuthor ">Emma L.  Duffy</span>, <span class="hlFld-ContribAuthor ">Dima  Semaan</span>, <span class="hlFld-ContribAuthor ">Louise C.  Young</span>, <span class="hlFld-ContribAuthor ">John M.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Simon J. F.  Macdonald</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>, <span class="hlFld-ContribAuthor ">Craig  Jamieson</span>, <span class="hlFld-ContribAuthor ">Allan J. B.  Watson</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of a novel class of autotaxin inhibitors through cross-screening. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (6)
                                     , 1149-1155. <a href="https://doi.org/10.1039/C5MD00081E" title="DOI URL">https://doi.org/10.1039/C5MD00081E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00081E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00081E%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DIdentification%252Bof%252Ba%252Bnovel%252Bclass%252Bof%252Bautotaxin%252Binhibitors%252Bthrough%252Bcross-screening%26aulast%3DCastagna%26aufirst%3DDiana%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D6%26spage%3D1149%26epage%3D1155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.-X.  Wang</span>, <span class="hlFld-ContribAuthor ">L.-L.  Wu</span>, <span class="hlFld-ContribAuthor ">Y.-M.  Wang</span>, <span class="hlFld-ContribAuthor ">Z.-H.  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Organocatalyzed asymmetric tandem Michael-cyclization reaction of 4-benzylidene-3-methylpyrazol-5-ones and malononitrile: stereocontrolled construction of pyrano[2,3-c]pyrazole scaffold. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (53)
                                     , 42836-42842. <a href="https://doi.org/10.1039/C5RA04356E" title="DOI URL">https://doi.org/10.1039/C5RA04356E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA04356E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA04356E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOrganocatalyzed%252Basymmetric%252Btandem%252BMichael-cyclization%252Breaction%252Bof%252B4-benzylidene-3-methylpyrazol-5-ones%252Band%252Bmalononitrile%25253A%252Bstereocontrolled%252Bconstruction%252Bof%252Bpyrano%25255B2%25252C3-c%25255Dpyrazole%252Bscaffold%26aulast%3DWang%26aufirst%3DH.-X.%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D53%26spage%3D42836%26epage%3D42842" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Achyutharao  Sidduri</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>, <span class="hlFld-ContribAuthor ">Maria E.  Fuentes</span>, <span class="hlFld-ContribAuthor ">Ted  Lambros</span>, <span class="hlFld-ContribAuthor ">Yonglin  Ren</span>, <span class="hlFld-ContribAuthor ">Vikram  Roongta</span>, <span class="hlFld-ContribAuthor ">Ryan C.  Schoenfeld</span>, <span class="hlFld-ContribAuthor ">Paul  Gillespie</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Stevenson</span>, <span class="hlFld-ContribAuthor ">Theresa  Truitt</span>, <span class="hlFld-ContribAuthor ">Yimin  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel non-carboxylic acid 5-amino-4-cyanopyrazole derivatives as potent and highly selective LPA1R antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (18)
                                     , 4450-4454. <a href="https://doi.org/10.1016/j.bmcl.2014.08.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.08.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.08.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.08.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bnon-carboxylic%252Bacid%252B5-amino-4-cyanopyrazole%252Bderivatives%252Bas%252Bpotent%252Band%252Bhighly%252Bselective%252BLPA1R%252Bantagonists%26aulast%3DSidduri%26aufirst%3DAchyutharao%26date%3D2014%26volume%3D24%26issue%3D18%26spage%3D4450%26epage%3D4454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abby L  Parrill</span>. </span><span class="cited-content_cbyCitation_article-title">Design of anticancer lysophosphatidic acid agonists and antagonists. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (8)
                                     , 871-883. <a href="https://doi.org/10.4155/fmc.14.52" title="DOI URL">https://doi.org/10.4155/fmc.14.52</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.52&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.52%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Bof%252Banticancer%252Blysophosphatidic%252Bacid%252Bagonists%252Band%252Bantagonists%26aulast%3DParrill%26aufirst%3DAbby%2BL%26date%3D2014%26volume%3D6%26issue%3D8%26spage%3D871%26epage%3D883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloé  Rancoule</span>, <span class="hlFld-ContribAuthor ">Manon  Viaud</span>, <span class="hlFld-ContribAuthor ">Sandra  Gres</span>, <span class="hlFld-ContribAuthor ">Nathalie  Viguerie</span>, <span class="hlFld-ContribAuthor ">Pauline  Decaunes</span>, <span class="hlFld-ContribAuthor ">Anne  Bouloumié</span>, <span class="hlFld-ContribAuthor ">Dominique  Langin</span>, <span class="hlFld-ContribAuthor ">Jean-Loup  Bascands</span>, <span class="hlFld-ContribAuthor ">Philippe  Valet</span>, <span class="hlFld-ContribAuthor ">Jean Sébastien  Saulnier-Blache</span>. </span><span class="cited-content_cbyCitation_article-title">Pro-fibrotic activity of lysophosphatidic acid in adipose tissue: In vivo and in vitro evidence. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids</span><span> <strong>2014,</strong> <em>1841 </em>
                                    (1)
                                     , 88-96. <a href="https://doi.org/10.1016/j.bbalip.2013.10.003" title="DOI URL">https://doi.org/10.1016/j.bbalip.2013.10.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbalip.2013.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbalip.2013.10.003%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520and%2520Cell%2520Biology%2520of%2520Lipids%26atitle%3DPro-fibrotic%252Bactivity%252Bof%252Blysophosphatidic%252Bacid%252Bin%252Badipose%252Btissue%25253A%252BIn%252Bvivo%252Band%252Bin%252Bvitro%252Bevidence%26aulast%3DRancoule%26aufirst%3DChlo%25C3%25A9%26date%3D2014%26volume%3D1841%26issue%3D1%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin  Darses</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Darren J.  Dixon</span>. </span><span class="cited-content_cbyCitation_article-title">Facile multi-decagram synthesis of methyl but-2-ynoate. </span><span class="cited-content_cbyCitation_journal-name">Organic Chemistry Frontiers</span><span> <strong>2014,</strong> <em>1 </em>
                                    (1)
                                     , 117. <a href="https://doi.org/10.1039/c3qo00072a" title="DOI URL">https://doi.org/10.1039/c3qo00072a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3qo00072a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3qo00072a%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Chemistry%2520Frontiers%26atitle%3DFacile%252Bmulti-decagram%252Bsynthesis%252Bof%252Bmethyl%252Bbut-2-ynoate%26aulast%3DDarses%26aufirst%3DBenjamin%26date%3D2014%26volume%3D1%26issue%3D1%26spage%3D117" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David C  Budd</span>, <span class="hlFld-ContribAuthor ">Yimin  Qian</span>. </span><span class="cited-content_cbyCitation_article-title">Development of lysophosphatidic acid pathway modulators as therapies for fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2013,</strong> <em>5 </em>
                                    (16)
                                     , 1935-1952. <a href="https://doi.org/10.4155/fmc.13.154" title="DOI URL">https://doi.org/10.4155/fmc.13.154</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.13.154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.13.154%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252Blysophosphatidic%252Bacid%252Bpathway%252Bmodulators%252Bas%252Btherapies%252Bfor%252Bfibrosis%26aulast%3DBudd%26aufirst%3DDavid%2BC%26date%3D2013%26volume%3D5%26issue%3D16%26spage%3D1935%26epage%3D1952" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew C.  Lucas</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging Targets for the Treatment of Idiopathic Pulmonary Fibrosis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 149-167. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00011-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00011-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00011-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00011-9%26sid%3Dliteratum%253Aachs%26atitle%3DEmerging%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BIdiopathic%252BPulmonary%252BFibrosis%26aulast%3DLucas%26aufirst%3DMatthew%2BC.%26date%3D2013%26spage%3D149%26epage%3D167%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yonglin  Ren</span>, <span class="hlFld-ContribAuthor ">Liang  Guo</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Tang</span>, <span class="hlFld-ContribAuthor ">Subramaniam  Apparsundaram</span>, <span class="hlFld-ContribAuthor ">Christopher  Kitson</span>, <span class="hlFld-ContribAuthor ">Jeremy  Deguzman</span>, <span class="hlFld-ContribAuthor ">Maria E.  Fuentes</span>, <span class="hlFld-ContribAuthor ">Luke  Coyle</span>, <span class="hlFld-ContribAuthor ">Rupal  Majmudar</span>, <span class="hlFld-ContribAuthor ">John  Allard</span>, <span class="hlFld-ContribAuthor ">Theresa  Truitt</span>, <span class="hlFld-ContribAuthor ">Rachid  Hamid</span>, <span class="hlFld-ContribAuthor ">Yun  Chen</span>, <span class="hlFld-ContribAuthor ">Yimin  Qian</span>, <span class="hlFld-ContribAuthor ">David C.  Budd</span>. </span><span class="cited-content_cbyCitation_article-title">Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells. </span><span class="cited-content_cbyCitation_journal-name">Microvascular Research</span><span> <strong>2013,</strong> <em>85 </em>, 59-67. <a href="https://doi.org/10.1016/j.mvr.2012.10.004" title="DOI URL">https://doi.org/10.1016/j.mvr.2012.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mvr.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mvr.2012.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DMicrovascular%2520Research%26atitle%3DComparing%252Bthe%252Bdifferential%252Beffects%252Bof%252BLPA%252Bon%252Bthe%252Bbarrier%252Bfunction%252Bof%252Bhuman%252Bpulmonary%252Bendothelial%252Bcells%26aulast%3DRen%26aufirst%3DYonglin%26date%3D2013%26volume%3D85%26spage%3D59%26epage%3D67" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norihiko  Sakai</span>, <span class="hlFld-ContribAuthor ">Andrew M.  Tager</span>. </span><span class="cited-content_cbyCitation_article-title">Lysophosphatidic acid (LPA) signaling through LPA1 in organ fibrosis: A pathway with pleiotropic pro-fibrotic effects. </span><span class="cited-content_cbyCitation_journal-name">Inflammation and Regeneration</span><span> <strong>2013,</strong> <em>33 </em>
                                    (2)
                                     , 078-089. <a href="https://doi.org/10.2492/inflammregen.33.078" title="DOI URL">https://doi.org/10.2492/inflammregen.33.078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2492/inflammregen.33.078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2492%2Finflammregen.33.078%26sid%3Dliteratum%253Aachs%26jtitle%3DInflammation%2520and%2520Regeneration%26atitle%3DLysophosphatidic%252Bacid%252B%252528LPA%252529%252Bsignaling%252Bthrough%252BLPA1%252Bin%252Borgan%252Bfibrosis%25253A%252BA%252Bpathway%252Bwith%252Bpleiotropic%252Bpro-fibrotic%252Beffects%26aulast%3DSakai%26aufirst%3DNorihiko%26date%3D2013%26volume%3D33%26issue%3D2%26spage%3D078%26epage%3D089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of LPAR antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Compounds <b>3</b>–<b>10</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) (i) Pd(PPh<sub>3</sub>)<sub>4</sub> (cat), Cs<sub>2</sub>CO<sub>3</sub>, DMF, 80 °C; (ii) LiOH (aq), THF, 60 °C; (b) diphenylphosphoryl azide, triethylamine, toluene, 85 °C; (c) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 95 °C; (d) triphosgene, triethylamine, dichloromethane, 85 °C; (e) THF/LiOH (aq), rt.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of Compounds <b>11</b>–<b>20</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) 4-hydroxyphenylboronic acid, Pd(PPh<sub>3</sub>)<sub>4</sub> (cat), K<sub>2</sub>CO<sub>3</sub>, DMF; (b) (CF<sub>3</sub>SO<sub>2</sub>)<sub>2</sub>O, triethylamine, dichloromethane, −78 °C to rt; (c) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf) (cat), dioxane, 90 °C; (d) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C; (e) LiOH (aq), THF, rt; (f) triphosgene, triethylamine, dichloromethane, 85 °C; (g) NaOH (aq), ethanol, THF, rt.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <i>N</i>-Aryltriazole Compounds <b>2</b> and <b>21</b>–<b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) sodium azide, Cu(OAc)<sub>2</sub> (cat), methanol, rt; (b) toluene, sealed vessel, 150 °C, 4.5 h; (c) (i) LiOH (aq), THF, rt; (ii) diphenylphosphoryl azide, triethylamine, toluene, 65 °C; (d) S-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C, 4 h; (e) NaOH (aq), THF, ethanol, rt; (f) bis(pinacolato)diboron, KOAc, PdCl<sub>2</sub>(dppf) (cat), dioxane, 90 °C; (g) TMSN<sub>3</sub>, n-Bu<sub>2</sub>SnO (2 equiv), 100 °C, 15 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 4-<i>N</i>-Aryl-[1,2,4]triazole Derivative <b>33</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) thiophosgene, CaCO<sub>3</sub>, dichloromethane; (b) NH<sub>3</sub>/THF; (c) MeI, methanol, rt; (d) hydrazine monohydrate; (e) formic acid, 120 °C, 3.5 h; (f) PdCl<sub>2</sub>(dppf) (cat), Na<sub>2</sub>CO<sub>3</sub> (aq), dioxane, 100 °C, 24 h; (g) LiHMDS, THF; (h) LiOH (aq), THF.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compounds <b>34</b>–<b>43</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reaction conditions: (a) benzene, reflux, 4 h; (b) TBAF, THF, 0 °C; (c) LiOH (aq), THF, rt; (d) diphenylphosphoryl azide, triethylamine, toluene, 80 °C; (e) X-Phos (cat), Pd(OAc)<sub>2</sub> (cat), K<sub>3</sub>PO<sub>4</sub>, toluene/water, 100 °C; (f) NaOH (aq), THF, ethanol, rt; (g) activated zinc, THF; (h) Pd(OAc)<sub>2</sub> (cat), S-Phos (cat), THF; (i) Pd/C, H<sub>2</sub>; (j) diphenylphosphoryl azide, (<i>R</i>)-phenylethanol, triethylamine, 80 °C; (k) NaOH (aq), THF, ethanol; (l) PdCl<sub>2</sub>(dppf) (cat), DPPF (cat), DMF, Na<sub>2</sub>CO<sub>3</sub> (aq), 80 °C.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Inhibition of LPA-induced NHLF proliferation by LPA1 and LPA2 antagonists. (A) LPA concentration-dependently increases NHLF proliferation. (B) Effects of compounds <b>1</b>, <b>8</b>, and <b>9</b> on LPA (18:1) (15 μM)-induced NHLF proliferation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Stable Conformation Analysis of <b>32</b> and <b>33</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Energy as a function of the triazole-carbamate torsion angle for the [1,2,3]-triazole compound <b>32</b> (magenta circles), its active 4-methyl analogue <b>2</b> (cyan squares), and the less active [1,2,4]-triazole compound <b>33</b> (green diamonds). A torsion angle of 0° or 360° corresponds to the conformations drawn on the left side of Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>, while a torsion angle of 180° corresponds to the conformations drawn on the right side of Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Inhibition of LPA (18:1)-induced NHLF proliferation by LPA1 and LPA1/3 dual antagonists. (A) Concentration-dependent inhibition of LPA (18:1) (15 μM)-stimulated NHLF proliferation by <b>2</b>, AM095, and Ki16425. (B) Effects of LPA1 and LPA1/3 dual antagonists (<b>41</b> and <b>42</b>) on LPA (18:1) (15 μM)-stimulated NHLF proliferation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. LPA-mediated contraction of NHLFs assessed in three-dimensional collagen gels. (A) LPA (18:1) concentration-dependently increased NHLF contraction. (B) Photo image of the effects of LPAR inhibitors on 15 μM LPA (18:1)-mediated contraction. (C) Effects of LPA1 and LPA1/3 dual antagonists (<b>41</b> and <b>42</b>) on 15 μM LPA (18:1)-mediated NHLF contraction.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/medium/jm-2012-01022v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. LPA-induced histamine release in C57BL/6 mice. (A) LPA (intravenous injection) dose-dependently increased plasma histamine levels. (B) Dose-dependent inhibition of LPA-mediated plasma histamine levels by orally dosed compound <b>2</b>. (C) Correlation of histamine levels with compound <b>2</b> concentrations in plasma. Significance is denoted as follows: * <i>p</i> < 0.05, **<i>p</i> < 0.01, and ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-17/jm301022v/production/images/large/jm-2012-01022v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm301022v&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i67">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Datta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scotton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, R. C.</span><span> </span><span class="NLM_article-title">Novel therapeutic approaches for pulmonary fibrosis</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">163</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">141</span><span class="NLM_x">–</span> <span class="NLM_lpage">172</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2011.01247.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21265830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXls1GjtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2011&pages=141-172&issue=1&author=A.+Dattaauthor=C.+J.+Scottonauthor=R.+C.+Chambers&title=Novel+therapeutic+approaches+for+pulmonary+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Novel therapeutic approaches for pulmonary fibrosis</span></div><div class="casAuthors">Datta, Arnab; Scotton, Chris J.; Chambers, Rachel C.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">141-172</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Pulmonary fibrosis represents the end stage of a no. of heterogeneous conditions and is, to a greater or lesser degree, the hallmark of the interstitial lung diseases.  It is characterized by the excessive deposition of extracellular matrix proteins within the pulmonary interstitium leading to the obliteration of functional alveolar units and in many cases, respiratory failure.  While a small no. of interstitial lung diseases have known etiologies, most are idiopathic in nature, and of these, idiopathic pulmonary fibrosis is the most common and carries with it an appalling prognosis - median survival from the time of diagnosis is less than 3 years.  This reflects the lack of any effective therapy to modify the course of the disease, which in turn is indicative of our incomplete understanding of the pathogenesis of this condition.  Current prevailing hypotheses focus on dysregulated epithelial-mesenchymal interactions promoting a cycle of continued epithelial cell injury and fibroblast activation leading to progressive fibrosis.  However, it is likely that multiple abnormalities in a myriad of biol. pathways affecting inflammation and wound repair - including matrix regulation, epithelial reconstitution, the coagulation cascade, neovascularization and antioxidant pathways - modulate this defective crosstalk and promote fibrogenesis.  This review aims to offer a pathogenetic rationale behind current therapies, briefly outlining previous and ongoing clin. trials, but will focus on recent and exciting advancements in our understanding of the pathogenesis of idiopathic pulmonary fibrosis, which may ultimately lead to the development of novel and effective therapeutic interventions for this devastating condition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGZh6zcVDUa7Vg90H21EOLACvtfcHk0ljYxgB0KWzO9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXls1GjtLc%253D&md5=a161ebe75b90c742137e12b92fbeee42</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01247.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01247.x%26sid%3Dliteratum%253Aachs%26aulast%3DDatta%26aufirst%3DA.%26aulast%3DScotton%26aufirst%3DC.%2BJ.%26aulast%3DChambers%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520therapeutic%2520approaches%2520for%2520pulmonary%2520fibrosis%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2011%26volume%3D163%26issue%3D1%26spage%3D141%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Scotton, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, R. C.</span><span> </span><span class="NLM_article-title">Molecular targets in pulmonary fibrosis: the myofibroblast in focus</span> <span class="citation_source-journal">Chest</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1311</span><span class="NLM_x">–</span> <span class="NLM_lpage">1321</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2007&pages=1311-1321&issue=4&author=C.+J.+Scottonauthor=R.+C.+Chambers&title=Molecular+targets+in+pulmonary+fibrosis%3A+the+myofibroblast+in+focus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScotton%26aufirst%3DC.%2BJ.%26aulast%3DChambers%26aufirst%3DR.%2BC.%26atitle%3DMolecular%2520targets%2520in%2520pulmonary%2520fibrosis%253A%2520the%2520myofibroblast%2520in%2520focus%26jtitle%3DChest%26date%3D2007%26volume%3D132%26issue%3D4%26spage%3D1311%26epage%3D1321" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Parrill, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span> </span><span class="NLM_article-title">Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">1619</span><span class="NLM_x">–</span> <span class="NLM_lpage">1625</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1517%2F13543776.2010.533658" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21047298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7fN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1619-1625&issue=12&author=A.+L.+Parrillauthor=D.+L.+Baker&title=Autotaxin+inhibitors%3A+a+perspective+on+initial+medicinal+chemistry+efforts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Autotaxin inhibitors: a perspective on initial medicinal chemistry efforts</span></div><div class="casAuthors">Parrill, Abby L.; Baker, Daniel L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1619-1625</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The lysophospholipase D enzyme, autotaxin (ATX), has been linked to numerous human diseases including cancer, neurophatic pain, obesity and Alzheimer's disease.  Although the ATX protein was initially purified and characterized in 1992, a link to bioactive lipid metab. was not made until 2002.  In the past decade, metal chelators, lysophospholipid product analogs, and more recently, small non-lipid inhibitors of the enzyme were successfully identified.  The majority of these inhibitors have been characterized using recombinant purified ATX in vitro, with very few examples studied in more complex systems.  Translation of ATX inhibitors from the hands of medicinal chemists to clin. use will require substantially expanded characterization of ATX inhibitors in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWuFyKHNmQC7Vg90H21EOLACvtfcHk0lhYiMfmGozKdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVekt7fN&md5=5aed6b92b1ccd459bfe0546e282c2d9d</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1517%2F13543776.2010.533658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2010.533658%26sid%3Dliteratum%253Aachs%26aulast%3DParrill%26aufirst%3DA.%2BL.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26atitle%3DAutotaxin%2520inhibitors%253A%2520a%2520perspective%2520on%2520initial%2520medicinal%2520chemistry%2520efforts%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2010%26volume%3D20%26issue%3D12%26spage%3D1619%26epage%3D1625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance</span> <span class="citation_source-journal">Prostaglandins Other Lipid Mediators</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">3–4</span><span class="NLM_x">) </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">138</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1016%2Fj.prostaglandins.2009.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20331961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2010&pages=130-138&issue=3%E2%80%934&author=M.+E.+Linauthor=D.+R.+Herrauthor=J.+Chun&title=Lysophosphatidic+acid+%28LPA%29+receptors%3A+signaling+properties+and+disease+relevance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance</span></div><div class="casAuthors">Lin, Mu-En; Herr, Deron R.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Prostaglandins & Other Lipid Mediators</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">130-138</span>CODEN:
                <span class="NLM_cas:coden">POLMFL</span>;
        ISSN:<span class="NLM_cas:issn">1098-8823</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA), a water-sol. phospholipid, has gained significant attention in recent years since the discovery that it acts as a potent signaling mol. with wide-ranging effects on many different target tissues.  There are currently five identified G protein-coupled receptors for LPA and more are undergoing validation.  The complexity of the expression pattern and signaling properties of LPA receptors results in multiple influences on developmental, physiol., and pathol. processes.  This review provides a summary of LPA receptor signaling and current views on the potential involvement of this pathway in human diseases that include cardiovascular, cancer, neuropathic pain, neuropsychiatric disorders, reproductive disorders, and fibrosis.  The involvement of LPA signaling in these processes implicates multiple, potential drug targets including LPA receptor subtypes and LPA metabolizing enzymes.  Modulation of LPA signaling may thus provide therapeutic inroads for the treatment of human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIqNSV9ngb7Vg90H21EOLACvtfcHk0lhYiMfmGozKdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjslSiu7k%253D&md5=097555859468db9673c1ccf9ea8c2a60</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.prostaglandins.2009.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.prostaglandins.2009.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLysophosphatidic%2520acid%2520%2528LPA%2529%2520receptors%253A%2520signaling%2520properties%2520and%2520disease%2520relevance%26jtitle%3DProstaglandins%2520Other%2520Lipid%2520Mediators%26date%3D2010%26volume%3D91%26issue%3D3%25E2%2580%25934%26spage%3D130%26epage%3D138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Choi, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herr, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yung, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosley, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">LPA receptors: subtypes and biological actions</span> <span class="citation_source-journal">Annu. Rev. Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">186</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1146%2Fannurev.pharmtox.010909.105753" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20055701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=157-186&author=J.+W.+Choiauthor=D.+R.+Herrauthor=K.+Noguchiauthor=Y.+C.+Yungauthor=C.+W.+Leeauthor=T.+Mutohauthor=M.+E.+Linauthor=S.+T.+Teoauthor=K.+E.+Parkauthor=A.+N.+Mosleyauthor=J.+Chun&title=LPA+receptors%3A+subtypes+and+biological+actions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">LPA receptors: subtypes and biological actions</span></div><div class="casAuthors">Choi, Ji Woong; Herr, Deron R.; Noguchi, Kyoko; Yung, Yun C.; Lee, Chang-Wook; Mutoh, Tetsuji; Lin, Mu-En; Teo, Siew T.; Park, Kristine E.; Mosley, Alycia N.; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Pharmacology and Toxicology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">157-186</span>CODEN:
                <span class="NLM_cas:coden">ARPTDI</span>;
        ISSN:<span class="NLM_cas:issn">0362-1642</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  Lysophosphatidic acid (LPA) is a small, ubiquitous phospholipid that acts as an extracellular signaling mol. by binding to and activating at least 5 known G protein-coupled receptors (GPCRs): LPA1-LPA5.  They are encoded by distinct genes named LPAR1-LPAR5 in humans and Lpar1-Lpar5 in mice.  The biol. roles of LPA are diverse and include developmental, physiol., and pathophysiol. effects.  This diversity is mediated by broad and overlapping expression patterns and multiple downstream signaling pathways activated by cognate LPA receptors.  Studies using cloned receptors and genetic knockout mice were instrumental in uncovering the significance of this signaling system, notably involving basic cellular processes as well as multiple organ systems such as the nervous system.  This has further provided valuable proof-of-concept data to support LPA receptors and LPA metabolic enzymes as targets for the treatment of medically important diseases that include neuropsychiatric disorders, neuropathic pain, infertility, cardiovascular disease, inflammation, fibrosis, and cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGru4MuMgWgZ7LVg90H21EOLACvtfcHk0lhYiMfmGozKdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisVelur8%253D&md5=995861e6d3dcc7193eba9b4948b4811d</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1146%2Fannurev.pharmtox.010909.105753&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.pharmtox.010909.105753%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DJ.%2BW.%26aulast%3DHerr%26aufirst%3DD.%2BR.%26aulast%3DNoguchi%26aufirst%3DK.%26aulast%3DYung%26aufirst%3DY.%2BC.%26aulast%3DLee%26aufirst%3DC.%2BW.%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DM.%2BE.%26aulast%3DTeo%26aufirst%3DS.%2BT.%26aulast%3DPark%26aufirst%3DK.%2BE.%26aulast%3DMosley%26aufirst%3DA.%2BN.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DLPA%2520receptors%253A%2520subtypes%2520and%2520biological%2520actions%26jtitle%3DAnnu.%2520Rev.%2520Pharmacol.%2520Toxicol.%26date%3D2010%26volume%3D50%26spage%3D157%26epage%3D186" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Mutoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivera, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span> </span><span class="NLM_article-title">Insights into the pharmacological relevance of lysophospholipid receptors</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">829</span><span class="NLM_x">–</span> <span class="NLM_lpage">844</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2011.01622.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21838759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=829-844&issue=4&author=T.+Mutohauthor=R.+Riveraauthor=J.+Chun&title=Insights+into+the+pharmacological+relevance+of+lysophospholipid+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the pharmacological relevance of lysophospholipid receptors</span></div><div class="casAuthors">Mutoh, Tetsuji; Rivera, Richard; Chun, Jerold</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">829-844</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The discovery of lysophospholipid (LP) 7-transmembrane, G protein-coupled receptors (GPCRs) that began in the 1990s, together with research into the functional roles of the major LPs known as lysophosphatidic acid (LPA) and sphingosine 1-phosphate (S1P), have opened new research avenues into their biol. processes and mechanisms.  Major examples of LP signaling effects include embryogenesis, nervous system development, vascular development, uterine implantation, immune cell trafficking, and inflammatory reactions.  LP signaling also influences the pathophysiol. of many diseases including cancer, autoimmune and inflammatory diseases, which indicate that LP receptors may be attractive targets for pharmacol. therapies.  A key example of such a therapeutic agent is the S1P receptor modulator FTY720, which upon phosphorylation and continued drug exposure, acts as an S1P receptor functional antagonist.  This compd. (also known as fingolimod or Gilenya) has recently been approved by the FDA for the treatment of relapsing forms of multiple sclerosis.  Continued basic and translational research on LP signaling should provide novel insights into both basic biol. mechanisms, as well as novel therapeutic approaches to combat a range of human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1qOGwbmBPirVg90H21EOLACvtfcHk0lgXG3g6gSFDOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvFGqsLs%253D&md5=cf240e202ccfa00c40366f7309e36b78</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01622.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01622.x%26sid%3Dliteratum%253Aachs%26aulast%3DMutoh%26aufirst%3DT.%26aulast%3DRivera%26aufirst%3DR.%26aulast%3DChun%26aufirst%3DJ.%26atitle%3DInsights%2520into%2520the%2520pharmacological%2520relevance%2520of%2520lysophospholipid%2520receptors%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26issue%3D4%26spage%3D829%26epage%3D844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shiomi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boudreault, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padem, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashiyama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drazen, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tschumperlin, D. J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts</span> <span class="citation_source-journal">Wound Repair Regener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">229</span><span class="NLM_x">–</span> <span class="NLM_lpage">240</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1524-475X.2010.00655.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21362091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A280%3ADC%252BC3M3ivF2iuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=229-240&issue=2&author=T.+Shiomiauthor=F.+Boudreaultauthor=N.+Pademauthor=S.+Higashiyamaauthor=J.+M.+Drazenauthor=D.+J.+Tschumperlin&title=Lysophosphatidic+acid+stimulates+epidermal+growth+factor-family+ectodomain+shedding+and+paracrine+signaling+from+human+lung+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid stimulates epidermal growth factor-family ectodomain shedding and paracrine signaling from human lung fibroblasts</span></div><div class="casAuthors">Shiomi Tetsuya; Boudreault Francis; Padem Nurcicek; Higashiyama Shigeki; Drazen Jeffrey M; Tschumperlin Daniel J</div><div class="citationInfo"><span class="NLM_cas:title">Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">229-40</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lysophospatidic acid (LPA) is a bioactive lipid mediator implicated in tissue repair and wound healing.  It mediates diverse functional effects in fibroblasts, including proliferation, migration and contraction, but less is known about its ability to evoke paracrine signaling to other cell types involved in wound healing.  We hypothesized that human pulmonary fibroblasts stimulated by LPA would exhibit ectodomain shedding of epidermal growth factor receptor (EGFR) ligands that signal to lung epithelial cells.  To test this hypothesis, we used alkaline phosphatase-tagged EGFR ligand plasmids transfected into lung fibroblasts, and enzyme-linked immunosorbent assays to detect shedding of native ligands.  LPA induced shedding of alkaline phosphatase-tagged heparin-binding epidermal growth factor (HB-EGF), amphiregulin, and transforming growth factor-a; non-transfected fibroblasts shed amphiregulin and HBEGF under baseline conditions, and increased shedding of HB-EGF in response to LPA.  Treatment of fibroblasts with LPA resulted in elevated phosphorylation of extracellular signal-regulated kinase 1/2, enhanced expression of mRNA for c-fos, HB-EGF and amphiregulin, and enhanced proliferation at 96 hours.  However, none of these fibroblast responses to LPA required ectodomain shedding or EGFR activity.  To test the ability of LPA to stimulate paracrine signaling from fibroblasts, we transferred conditioned medium from LPA-stimulated cells, and found enhanced EGFR and extracellular signal-regulated kinase 1/2 phosphorylation in reporter A549 cells in excess of what could be accounted for by transferred LPA alone.  These data show that LPA mediates EGF-family ectodomain shedding, resulting in enhanced paracrine signaling from lung fibroblasts to epithelial cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcStZlLCCqCSB3thwrmtH4OBfW6udTcc2eZH_EIhwe6Vdbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M3ivF2iuw%253D%253D&md5=daab9ffaae21bf4b386fd812f5520167</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1111%2Fj.1524-475X.2010.00655.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1524-475X.2010.00655.x%26sid%3Dliteratum%253Aachs%26aulast%3DShiomi%26aufirst%3DT.%26aulast%3DBoudreault%26aufirst%3DF.%26aulast%3DPadem%26aufirst%3DN.%26aulast%3DHigashiyama%26aufirst%3DS.%26aulast%3DDrazen%26aufirst%3DJ.%2BM.%26aulast%3DTschumperlin%26aufirst%3DD.%2BJ.%26atitle%3DLysophosphatidic%2520acid%2520stimulates%2520epidermal%2520growth%2520factor-family%2520ectodomain%2520shedding%2520and%2520paracrine%2520signaling%2520from%2520human%2520lung%2520fibroblasts%26jtitle%3DWound%2520Repair%2520Regener.%26date%3D2011%26volume%3D19%26issue%3D2%26spage%3D229%26epage%3D240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Yin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watsky, M. A.</span><span> </span><span class="NLM_article-title">Chloride channel activity in human lung fibroblasts and myofibroblasts</span> <span class="citation_source-journal">Am. J. Physiol. Lung Cell Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">288</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">L1110</span><span class="NLM_x">–</span> <span class="NLM_lpage">1116</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=288&publication_year=2005&pages=L1110-1116&issue=6&author=Z.+Yinauthor=M.+A.+Watsky&title=Chloride+channel+activity+in+human+lung+fibroblasts+and+myofibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DZ.%26aulast%3DWatsky%26aufirst%3DM.%2BA.%26atitle%3DChloride%2520channel%2520activity%2520in%2520human%2520lung%2520fibroblasts%2520and%2520myofibroblasts%26jtitle%3DAm.%2520J.%2520Physiol.%2520Lung%2520Cell%2520Mol.%2520Physiol.%26date%3D2005%26volume%3D288%26issue%3D6%26spage%3DL1110%26epage%3D1116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mio, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rennard, S. I.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid augments fibroblast-mediated contraction of released collagen gels</span> <span class="citation_source-journal">J. Lab. Clin. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">139</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">20</span><span class="NLM_x">–</span> <span class="NLM_lpage">27</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2002&pages=20-27&issue=1&author=T.+Mioauthor=X.+Liuauthor=M.+L.+Toewsauthor=S.+I.+Rennard&title=Lysophosphatidic+acid+augments+fibroblast-mediated+contraction+of+released+collagen+gels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMio%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DRennard%26aufirst%3DS.%2BI.%26atitle%3DLysophosphatidic%2520acid%2520augments%2520fibroblast-mediated%2520contraction%2520of%2520released%2520collagen%2520gels%26jtitle%3DJ.%2520Lab.%2520Clin.%2520Med.%26date%3D2002%26volume%3D139%26issue%3D1%26spage%3D20%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Pradere, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gres, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guigne, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neau, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calise, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bascands, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schanstra, J. P.</span><span> </span><span class="NLM_article-title">LPA1 receptor activation promotes renal interstitial fibrosis</span> <span class="citation_source-journal">J. Am. Soc. Nephrol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">3110</span><span class="NLM_x">–</span> <span class="NLM_lpage">3118</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1681%2FASN.2007020196" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=18003779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVGgu73J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2007&pages=3110-3118&issue=12&author=J.+P.+Pradereauthor=J.+Kleinauthor=S.+Gresauthor=C.+Guigneauthor=E.+Neauauthor=P.+Valetauthor=D.+Caliseauthor=J.+Chunauthor=J.+L.+Bascandsauthor=J.+S.+Saulnier-Blacheauthor=J.+P.+Schanstra&title=LPA1+receptor+activation+promotes+renal+interstitial+fibrosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">LPA1 receptor activation promotes renal interstitial fibrosis</span></div><div class="casAuthors">Pradere, Jean-Philippe; Klein, Julie; Gres, Sandra; Guigne, Charlotte; Neau, Eric; Valet, Philippe; Calise, Denis; Chun, Jerold; Bascands, Jean-Loup; Saulnier-Blache, Jean-Sebastien; Schanstra, Joost P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Society of Nephrology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3110-3118</span>CODEN:
                <span class="NLM_cas:coden">JASNEU</span>;
        ISSN:<span class="NLM_cas:issn">1046-6673</span>.
    
            (<span class="NLM_cas:orgname">American Society of Nephrology</span>)
        </div><div class="casAbstract">Tubulointerstitial fibrosis in chronic renal disease is strongly assocd. with progressive loss of renal function.  We studied the potential involvement of lysophosphatidic acid (LPA), a growth factor-like phospholipid, and its receptors LPA1-4 in the development of tubulointerstitial fibrosis (TIF).  Renal fibrosis was induced in mice by unilateral ureteral obstruction (UUO) for up to 8 d, and kidney explants were prepd. from the distal poles to measure LPA release into conditioned media.  After obstruction, the extracellular release of LPA increased approx. 3-fold.  Real-time reverse transcription PCR (RT-PCR) anal. demonstrated significant upregulation in the expression of the LPA1 receptor subtype, downregulation of LPA3, and no change of LPA2 or LPA4.  TIF was significantly attenuated in LPA1 (-/-) mice compared to wild-type littermates, as measured by expression of collagen III, α-smooth muscle actin (α-SMA), and F4/80.  Furthermore, treatment of wild-type mice with the LPA1 antagonist Ki16425 similarly reduced fibrosis and significantly attenuated renal expression of the profibrotic cytokines connective tissue growth factor (CTGF) and transforming growth factor β (TGFβ).  In vitro, LPA induced a rapid, dose-dependent increase in CTGF expression that was inhibited by Ki16425.  In conclusion, LPA, likely acting through LPA1, is involved in obstruction-induced TIF.  Therefore, the LPA1 receptor might be a pharmaceutical target to treat renal fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfduq2hWxxr7Vg90H21EOLACvtfcHk0lgXG3g6gSFDOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVGgu73J&md5=6d212bb8e2ea41a78e0f8f7140c87423</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1681%2FASN.2007020196&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1681%252FASN.2007020196%26sid%3Dliteratum%253Aachs%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DGres%26aufirst%3DS.%26aulast%3DGuigne%26aufirst%3DC.%26aulast%3DNeau%26aufirst%3DE.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DCalise%26aufirst%3DD.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DBascands%26aufirst%3DJ.%2BL.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26aulast%3DSchanstra%26aufirst%3DJ.%2BP.%26atitle%3DLPA1%2520receptor%2520activation%2520promotes%2520renal%2520interstitial%2520fibrosis%26jtitle%3DJ.%2520Am.%2520Soc.%2520Nephrol.%26date%3D2007%26volume%3D18%26issue%3D12%26spage%3D3110%26epage%3D3118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Tager, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaCamera, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shea, B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campanella, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polosukhin, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karimi-Shah, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, W. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackwell, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span> <span class="citation_source-journal">Nat. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">54</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1038%2Fnm1685" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=18066075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=45-54&issue=1&author=A.+M.+Tagerauthor=P.+LaCameraauthor=B.+S.+Sheaauthor=G.+S.+Campanellaauthor=M.+Selmanauthor=Z.+Zhaoauthor=V.+Polosukhinauthor=J.+Wainauthor=B.+A.+Karimi-Shahauthor=N.+D.+Kimauthor=W.+K.+Hartauthor=A.+Pardoauthor=T.+S.+Blackwellauthor=Y.+Xuauthor=J.+Chunauthor=A.+D.+Luster&title=The+lysophosphatidic+acid+receptor+LPA1+links+pulmonary+fibrosis+to+lung+injury+by+mediating+fibroblast+recruitment+and+vascular+leak"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak</span></div><div class="casAuthors">Tager, Andrew M.; LaCamera, Peter; Shea, Barry S.; Campanella, Gabriele S.; Selman, Moises; Zhao, Zhenwen; Polosukhin, Vasiliy; Wain, John; Karimi-Shah, Banu A.; Kim, Nancy D.; Hart, William K.; Pardo, Annie; Blackwell, Timothy S.; Xu, Yan; Chun, Jerold; Luster, Andrew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-54</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Aberrant wound-healing responses to injury have been implicated in the development of pulmonary fibrosis, but the mediators directing these pathol. responses have yet to be fully identified.  We show that lysophosphatidic acid levels increase in bronchoalveolar lavage fluid following lung injury in the bleomycin model of pulmonary fibrosis, and that mice lacking one of its receptors, LPA1, are markedly protected from fibrosis and mortality in this model.  The absence of LPA1 led to reduced fibroblast recruitment and vascular leak, two responses that may be excessive when injury leads to fibrosis rather than to repair, whereas leukocyte recruitment was preserved during the first week after injury.  In persons with idiopathic pulmonary fibrosis, lysophosphatidic acid levels in bronchoalveolar lavage fluid were also increased, and inhibition of LPA1 markedly reduced fibroblast responses to the chemotactic activity of this fluid.  LPA1 therefore represents a new therapeutic target for diseases in which aberrant responses to injury contribute to fibrosis, such as idiopathic pulmonary fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8pk5JY4qBbLVg90H21EOLACvtfcHk0lhBcsJQ0vvgqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXisVWisQ%253D%253D&md5=1a7e86264154df8960699d18a7ef2407</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnm1685&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1685%26sid%3Dliteratum%253Aachs%26aulast%3DTager%26aufirst%3DA.%2BM.%26aulast%3DLaCamera%26aufirst%3DP.%26aulast%3DShea%26aufirst%3DB.%2BS.%26aulast%3DCampanella%26aufirst%3DG.%2BS.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DPolosukhin%26aufirst%3DV.%26aulast%3DWain%26aufirst%3DJ.%26aulast%3DKarimi-Shah%26aufirst%3DB.%2BA.%26aulast%3DKim%26aufirst%3DN.%2BD.%26aulast%3DHart%26aufirst%3DW.%2BK.%26aulast%3DPardo%26aufirst%3DA.%26aulast%3DBlackwell%26aufirst%3DT.%2BS.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520links%2520pulmonary%2520fibrosis%2520to%2520lung%2520injury%2520by%2520mediating%2520fibroblast%2520recruitment%2520and%2520vascular%2520leak%26jtitle%3DNat.%2520Med.%26date%3D2008%26volume%3D14%26issue%3D1%26spage%3D45%26epage%3D54" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ao, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span> </span><span class="NLM_article-title">Effects of lysophosphatidic acid and its receptors LPA(1/3) on radiation pneumonitis</span> <span class="citation_source-journal">Oncol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1515</span><span class="NLM_x">–</span> <span class="NLM_lpage">1520</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21042747" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sit7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=1515-1520&issue=6&author=J.+Xueauthor=L.+Ganauthor=X.+Liauthor=J.+Liauthor=G.+Qiauthor=Y.+Wuauthor=X.+Fuauthor=Q.+Maoauthor=R.+Aoauthor=J.+Langauthor=Y.+Lu&title=Effects+of+lysophosphatidic+acid+and+its+receptors+LPA%281%2F3%29+on+radiation+pneumonitis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of lysophosphatidic acid and its receptors LPA1/3 on radiation pneumonitis</span></div><div class="casAuthors">Xue, Jianxin; Gan, Lu; Li, Xin; Li, Jian; Qi, Guohai; Wu, Yalan; Fu, Xiaoyue; Mao, Qing; Ao, Rui; Lang, Jingyi; Lu, You</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1515-1520</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Oncology Reports</span>)
        </div><div class="casAbstract">Radiation pneumonitis (RP) is a serious complication of radiation therapy for thoracic tumors.  Lyso-phosphatidic acid (LPA) and its receptors LPA1/3 were reported to participate in the processes of inflammation.  We tested the hypothesis that LPA and its receptors LPA1/3, take part in the pathogenesis of RP.  In our study, irradn. increased LPA levels in the lung and expression of LPA1/3.  To further det. the role of LPA1/3, we performed pharmacol. knockout of LPA1/3 by a specific antagonist, VPC-12249.  On day 60 post-irradn., RP was significantly alleviated in a dose-dependent manner in mice treated with VPC-12249, as shown by H&E staining, malondialdehyde (MDA, an indicator of oxidative damage) assay in lung, and concns. of proinflammatory and profibrotic cytokines in plasma, including IL-1β, TNF-α, and TGF-β1.  Addnl., VPC-12249 administration decreased the phosphorylation of IκB-α (the initial event that activates the NF-κB signal way), and expression of TGF-β1, CTGF, and α-SMA mRNA.  Our findings suggest that LPA and LPA1/3 may play a pivotal role in RP, and LPA-LPA1/3 may serve as novel therapeutic targets for the treatment of RP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopubf3UJxFCLVg90H21EOLACvtfcHk0lhBcsJQ0vvgqw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sit7zO&md5=6105ad83f62414458f4a80d7533e4c61</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DGan%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DQi%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DFu%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DQ.%26aulast%3DAo%26aufirst%3DR.%26aulast%3DLang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DY.%26atitle%3DEffects%2520of%2520lysophosphatidic%2520acid%2520and%2520its%2520receptors%2520LPA%25281%252F3%2529%2520on%2520radiation%2520pneumonitis%26jtitle%3DOncol.%2520Rep.%26date%3D2010%26volume%3D24%26issue%3D6%26spage%3D1515%26epage%3D1520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Rancoule, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pradere, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valet, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bascands, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schanstra, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saulnier-Blache, J. S.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid-1-receptor targeting agents for fibrosis</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">657</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2011&pages=657-667&issue=5&author=C.+Rancouleauthor=J.+P.+Pradereauthor=J.+Gonzalezauthor=J.+Kleinauthor=P.+Valetauthor=J.+L.+Bascandsauthor=J.+P.+Schanstraauthor=J.+S.+Saulnier-Blache&title=Lysophosphatidic+acid-1-receptor+targeting+agents+for+fibrosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRancoule%26aufirst%3DC.%26aulast%3DPradere%26aufirst%3DJ.%2BP.%26aulast%3DGonzalez%26aufirst%3DJ.%26aulast%3DKlein%26aufirst%3DJ.%26aulast%3DValet%26aufirst%3DP.%26aulast%3DBascands%26aufirst%3DJ.%2BL.%26aulast%3DSchanstra%26aufirst%3DJ.%2BP.%26aulast%3DSaulnier-Blache%26aufirst%3DJ.%2BS.%26atitle%3DLysophosphatidic%2520acid-1-receptor%2520targeting%2520agents%2520for%2520fibrosis%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2011%26volume%3D20%26issue%3D5%26spage%3D657%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fells, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsukahara, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Structure-based drug design identifies novel LPA3 antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">7457</span><span class="NLM_x">–</span> <span class="NLM_lpage">7464</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=7457-7464&issue=21&author=J.+I.+Fellsauthor=R.+Tsukaharaauthor=J.+Liuauthor=G.+Tigyiauthor=A.+L.+Parrill&title=Structure-based+drug+design+identifies+novel+LPA3+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFells%26aufirst%3DJ.%2BI.%26aulast%3DTsukahara%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DStructure-based%2520drug%2520design%2520identifies%2520novel%2520LPA3%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26issue%3D21%26spage%3D7457%26epage%3D7464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Heasley, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jarosz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Initial structure-activity relationships of lysophosphatidic acid receptor antagonists: discovery of a high-affinity LPA1/LPA3 receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2735</span><span class="NLM_x">–</span> <span class="NLM_lpage">2740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=2735-2740&issue=11&author=B.+H.+Heasleyauthor=R.+Jaroszauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Initial+structure-activity+relationships+of+lysophosphatidic+acid+receptor+antagonists%3A+discovery+of+a+high-affinity+LPA1%2FLPA3+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHeasley%26aufirst%3DB.%2BH.%26aulast%3DJarosz%26aufirst%3DR.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DInitial%2520structure-activity%2520relationships%2520of%2520lysophosphatidic%2520acid%2520receptor%2520antagonists%253A%2520discovery%2520of%2520a%2520high-affinity%2520LPA1%252FLPA3%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D11%26spage%3D2735%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">East, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Toews, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lynch, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, T. L.</span><span> </span><span class="NLM_article-title">Development of a phosphatase-resistant, L-tyrosine derived LPA1/LPA3 dual antagonist</span> <span class="citation_source-journal">MedChemComm</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">325</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=325-330&issue=4&author=J.+E.+Eastauthor=K.+M.+Carterauthor=P.+C.+Kennedyauthor=N.+A.+Schulteauthor=M.+L.+Toewsauthor=K.+R.+Lynchauthor=T.+L.+Macdonald&title=Development+of+a+phosphatase-resistant%2C+L-tyrosine+derived+LPA1%2FLPA3+dual+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEast%26aufirst%3DJ.%2BE.%26aulast%3DCarter%26aufirst%3DK.%2BM.%26aulast%3DKennedy%26aufirst%3DP.%2BC.%26aulast%3DSchulte%26aufirst%3DN.%2BA.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DLynch%26aufirst%3DK.%2BR.%26aulast%3DMacdonald%26aufirst%3DT.%2BL.%26atitle%3DDevelopment%2520of%2520a%2520phosphatase-resistant%252C%2520L-tyrosine%2520derived%2520LPA1%252FLPA3%2520dual%2520antagonist%26jtitle%3DMedChemComm%26date%3D2011%26volume%3D2%26issue%3D4%26spage%3D325%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ohta, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damirin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchinkhuu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tobo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watanabe, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yagi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murooka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakai, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishitoba, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Im, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nochi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomura, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okajima, F.</span><span> </span><span class="NLM_article-title">Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">994</span><span class="NLM_x">–</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2003&pages=994-1005&issue=4&author=H.+Ohtaauthor=K.+Satoauthor=N.+Murataauthor=A.+Damirinauthor=E.+Malchinkhuuauthor=J.+Konauthor=T.+Kimuraauthor=M.+Toboauthor=Y.+Yamazakiauthor=T.+Watanabeauthor=M.+Yagiauthor=M.+Satoauthor=R.+Suzukiauthor=H.+Murookaauthor=T.+Sakaiauthor=T.+Nishitobaauthor=D.+S.+Imauthor=H.+Nochiauthor=K.+Tamotoauthor=H.+Tomuraauthor=F.+Okajima&title=Ki16425%2C+a+subtype-selective+antagonist+for+EDG-family+lysophosphatidic+acid+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhta%26aufirst%3DH.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DMurata%26aufirst%3DN.%26aulast%3DDamirin%26aufirst%3DA.%26aulast%3DMalchinkhuu%26aufirst%3DE.%26aulast%3DKon%26aufirst%3DJ.%26aulast%3DKimura%26aufirst%3DT.%26aulast%3DTobo%26aufirst%3DM.%26aulast%3DYamazaki%26aufirst%3DY.%26aulast%3DWatanabe%26aufirst%3DT.%26aulast%3DYagi%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DR.%26aulast%3DMurooka%26aufirst%3DH.%26aulast%3DSakai%26aufirst%3DT.%26aulast%3DNishitoba%26aufirst%3DT.%26aulast%3DIm%26aufirst%3DD.%2BS.%26aulast%3DNochi%26aufirst%3DH.%26aulast%3DTamoto%26aufirst%3DK.%26aulast%3DTomura%26aufirst%3DH.%26aulast%3DOkajima%26aufirst%3DF.%26atitle%3DKi16425%252C%2520a%2520subtype-selective%2520antagonist%2520for%2520EDG-family%2520lysophosphatidic%2520acid%2520receptors%26jtitle%3DMol.%2520Pharmacol.%26date%3D2003%26volume%3D64%26issue%3D4%26spage%3D994%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundey, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prodanovich, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fagan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span> </span><span class="NLM_article-title">A novel, orally active LPA(1) receptor antagonist inhibits lung fibrosis in the mouse bleomycin model</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1699</span><span class="NLM_x">–</span> <span class="NLM_lpage">1713</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1111%2Fj.1476-5381.2010.00828.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=20649573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlejsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2010&pages=1699-1713&issue=7&author=J.+S.+Swaneyauthor=C.+Chapmanauthor=L.+D.+Correaauthor=K.+J.+Stebbinsauthor=R.+A.+Bundeyauthor=P.+C.+Prodanovichauthor=P.+Faganauthor=C.+S.+Bacceiauthor=A.+M.+Santiniauthor=J.+H.+Hutchinsonauthor=T.+J.+Seidersauthor=T.+A.+Parrauthor=P.+Prasitauthor=J.+F.+Evansauthor=D.+S.+Lorrain&title=A+novel%2C+orally+active+LPA%281%29+receptor+antagonist+inhibits+lung+fibrosis+in+the+mouse+bleomycin+model"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A novel, orally active LPA1 receptor antagonist inhibits lung fibrosis in the mouse bleomycin model</span></div><div class="casAuthors">Swaney, J. S.; Chapman, C.; Correa, L. D.; Stebbins, K. J.; Bundey, R. A.; Prodanovich, P. C.; Fagan, P.; Baccei, C. S.; Santini, A. M.; Hutchinson, J. H.; Seiders, T. J.; Parr, T. A.; Prasit, P.; Evans, J. F.; Lorrain, D. S.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1699-1713</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The aim of this study was to assess the potential of an antagonist selective for the lysophosphatidic acid receptor, LPA1, in treating lung fibrosis.  We evaluated the in vitro and in vivo pharmacol. properties of the high affinity, selective, oral LPA1-antagonist (4'-{4-[(R)-1-(2-chloro-phenyl)-ethoxycarbonylamino]-3-methyl-isoxazol-5-yl}-biphenyl-4-yl)-acetic acid (AM966).  The potency and selectivity of AM966 for LPA1 receptors was detd. in vitro by calcium flux and cell chemotaxis assays using recombinant and native cell cultures.  The in vivo efficacy of AM966 to reduce tissue injury, vascular leakage, inflammation and fibrosis was assessed at several time points in the mouse bleomycin model.  AM966 was a potent antagonist of LPA1 receptors, with selectivity for this receptor over the other LPA receptors.  In vitro, AM966 inhibited LPA-stimulated intracellular calcium release (IC50 = 17 nM) from Chinese hamster ovary cells stably expressing human LPA1 receptors and inhibited LPA-induced chemotaxis (IC50 = 181 nM) of human IMR-90 lung fibroblasts expressing LPA1 receptors.  AM966 demonstrated a good pharmacokinetic profile following oral dosing in mice.  In the mouse, AM966 reduced lung injury, vascular leakage, inflammation and fibrosis at multiple time points following intratracheal bleomycin instillation.  AM966 also decreased lactate dehydrogenase activity and tissue inhibitor of metalloproteinase-1, transforming growth factor β1, hyaluronan and matrix metalloproteinase-7, in bronchoalveolar lavage fluid.  These findings demonstrate that AM966 is a potent, selective, orally bioavailable LPA1 receptor antagonist that may be beneficial in treating lung injury and fibrosis, as well as other diseases that are characterized by pathol. inflammation, edema and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK0rImMbkAWbVg90H21EOLACvtfcHk0ljmrAK7tNkDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlejsbzJ&md5=73f26734408141d8b0350d7488b54a6c</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.00828.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.00828.x%26sid%3Dliteratum%253Aachs%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DStebbins%26aufirst%3DK.%2BJ.%26aulast%3DBundey%26aufirst%3DR.%2BA.%26aulast%3DProdanovich%26aufirst%3DP.%2BC.%26aulast%3DFagan%26aufirst%3DP.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DParr%26aufirst%3DT.%2BA.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26atitle%3DA%2520novel%252C%2520orally%2520active%2520LPA%25281%2529%2520receptor%2520antagonist%2520inhibits%2520lung%2520fibrosis%2520in%2520the%2520mouse%2520bleomycin%2520model%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D160%26issue%3D7%26spage%3D1699%26epage%3D1713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correa, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stebbins, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broadhead, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Darlington, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baccei, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parr, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roppe, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziff, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasit, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span> </span><span class="NLM_article-title">Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">336</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">693</span><span class="NLM_x">–</span> <span class="NLM_lpage">700</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1124%2Fjpet.110.175901" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21159750" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqtr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=693-700&issue=3&author=J.+S.+Swaneyauthor=C.+Chapmanauthor=L.+D.+Correaauthor=K.+J.+Stebbinsauthor=A.+R.+Broadheadauthor=G.+Bainauthor=A.+M.+Santiniauthor=J.+Darlingtonauthor=C.+D.+Kingauthor=C.+S.+Bacceiauthor=C.+Leeauthor=T.+A.+Parrauthor=J.+R.+Roppeauthor=T.+J.+Seidersauthor=J.+Ziffauthor=P.+Prasitauthor=J.+H.+Hutchinsonauthor=J.+F.+Evansauthor=D.+S.+Lorrain&title=Pharmacokinetic+and+pharmacodynamic+characterization+of+an+oral+lysophosphatidic+acid+type+1+receptor-selective+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic and pharmacodynamic characterization of an oral lysophosphatidic acid type 1 receptor-selective antagonist</span></div><div class="casAuthors">Swaney, J. S.; Chapman, C.; Correa, L. D.; Stebbins, K. J.; Broadhead, A. R.; Bain, G.; Santini, A. M.; Darlington, J.; King, C. D.; Baccei, C. S.; Lee, C.; Parr, T. A.; Roppe, J. R.; Seiders, T. J.; Ziff, J.; Prasit, P.; Hutchinson, J. H.; Evans, J. F.; Lorrain, D. S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">693-700</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive phospholipid that signals through a family of at least six G protein-coupled receptors designated LPA1-6.  LPA type 1 receptor (LPA1) exhibits wide-spread tissue distribution and regulates a variety of physiol. and pathol. cellular functions.  Here, we evaluated the in vitro pharmacol., pharmacokinetic, and pharmacodynamic properties of the LPA1-selective antagonist AM095 (sodium, {4'-[3-methyl-4-((R)-1-phenyl-ethoxycarbonylamino)-isoxazol-5-yl]-biphenyl-4-yl}-acetate) and assessed the effects of AM095 in rodent models of lung and kidney fibrosis and dermal wound healing.  In vitro, AM095 was a potent LPA1 receptor antagonist because it inhibited GTPγS binding to Chinese hamster ovary (CHO) cell membranes overexpressing recombinant human or mouse LPA1 with IC50 values of 0.98 and 0.73 μM, resp., and exhibited no LPA1 agonism.  In functional assays, AM095 inhibited LPA-driven chemotaxis of CHO cells overexpressing mouse LPA1 (IC50 = 778 nM) and human A2058 melanoma cells (IC50 = 233 nM).  In vivo, we demonstrated that AM095: (1) had high oral bioavailability and a moderate half-life and was well tolerated at the doses tested in rats and dogs after oral and i.v. dosing, (2) dose-dependently reduced LPA-stimulated histamine release, (3) attenuated bleomycin-induced increases in collagen, protein, and inflammatory cell infiltration in bronchalveolar lavage fluid, and (4) decreased kidney fibrosis in a mouse unilateral ureteral obstruction model.  Despite its antifibrotic activity, AM095 had no effect on normal wound healing after incisional and excisional wounding in rats.  These data demonstrate that AM095 is an LPA1 receptor antagonist with good oral exposure and antifibrotic activity in rodent models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVYo8MBYXos7Vg90H21EOLACvtfcHk0ljmrAK7tNkDoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqtr4%253D&md5=72388f534912ad0e440a6fff949d7710</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.175901&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.175901%26sid%3Dliteratum%253Aachs%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DChapman%26aufirst%3DC.%26aulast%3DCorrea%26aufirst%3DL.%2BD.%26aulast%3DStebbins%26aufirst%3DK.%2BJ.%26aulast%3DBroadhead%26aufirst%3DA.%2BR.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DSantini%26aufirst%3DA.%2BM.%26aulast%3DDarlington%26aufirst%3DJ.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DBaccei%26aufirst%3DC.%2BS.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DParr%26aufirst%3DT.%2BA.%26aulast%3DRoppe%26aufirst%3DJ.%2BR.%26aulast%3DSeiders%26aufirst%3DT.%2BJ.%26aulast%3DZiff%26aufirst%3DJ.%26aulast%3DPrasit%26aufirst%3DP.%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26aulast%3DEvans%26aufirst%3DJ.%2BF.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26atitle%3DPharmacokinetic%2520and%2520pharmacodynamic%2520characterization%2520of%2520an%2520oral%2520lysophosphatidic%2520acid%2520type%25201%2520receptor-selective%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26issue%3D3%26spage%3D693%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Castelino, F. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bain, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swaney, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorrain, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luster, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma</span> <span class="citation_source-journal">Arthritis Rheum.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1405</span><span class="NLM_x">–</span> <span class="NLM_lpage">1415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1002%2Fart.30262" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=21305523" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXltlGhtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2011&pages=1405-1415&issue=5&author=F.+V.+Castelinoauthor=J.+Seidersauthor=G.+Bainauthor=S.+F.+Brooksauthor=C.+D.+Kingauthor=J.+S.+Swaneyauthor=D.+S.+Lorrainauthor=J.+Chunauthor=A.+D.+Lusterauthor=A.+M.+Tager&title=Amelioration+of+dermal+fibrosis+by+genetic+deletion+or+pharmacologic+antagonism+of+lysophosphatidic+acid+receptor+1+in+a+mouse+model+of+scleroderma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma</span></div><div class="casAuthors">Castelino, Flavia V.; Seiders, Jon; Bain, Gretchen; Brooks, Sarah F.; King, Christopher D.; Swaney, James S.; Lorrain, Daniel S.; Chun, Jerold; Luster, Andrew D.; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Arthritis & Rheumatism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1405-1415</span>CODEN:
                <span class="NLM_cas:coden">ARHEAW</span>;
        ISSN:<span class="NLM_cas:issn">0004-3591</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">Objective : Scleroderma (systemic sclerosis [SSc]), is characterized by progressive multiorgan fibrosis.  We recently implicated lysophosphatidic acid (LPA) in the pathogenesis of pulmonary fibrosis.  The purpose of the present study was to investigate the roles of LPA and two of its receptors, LPA1 and LPA2, in dermal fibrosis in a mouse model of SSc.  Methods : Wild type (WT), and LPA1-knockout (KO) and LPA2-KO mice were injected s.c. with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.  Dermal thickness, collagen content, and nos. of cells pos. for α-smooth muscle actin (α-SMA) or phospho-Smad2 were detd. in bleomycin-injected and PBS-injected skin.  In sep. expts., a novel selective LPA1 antagonist AM095 or vehicle alone was administered by oral gavage to C57BL/6 mice that were challenged with 28 daily injections of bleomycin or PBS.  AM095 or vehicle treatments were initiated concurrently with, or 7 or 14 days after, the initiation of bleomycin and PBS injections and continued to the end of the expts.  Dermal thickness and collagen content were detd. in injected skin.  Results : The LPA1-KO mice were markedly resistant to bleomycin-induced increases in dermal thickness and collagen content, whereas the LPA2-KO mice were as susceptible as the WT mice.  Bleomycin-induced increases in dermal α-SMA+ and phospho-Smad2+ cells were abrogated in LPA1-KO mice.  Pharmacol. antagonism of LPA1 with AM095 significantly attenuated bleomycin-induced dermal fibrosis when administered according to either a preventive regimen or two therapeutic regimens.  Conclusion : These results suggest that LPA/LPA1 pathway inhibition has the potential to be an effective new therapeutic strategy for SSc, and that LPA1 is an attractive pharmacol. target in dermal fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqR6SISG5m67LVg90H21EOLACvtfcHk0lhswJWk89EBSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXltlGhtrY%253D&md5=a13b1f9f7826b3075728ed13e533102c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fart.30262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fart.30262%26sid%3Dliteratum%253Aachs%26aulast%3DCastelino%26aufirst%3DF.%2BV.%26aulast%3DSeiders%26aufirst%3DJ.%26aulast%3DBain%26aufirst%3DG.%26aulast%3DBrooks%26aufirst%3DS.%2BF.%26aulast%3DKing%26aufirst%3DC.%2BD.%26aulast%3DSwaney%26aufirst%3DJ.%2BS.%26aulast%3DLorrain%26aufirst%3DD.%2BS.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DLuster%26aufirst%3DA.%2BD.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DAmelioration%2520of%2520dermal%2520fibrosis%2520by%2520genetic%2520deletion%2520or%2520pharmacologic%2520antagonism%2520of%2520lysophosphatidic%2520acid%2520receptor%25201%2520in%2520a%2520mouse%2520model%2520of%2520scleroderma%26jtitle%3DArthritis%2520Rheum.%26date%3D2011%26volume%3D63%26issue%3D5%26spage%3D1405%26epage%3D1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Xu, M. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knox, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinreb, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maher, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Violette, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAnulty, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheppard, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, G.</span><span> </span><span class="NLM_article-title">Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q)</span> <span class="citation_source-journal">Am. J. Pathol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">174</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.2353%2Fajpath.2009.080160" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=19147812" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2009&pages=1264-1279&issue=4&author=M.+Y.+Xuauthor=J.+Porteauthor=A.+J.+Knoxauthor=P.+H.+Weinrebauthor=T.+M.+Maherauthor=S.+M.+Violetteauthor=R.+J.+McAnultyauthor=D.+Sheppardauthor=G.+Jenkins&title=Lysophosphatidic+acid+induces+alphavbeta6+integrin-mediated+TGF-beta+activation+via+the+LPA2+receptor+and+the+small+G+protein+G+alpha%28q%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Lysophosphatidic acid induces αvβ6 integrin-mediated TGF-β activation via the LPA2 receptor and the small G protein Gαq</span></div><div class="casAuthors">Xu, Ming Yan; Porte, Joanne; Knox, Alan J.; Weinreb, Paul H.; Maher, Toby M.; Violette, Shelia M.; McAnulty, Robin J.; Sheppard, Dean; Jenkins, Gisli</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Pathology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1264-1279</span>CODEN:
                <span class="NLM_cas:coden">AJPAA4</span>;
        ISSN:<span class="NLM_cas:issn">0002-9440</span>.
    
            (<span class="NLM_cas:orgname">American Society for Investigative Pathology</span>)
        </div><div class="casAbstract">Activation of latent transforming growth factor β (TGF-β) by αvβ6 integrin is crit. in the pathogenesis of lung injury and fibrosis.  We have previously demonstrated that the stimulation of protease activated receptor 1 promotes αvβ6 integrin-mediated TGF-β activation via RhoA, which is known to modulate cell contraction.  However, whether other G protein-coupled receptors can also induce αvβ6 integrin-mediated TGF-β activation is unknown; in addn., the αvβ6 integrin signaling pathway has not yet been fully characterized.  In this study, we show that lysophosphatidic acid (LPA) induces αvβ6-mediated TGF-β activation in human epithelial cells via both RhoA and Rho kinase.  Furthermore, we demonstrate that LPA-induced αvβ6 integrin-mediated TGF-β activity is mediated via the LPA2 receptor, which signals via Gαq.  Finally, we show that the expression levels of both the LPA2 receptor and αvβ6 integrin are up-regulated and are spatially and temporally assocd. following bleomycin-induced lung injury.  Furthermore, both the LPA2 receptor and αvβ6 integrin are up-regulated in the overlying epithelial areas of fibrosis in patients with usual interstitial pneumonia.  These studies demonstrate that LPA induces αvβ6 integrin-mediated TGF-β activation in epithelial cells via LPA2, Gαq, RhoA, and Rho kinase, and that this pathway might be clin. relevant to the development of lung injury and fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRLfe65xAfj7Vg90H21EOLACvtfcHk0lhswJWk89EBSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXksVOkt7s%253D&md5=0b9c319e5b3e4f6794333d2810edd958</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2353%2Fajpath.2009.080160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2353%252Fajpath.2009.080160%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DM.%2BY.%26aulast%3DPorte%26aufirst%3DJ.%26aulast%3DKnox%26aufirst%3DA.%2BJ.%26aulast%3DWeinreb%26aufirst%3DP.%2BH.%26aulast%3DMaher%26aufirst%3DT.%2BM.%26aulast%3DViolette%26aufirst%3DS.%2BM.%26aulast%3DMcAnulty%26aufirst%3DR.%2BJ.%26aulast%3DSheppard%26aufirst%3DD.%26aulast%3DJenkins%26aufirst%3DG.%26atitle%3DLysophosphatidic%2520acid%2520induces%2520alphavbeta6%2520integrin-mediated%2520TGF-beta%2520activation%2520via%2520the%2520LPA2%2520receptor%2520and%2520the%2520small%2520G%2520protein%2520G%2520alpha%2528q%2529%26jtitle%3DAm.%2520J.%2520Pathol.%26date%3D2009%26volume%3D174%26issue%3D4%26spage%3D1264%26epage%3D1279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Beck, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rubenstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwandner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasslinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wesche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">An, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickramasinghe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medina, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hungate, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, W.</span><span> </span><span class="NLM_article-title">Discovery of potent LPA2 (EDG4) antagonists as potential anticancer agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1037</span><span class="NLM_x">–</span> <span class="NLM_lpage">1041</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1037-1041&issue=3&author=H.+P.+Beckauthor=T.+Kohnauthor=S.+Rubensteinauthor=C.+Hedbergauthor=R.+Schwandnerauthor=K.+Hasslingerauthor=K.+Daiauthor=C.+Liauthor=L.+Liangauthor=H.+Wescheauthor=B.+Frankauthor=S.+Anauthor=D.+Wickramasingheauthor=J.+Jaenauthor=J.+Medinaauthor=R.+Hungateauthor=W.+Shen&title=Discovery+of+potent+LPA2+%28EDG4%29+antagonists+as+potential+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeck%26aufirst%3DH.%2BP.%26aulast%3DKohn%26aufirst%3DT.%26aulast%3DRubenstein%26aufirst%3DS.%26aulast%3DHedberg%26aufirst%3DC.%26aulast%3DSchwandner%26aufirst%3DR.%26aulast%3DHasslinger%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DK.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DWesche%26aufirst%3DH.%26aulast%3DFrank%26aufirst%3DB.%26aulast%3DAn%26aufirst%3DS.%26aulast%3DWickramasinghe%26aufirst%3DD.%26aulast%3DJaen%26aufirst%3DJ.%26aulast%3DMedina%26aufirst%3DJ.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DShen%26aufirst%3DW.%26atitle%3DDiscovery%2520of%2520potent%2520LPA2%2520%2528EDG4%2529%2520antagonists%2520as%2520potential%2520anticancer%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D3%26spage%3D1037%26epage%3D1041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Lukyanov, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bliznets, I. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shorshnev, S. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aleksandrov, G. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stepanov, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vasil’ev, A. A.</span><span> </span><span class="NLM_article-title">Microve-assisted synthesis and transformations of sterically hindered 3-(5-tetrazolyl)pyridines</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1849</span><span class="NLM_x">–</span> <span class="NLM_lpage">1863</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2006&pages=1849-1863&author=S.+M.+Lukyanovauthor=I.+V.+Bliznetsauthor=S.+V.+Shorshnevauthor=G.+G.+Aleksandrovauthor=A.+E.+Stepanovauthor=A.+A.+Vasil%E2%80%99ev&title=Microve-assisted+synthesis+and+transformations+of+sterically+hindered+3-%285-tetrazolyl%29pyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLukyanov%26aufirst%3DS.%2BM.%26aulast%3DBliznets%26aufirst%3DI.%2BV.%26aulast%3DShorshnev%26aufirst%3DS.%2BV.%26aulast%3DAleksandrov%26aufirst%3DG.%2BG.%26aulast%3DStepanov%26aufirst%3DA.%2BE.%26aulast%3DVasil%25E2%2580%2599ev%26aufirst%3DA.%2BA.%26atitle%3DMicrove-assisted%2520synthesis%2520and%2520transformations%2520of%2520sterically%2520hindered%25203-%25285-tetrazolyl%2529pyridines%26jtitle%3DTetrahedron%26date%3D2006%26volume%3D62%26spage%3D1849%26epage%3D1863" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisosteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&issue=8&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisosteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Synopsis of Some Recent Tactical Application of Bioisosteres in Drug Design</span></div><div class="casAuthors">Meanwell, Nicholas A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2529-2591</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  The established utility of bioisosteres is broad in nature, extending to improving potency, enhancing selectivity, altering phys. properties, reducing or redirecting metab., eliminating or modifying toxicophores, and acquiring novel intellectual property.  In this Perspective, some contemporary themes exploring the role of isosteres in drug design are sampled, with an emphasis placed on tactical applications designed to solve the kinds of problems that impinge on compd. optimization and the long-term success of drug candidates.  Interesting concepts that may have been poorly effective in the context examd. are captured, since the ideas may have merit in alternative circumstances.  A comprehensive cataloging of bioisosteres is beyond the scope of what will be provided, although a synopsis of relevant isosteres of a particular functionality is summarized in a succinct fashion in several sections.  Isosterism has also found productive application in the design and optimization of organocatalysts, and there are several examples in which functional mimicry established initially in a medicinal chem. setting has been adopted by this community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZ9z_aPcU4ubVg90H21EOLACvtfcHk0lhjBCmw93UtEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsVCnu7o%253D&md5=0637ab60c379bef535f3f709b26f3582</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisosteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D8%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Sardar, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bautista, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nusser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Virag, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tigyi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parrill, A. L.</span><span> </span><span class="NLM_article-title">Molecular basis for lysophosphatidic acid receptor antagonist selectivity</span> <span class="citation_source-journal">Biochim. Biophys. Acta</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">1582</span><span class="NLM_x"> (</span><span class="NLM_issue">1–3</span><span class="NLM_x">) </span> <span class="NLM_fpage">309</span><span class="NLM_x">–</span> <span class="NLM_lpage">317</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1582&publication_year=2002&pages=309-317&issue=1%E2%80%933&author=V.+M.+Sardarauthor=D.+L.+Bautistaauthor=D.+J.+Fischerauthor=K.+Yokoyamaauthor=N.+Nusserauthor=T.+Viragauthor=D.+A.+Wangauthor=D.+L.+Bakerauthor=G.+Tigyiauthor=A.+L.+Parrill&title=Molecular+basis+for+lysophosphatidic+acid+receptor+antagonist+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSardar%26aufirst%3DV.%2BM.%26aulast%3DBautista%26aufirst%3DD.%2BL.%26aulast%3DFischer%26aufirst%3DD.%2BJ.%26aulast%3DYokoyama%26aufirst%3DK.%26aulast%3DNusser%26aufirst%3DN.%26aulast%3DVirag%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DD.%2BA.%26aulast%3DBaker%26aufirst%3DD.%2BL.%26aulast%3DTigyi%26aufirst%3DG.%26aulast%3DParrill%26aufirst%3DA.%2BL.%26atitle%3DMolecular%2520basis%2520for%2520lysophosphatidic%2520acid%2520receptor%2520antagonist%2520selectivity%26jtitle%3DBiochim.%2520Biophys.%2520Acta%26date%3D2002%26volume%3D1582%26issue%3D1%25E2%2580%25933%26spage%3D309%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Pierce, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">ter Haar, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Binch, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kay, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span> </span><span class="NLM_article-title">CH-O and CH-N hydrogen bonds in ligand design: a novel quinazolin-4-ylthiazol-2-ylamine protein kinase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1278</span><span class="NLM_x">–</span> <span class="NLM_lpage">1281</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0492249" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1278-1281&author=A.+C.+Pierceauthor=E.+ter+Haarauthor=H.+M.+Binchauthor=D.+P.+Kayauthor=S.+R.+Patelauthor=P.+Li&title=CH-O+and+CH-N+hydrogen+bonds+in+ligand+design%3A+a+novel+quinazolin-4-ylthiazol-2-ylamine+protein+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0492249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0492249%26sid%3Dliteratum%253Aachs%26aulast%3DPierce%26aufirst%3DA.%2BC.%26aulast%3Dter%2BHaar%26aufirst%3DE.%26aulast%3DBinch%26aufirst%3DH.%2BM.%26aulast%3DKay%26aufirst%3DD.%2BP.%26aulast%3DPatel%26aufirst%3DS.%2BR.%26aulast%3DLi%26aufirst%3DP.%26atitle%3DCH-O%2520and%2520CH-N%2520hydrogen%2520bonds%2520in%2520ligand%2520design%253A%2520a%2520novel%2520quinazolin-4-ylthiazol-2-ylamine%2520protein%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1278%26epage%3D1281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Hayashi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukui, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsujiuchi, T.</span><span> </span><span class="NLM_article-title">Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells</span> <span class="citation_source-journal">Cancer Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">91</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1016%2Fj.canlet.2011.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=22079467" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xkslamug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=2012&pages=91-96&issue=1&author=M.+Hayashiauthor=K.+Okabeauthor=K.+Katoauthor=M.+Okumuraauthor=R.+Fukuiauthor=N.+Fukushimaauthor=T.+Tsujiuchi&title=Differential+function+of+lysophosphatidic+acid+receptors+in+cell+proliferation+and+migration+of+neuroblastoma+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Differential function of lysophosphatidic acid receptors in cell proliferation and migration of neuroblastoma cells</span></div><div class="casAuthors">Hayashi, Mai; Okabe, Kyoko; Kato, Kohei; Okumura, Mai; Fukui, Rie; Fukushima, Nobuyuki; Tsujiuchi, Toshifumi</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Letters (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">91-96</span>CODEN:
                <span class="NLM_cas:coden">CALEDQ</span>;
        ISSN:<span class="NLM_cas:issn">0304-3835</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Lysophosphatidic acid (LPA) is a bioactive lipid mediator that induces diverse cellular biol. effects and interacts with G protein-coupled transmembrane LPA receptors.  In the present study, to assess biol. roles of LPA receptors in the pathogenesis of tumor cells, each LPA receptor (Lpar1, Lpar2 or Lpar3)-expressing rat neuroblastoma B103 cells (lpa1-1, lpa2-2 or lpa3-3-2 cells, resp.) were used.  In cell motility and invasion assay, lpa2-2 and lpa3-3-2 cells showed significant higher intrinsic activity without LPA treatment than LPA receptor-unexpressing AB2-1bf cells.  LPA treatment further increased cell motility of these cells, which was suppressed by the pretreatment with inhibitors of Gi, Gq protein, or ROCK.  By contrast, lpa1-1 cells markedly decreased intrinsic cell motility and invasion, compared with AB2-1bf cells.  Constitutively active mutant Lpar1-expressing cells (lpa1Δ-1) showed significant high motility, comparable with those of lpa2-2 and lpa3-3-2.  In soft agar assay, lpa3-3-2 and lpa1Δ-1 cells showed colony formation, but other cells failed.  These results suggest that LPA receptors may play different roles in cell proliferation and migration of rat neuroblastoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvl00AWhJHObVg90H21EOLACvtfcHk0lguuyNQuTa2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xkslamug%253D%253D&md5=eaa74a58ace52d38c66fc7663776ee14</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.canlet.2011.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.canlet.2011.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DHayashi%26aufirst%3DM.%26aulast%3DOkabe%26aufirst%3DK.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DOkumura%26aufirst%3DM.%26aulast%3DFukui%26aufirst%3DR.%26aulast%3DFukushima%26aufirst%3DN.%26aulast%3DTsujiuchi%26aufirst%3DT.%26atitle%3DDifferential%2520function%2520of%2520lysophosphatidic%2520acid%2520receptors%2520in%2520cell%2520proliferation%2520and%2520migration%2520of%2520neuroblastoma%2520cells%26jtitle%3DCancer%2520Lett.%26date%3D2012%26volume%3D316%26issue%3D1%26spage%3D91%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Ramirez, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagood, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanders, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramirez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becerril, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segura, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrera, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pardo, A.</span><span> </span><span class="NLM_article-title">Absence of Thy-1 results in TGF-beta induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts</span> <span class="citation_source-journal">Lab. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1206</span><span class="NLM_x">–</span> <span class="NLM_lpage">1218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=1206-1218&issue=8&author=G.+Ramirezauthor=J.+S.+Hagoodauthor=Y.+Sandersauthor=R.+Ramirezauthor=C.+Becerrilauthor=L.+Seguraauthor=L.+Barreraauthor=M.+Selmanauthor=A.+Pardo&title=Absence+of+Thy-1+results+in+TGF-beta+induced+MMP-9+expression+and+confers+a+profibrotic+phenotype+to+human+lung+fibroblasts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRamirez%26aufirst%3DG.%26aulast%3DHagood%26aufirst%3DJ.%2BS.%26aulast%3DSanders%26aufirst%3DY.%26aulast%3DRamirez%26aufirst%3DR.%26aulast%3DBecerril%26aufirst%3DC.%26aulast%3DSegura%26aufirst%3DL.%26aulast%3DBarrera%26aufirst%3DL.%26aulast%3DSelman%26aufirst%3DM.%26aulast%3DPardo%26aufirst%3DA.%26atitle%3DAbsence%2520of%2520Thy-1%2520results%2520in%2520TGF-beta%2520induced%2520MMP-9%2520expression%2520and%2520confers%2520a%2520profibrotic%2520phenotype%2520to%2520human%2520lung%2520fibroblasts%26jtitle%3DLab.%2520Invest.%26date%3D2011%26volume%3D91%26issue%3D8%26spage%3D1206%26epage%3D1218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Funke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tager, A. M.</span><span> </span><span class="NLM_article-title">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span> <span class="citation_source-journal">Am. J. Respir. Cell Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">355</span><span class="NLM_x">–</span> <span class="NLM_lpage">364</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm301022v&amp;key=10.1165%2Frcmb.2010-0155OC" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm301022v&amp;key=22021336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm301022v&amp;key=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2012&pages=355-364&issue=3&author=M.+Funkeauthor=Z.+Zhaoauthor=Y.+Xuauthor=J.+Chunauthor=A.+M.+Tager&title=The+lysophosphatidic+acid+receptor+LPA1+promotes+epithelial+cell+apoptosis+after+lung+injury"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury</span></div><div class="casAuthors">Funke, Manuela; Zhao, Zhenwen; Xu, Yan; Chun, Jerold; Tager, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Respiratory Cell and Molecular Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">355-364</span>CODEN:
                <span class="NLM_cas:coden">AJRBEL</span>;
        ISSN:<span class="NLM_cas:issn">1044-1549</span>.
    
            (<span class="NLM_cas:orgname">American Thoracic Society</span>)
        </div><div class="casAbstract">Increased epithelial cell apoptosis in response to lung injury has been implicated in the development of idiopathic pulmonary fibrosis (IPF), but the mol. pathways promoting epithelial cell apoptosis in this disease have yet to be fully identified.  Lysophosphatidic acid (LPA), which we have previously demonstrated to mediate bleomycin lung injury-induced fibroblast recruitment and vascular leak in mice and fibroblast recruitment in patients with IPF, is an important regulator of survival and apoptosis in many cell types.  We now show that LPA signaling through its receptor LPA1 promotes epithelial cell apoptosis induced by bleomycin injury.  The no. of apoptotic cells present in the alveolar and bronchial epithelia of LPA1-deficient mice was significantly reduced compared with wild-type mice at Day 3 after bleomycin challenge, as was lung caspase-3 activity.  Consistent with these in vivo results, we found that LPA signaling through LPA1 induced apoptosis in normal human bronchial epithelial cells in culture.  LPA-LPA1 signaling appeared to specifically mediate anoikis, the apoptosis of anchorage-dependent cells induced by their detachment.  Similarly, LPA neg. regulated attachment of R3/1 rat alveolar epithelial cell line cells.  In contrast, LPA signaling through LPA1 promoted the resistance of lung fibroblasts to apoptosis, which has also been implicated in IPF.  The ability of LPA-LPA1 signaling to promote epithelial cell apoptosis and fibroblast resistance to apoptosis may therefore contribute to the capacity of this signaling pathway to regulate the development of pulmonary fibrosis after lung injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_okuklehf2bVg90H21EOLACvtfcHk0lguuyNQuTa2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xks1ertbw%253D&md5=ae97ec6b86cb2006ed7c3ce6b7d35c0b</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1165%2Frcmb.2010-0155OC&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1165%252Frcmb.2010-0155OC%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DM.%26aulast%3DZhao%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChun%26aufirst%3DJ.%26aulast%3DTager%26aufirst%3DA.%2BM.%26atitle%3DThe%2520lysophosphatidic%2520acid%2520receptor%2520LPA1%2520promotes%2520epithelial%2520cell%2520apoptosis%2520after%2520lung%2520injury%26jtitle%3DAm.%2520J.%2520Respir.%2520Cell%2520Mol.%2520Biol.%26date%3D2012%26volume%3D46%26issue%3D3%26spage%3D355%26epage%3D364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asari, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chiba, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kataba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohsumi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohmuta, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijichi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwayama, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuchi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoji, M.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of isoxazole derivatives as lysophosphatidic acid (LPA) antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">3736</span><span class="NLM_x">–</span> <span class="NLM_lpage">3740</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=3736-3740&issue=13&author=T.+Yamamotoauthor=K.+Fujitaauthor=S.+Asariauthor=A.+Chibaauthor=Y.+Katabaauthor=K.+Ohsumiauthor=N.+Ohmutaauthor=Y.+Iidaauthor=C.+Ijichiauthor=S.+Iwayamaauthor=N.+Fukuchiauthor=M.+Shoji&title=Synthesis+and+evaluation+of+isoxazole+derivatives+as+lysophosphatidic+acid+%28LPA%29+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DFujita%26aufirst%3DK.%26aulast%3DAsari%26aufirst%3DS.%26aulast%3DChiba%26aufirst%3DA.%26aulast%3DKataba%26aufirst%3DY.%26aulast%3DOhsumi%26aufirst%3DK.%26aulast%3DOhmuta%26aufirst%3DN.%26aulast%3DIida%26aufirst%3DY.%26aulast%3DIjichi%26aufirst%3DC.%26aulast%3DIwayama%26aufirst%3DS.%26aulast%3DFukuchi%26aufirst%3DN.%26aulast%3DShoji%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520isoxazole%2520derivatives%2520as%2520lysophosphatidic%2520acid%2520%2528LPA%2529%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D13%26spage%3D3736%26epage%3D3740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31a"><span><span class="NLM_contrib-group">Hutchinson, J. H.; Seiders, T. J.; Wang, B.</span><span> </span><span class="NLM_article-title">Compounds as Lysophosphatidic Acid Receptor Antagonists</span>. Patent application WO2011/017350.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchinson%2C+J.+H.%3B+Seiders%2C+T.+J.%3B+Wang%2C+B.+Compounds+as+Lysophosphatidic+Acid+Receptor+Antagonists.+Patent+application+WO2011%2F017350."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DCompounds%2520as%2520Lysophosphatidic%2520Acid%2520Receptor%2520Antagonists" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutchinson, J. H.; DeArmond, I. M.; Seiders, T. J.</span><span> </span><span class="NLM_article-title">Lysophosphatidic Acid Receptor Antagonist for the Treatment of Dermal Conditions</span>. Patent application WO2011/159635.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchinson%2C+J.+H.%3B+DeArmond%2C+I.+M.%3B+Seiders%2C+T.+J.+Lysophosphatidic+Acid+Receptor+Antagonist+for+the+Treatment+of+Dermal+Conditions.+Patent+application+WO2011%2F159635."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHutchinson%26aufirst%3DJ.%2BH.%26atitle%3DLysophosphatidic%2520Acid%2520Receptor%2520Antagonist%2520for%2520the%2520Treatment%2520of%2520Dermal%2520Conditions" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit31c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Brittain, J. E.; Seiders, T. J.; Hutchinson, J. H.; King, C. D.; Rosso, V. W.</span> Patent application WO2012/078805.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Brittain%2C+J.+E.%3B+Seiders%2C+T.+J.%3B+Hutchinson%2C+J.+H.%3B+King%2C+C.+D.%3B+Rosso%2C+V.+W.+Patent+application+WO2012%2F078805."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBrittain%26aufirst%3DJ.%2BE." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm301022v&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-17%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm301022v" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm301022v" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aae0fd9243cee","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
